,Open,High,Low,Close,Adjusted Close,Volume,Dividend Amount,Split Coefficient,Symbol,AssetType,Name,Description,CIK,Exchange,Currency,Country,Sector,Industry,Address,OfficialSite,FiscalYearEnd,LatestQuarter,MarketCapitalization,EBITDA,PERatio,PEGRatio,BookValue,DividendPerShare,DividendYield,EPS,RevenuePerShareTTM,ProfitMargin,OperatingMarginTTM,ReturnOnAssetsTTM,ReturnOnEquityTTM,RevenueTTM,GrossProfitTTM,DilutedEPSTTM,QuarterlyEarningsGrowthYOY,QuarterlyRevenueGrowthYOY,AnalystTargetPrice,AnalystRatingStrongBuy,AnalystRatingBuy,AnalystRatingHold,AnalystRatingSell,AnalystRatingStrongSell,TrailingPE,ForwardPE,PriceToSalesRatioTTM,PriceToBookRatio,EVToRevenue,EVToEBITDA,Beta,52WeekHigh,52WeekLow,50DayMovingAverage,200DayMovingAverage,SharesOutstanding,SharesFloat,PercentInsiders,PercentInstitutions,DividendDate,ExDividendDate
2010-01-04,4.170000,4.170000,3.990000,4.040000,4.040000,501900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-05,4.060000,4.100000,3.940000,3.960000,3.960000,149900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-06,3.970000,4.050000,3.810000,3.830000,3.830000,82000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-07,3.850000,3.900000,3.830000,3.850000,3.850000,96300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-08,3.850000,3.880000,3.780000,3.790000,3.790000,65400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-11,3.810000,3.830000,3.780000,3.830000,3.830000,133500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-12,3.800000,3.830000,3.710000,3.710000,3.710000,83800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-13,3.730000,3.730000,3.640000,3.650000,3.650000,96800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-14,3.650000,3.690000,3.620000,3.650000,3.650000,44500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-15,3.680000,3.720000,3.550000,3.550000,3.550000,123500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-19,3.570000,3.610000,3.560000,3.610000,3.610000,122000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-20,3.600000,3.600000,3.520000,3.540000,3.540000,117100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-21,3.540000,3.650000,3.500000,3.590000,3.590000,163100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-22,3.580000,3.630000,3.570000,3.610000,3.610000,219100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-25,3.620000,3.650000,3.550000,3.620000,3.620000,398200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-26,3.610000,3.640000,3.400000,3.410000,3.410000,79400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-27,3.410000,3.550000,3.400000,3.540000,3.540000,72800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-28,3.660000,3.740000,3.500000,3.580000,3.580000,108600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-01-29,3.590000,3.650000,3.430000,3.450000,3.450000,200400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-01,3.470000,3.500000,3.460000,3.500000,3.500000,112700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-02,3.510000,3.539900,3.420000,3.430000,3.430000,152500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-03,3.440000,3.500000,3.420000,3.430000,3.430000,129700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-04,3.430000,3.460000,3.370000,3.380000,3.380000,285700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-05,3.400000,3.510000,3.370000,3.500000,3.500000,114700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-08,3.500000,3.500000,3.350000,3.350000,3.350000,114200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-09,3.390000,3.500000,3.370000,3.400000,3.400000,61800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-10,3.390000,3.420000,3.340000,3.390000,3.390000,102400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-11,3.380000,3.500000,3.340000,3.500000,3.500000,120200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-12,3.500000,3.540000,3.400000,3.500000,3.500000,130200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-16,3.530000,3.670000,3.520000,3.650000,3.650000,54200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-17,3.650000,3.650000,3.500000,3.520000,3.520000,54300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-18,3.510000,3.540000,3.430000,3.490000,3.490000,94300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-19,3.470000,3.470000,3.390000,3.400000,3.400000,98000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-22,3.420000,3.450000,3.360000,3.390000,3.390000,44500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-23,3.400000,3.460000,3.380000,3.390000,3.390000,76700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-24,3.400000,3.440000,3.350000,3.370000,3.370000,34900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-25,3.360000,3.380000,3.340000,3.350000,3.350000,43100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-02-26,3.350000,3.430000,3.350000,3.370000,3.370000,149800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-01,3.430000,3.580000,3.410000,3.580000,3.580000,84000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-02,3.570000,3.650000,3.540000,3.650000,3.650000,86000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-03,3.640000,3.740000,3.610000,3.730000,3.730000,53700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-04,3.730000,3.750000,3.650000,3.720000,3.720000,45000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-05,3.720000,3.740000,3.670000,3.740000,3.740000,33500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-08,3.720000,3.740000,3.600000,3.740000,3.740000,64700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-09,3.720000,3.799900,3.690000,3.770000,3.770000,44500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-10,3.760000,3.770000,3.690000,3.770000,3.770000,58500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-11,3.730000,3.780000,3.700000,3.780000,3.780000,40600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-12,3.780000,3.780000,3.670000,3.720000,3.720000,68600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-15,3.730000,3.780000,3.600000,3.640000,3.640000,60700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-16,3.640000,3.740000,3.630000,3.740000,3.740000,32000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-17,3.710000,3.770100,3.700000,3.710000,3.710000,55600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-18,3.640000,3.730000,3.640000,3.710000,3.710000,27600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-19,3.730000,3.750000,3.630000,3.750000,3.750000,119500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-22,3.670000,3.760000,3.670000,3.740000,3.740000,32300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-23,3.730000,3.800000,3.680000,3.790000,3.790000,42800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-24,3.770000,3.790000,3.680000,3.690000,3.690000,50800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-25,3.690000,3.760000,3.610000,3.620000,3.620000,42700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-26,3.620000,3.660000,3.570000,3.600000,3.600000,46100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-29,3.600000,3.620000,3.540000,3.620000,3.620000,56400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-30,3.610000,3.650000,3.550000,3.570000,3.570000,41300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-03-31,3.550000,4.060000,3.550000,4.060000,4.060000,177600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-01,4.000000,4.020000,3.670000,3.710000,3.710000,124600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-05,3.710000,3.760000,3.590000,3.680000,3.680000,61100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-06,3.660000,3.700000,3.600000,3.620000,3.620000,31100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-07,3.600000,3.620000,3.560000,3.610000,3.610000,51100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-08,3.590000,3.620000,3.510000,3.520000,3.520000,82400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-09,3.520000,3.670000,3.520000,3.590000,3.590000,34200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-12,3.580000,3.600000,3.520000,3.540000,3.540000,38200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-13,3.530000,3.670000,3.520000,3.610000,3.610000,45500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-14,3.620000,3.640000,3.600000,3.640000,3.640000,50500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-15,3.650000,3.940000,3.630000,3.920000,3.920000,97200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-16,3.900000,3.900000,3.590000,3.660000,3.660000,137000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-19,3.640000,3.770000,3.640000,3.720000,3.720000,40100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-20,3.640000,3.760000,3.640000,3.760000,3.760000,65900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-21,3.750000,3.780000,3.640000,3.750000,3.750000,45000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-22,3.720000,3.720000,3.650000,3.700000,3.700000,41500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-23,3.690000,3.690000,3.580000,3.610000,3.610000,65200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-26,3.600000,3.660000,3.580000,3.600000,3.600000,27400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-27,3.590000,3.610000,3.560000,3.560000,3.560000,36300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-28,3.580000,3.600000,3.570000,3.590000,3.590000,24600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-29,3.620000,3.640000,3.560000,3.600000,3.600000,39000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-04-30,3.620000,3.700000,3.490000,3.510000,3.510000,102900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-03,3.520000,3.530000,3.460000,3.530000,3.530000,72200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-04,3.490000,3.530000,3.430000,3.500000,3.500000,81100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-05,3.480000,3.530000,3.410000,3.430000,3.430000,63600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-06,3.420000,3.490000,3.270000,3.270000,3.270000,102800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-07,3.260000,3.310000,3.150000,3.150000,3.150000,140600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-10,3.200000,3.320000,3.200000,3.300000,3.300000,152000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-11,3.270000,3.300000,3.190000,3.280000,3.280000,106700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-12,3.280000,3.390000,3.200000,3.380000,3.380000,73900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-13,3.360000,3.460000,3.260000,3.360000,3.360000,66800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-14,3.330000,3.400000,3.220000,3.290000,3.290000,72600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-17,3.340000,3.480000,3.210000,3.430000,3.430000,144400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-18,3.450000,3.600000,3.330000,3.500000,3.500000,177400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-19,3.480000,3.600000,3.300000,3.360000,3.360000,94300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-20,3.330000,3.440000,3.150000,3.200000,3.200000,131100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-21,3.100000,3.250000,3.100000,3.210000,3.210000,107100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-24,3.210000,3.700000,3.160000,3.190000,3.190000,381900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-25,3.120000,3.260000,3.000000,3.220000,3.220000,92200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-26,3.230000,3.360000,3.190000,3.190000,3.190000,91900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-27,3.500000,3.510000,3.300000,3.500000,3.500000,121100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-05-28,3.480000,3.660000,3.370000,3.550000,3.550000,114100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-01,3.540000,3.580000,3.300000,3.330000,3.330000,82200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-02,3.450000,3.550000,3.390000,3.530000,3.530000,46800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-03,3.510000,3.600000,3.240000,3.450000,3.450000,42800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-04,3.370000,3.410000,3.300000,3.310000,3.310000,67700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-07,3.330000,3.380000,3.210000,3.250000,3.250000,84800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-08,3.250000,3.250000,3.200000,3.215000,3.215000,80700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-09,3.260000,3.310000,3.200000,3.270000,3.270000,53300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-10,3.320000,3.420000,3.270000,3.360000,3.360000,108600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-11,3.300000,3.370000,3.260000,3.360000,3.360000,29500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-14,3.390000,3.400000,3.300000,3.330000,3.330000,22900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-15,3.360000,3.460000,3.300000,3.450000,3.450000,63900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-16,3.440000,3.500000,3.350000,3.360000,3.360000,54300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-17,3.360000,3.393000,3.300000,3.340000,3.340000,51200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-18,3.350000,3.350000,3.300000,3.300000,3.300000,131900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-21,3.330000,3.390000,3.270000,3.280000,3.280000,74100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-22,3.300000,3.370000,3.210000,3.230000,3.230000,48800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-23,3.220000,3.270000,3.220000,3.240000,3.240000,32400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-24,3.210000,3.240000,3.100000,3.150000,3.150000,172000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-25,3.200000,3.360000,3.050000,3.130000,3.130000,4585200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-28,3.110000,3.370000,3.110000,3.210000,3.210000,111100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-29,3.150000,3.190000,3.130000,3.140000,3.140000,94900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-06-30,3.150000,3.230000,3.150000,3.210000,3.210000,38700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-01,3.200000,3.230000,3.160000,3.200000,3.200000,50500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-02,3.220000,3.250000,3.110000,3.220000,3.220000,26900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-06,3.220000,3.250000,3.150000,3.220000,3.220000,75300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-07,3.200000,3.200100,3.140000,3.150000,3.150000,98700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-08,3.209900,3.210000,3.140000,3.170000,3.170000,34000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-09,3.160000,3.310000,3.120000,3.290000,3.290000,41700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-12,3.240000,3.300000,3.120000,3.240000,3.240000,90000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-13,3.330000,3.470000,3.320000,3.470000,3.470000,43500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-14,3.410000,3.460000,3.300000,3.390000,3.390000,15400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-15,3.360000,3.400000,3.220000,3.330000,3.330000,51500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-16,3.320000,3.320000,3.210000,3.250000,3.250000,19700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-19,3.250000,3.390000,3.240000,3.260000,3.260000,31800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-20,3.260000,3.380000,3.260000,3.380000,3.380000,30300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-21,3.330000,3.440000,3.170000,3.240000,3.240000,112200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-22,3.230000,3.320000,3.230000,3.310000,3.310000,21700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-23,3.270000,3.290000,3.220000,3.280000,3.280000,67300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-26,3.260000,3.320000,3.260000,3.300000,3.300000,23300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-27,3.300000,3.320000,3.160000,3.160000,3.160000,111100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-28,3.160000,3.260000,3.160000,3.250000,3.250000,46400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-29,3.200000,3.290000,3.190000,3.240000,3.240000,23800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-07-30,3.200000,3.300000,3.200000,3.230000,3.230000,50400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-02,3.240000,3.460000,3.240000,3.430000,3.430000,43900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-03,3.380000,3.480000,3.250000,3.460000,3.460000,44700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-04,3.470000,3.580000,3.420000,3.540000,3.540000,34900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-05,3.500000,3.620000,3.500000,3.520000,3.520000,35300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-06,3.570000,3.570000,3.380000,3.480000,3.480000,18400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-09,3.480000,3.550000,3.340000,3.380000,3.380000,19600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-10,3.370000,3.510000,3.330000,3.440000,3.440000,11400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-11,3.340000,3.520000,3.260000,3.350000,3.350000,25600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-12,3.330000,3.370000,3.200000,3.350000,3.350000,79300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-13,3.330000,3.330000,3.220000,3.290000,3.290000,9800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-16,3.290000,3.440000,3.290000,3.410000,3.410000,20900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-17,3.330000,3.460000,3.320000,3.370000,3.370000,11300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-18,3.360000,3.450000,3.293000,3.395000,3.395000,17700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-19,3.410000,3.410000,3.290000,3.360000,3.360000,7200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-20,3.440000,3.500000,3.360000,3.450000,3.450000,14400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-23,3.450000,3.479000,3.390000,3.440000,3.440000,23700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-24,3.420000,3.550000,3.280000,3.290000,3.290000,21000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-25,3.280000,3.510000,3.260000,3.510000,3.510000,93000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-26,3.380000,3.410000,3.280000,3.400000,3.400000,27200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-27,3.450000,3.480000,3.390000,3.390000,3.390000,43100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-30,3.350000,3.370000,3.290000,3.290000,3.290000,8100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-08-31,3.330000,3.390000,3.290000,3.390000,3.390000,12600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-01,3.350000,3.400000,3.300000,3.384000,3.384000,22400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-02,3.350000,3.560000,3.290000,3.560000,3.560000,80600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-03,3.510000,3.550000,3.340000,3.360000,3.360000,18700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-07,3.380000,3.389900,3.310000,3.310000,3.310000,8900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-08,3.400000,3.500000,3.400000,3.490000,3.490000,29800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-09,3.440000,3.500000,3.370000,3.450000,3.450000,37100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-10,3.420000,3.520000,3.380000,3.460000,3.460000,29300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-13,3.450000,3.600000,3.410000,3.420000,3.420000,33400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-14,3.450000,3.450000,3.240000,3.340000,3.340000,50100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-15,3.350000,3.380000,3.280000,3.290000,3.290000,14600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-16,3.320000,3.320000,3.280000,3.300000,3.300000,5500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-17,3.300000,3.400000,3.290000,3.400000,3.400000,37600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-20,3.420000,3.450000,3.270000,3.410000,3.410000,40500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-21,3.400000,3.449000,3.340000,3.410000,3.410000,9900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-22,3.400000,3.400000,3.310000,3.310000,3.310000,21300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-23,3.326000,3.350000,3.290000,3.320000,3.320000,15100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-24,3.360000,3.370000,3.300000,3.310000,3.310000,9800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-27,3.330000,3.400000,3.295000,3.310000,3.310000,10000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-28,3.300000,3.316500,3.270000,3.310000,3.310000,23400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-29,3.310000,3.400000,3.260000,3.310000,3.310000,31400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-09-30,3.370000,3.440000,3.340000,3.380000,3.380000,70500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-01,3.380000,3.430000,3.330000,3.340000,3.340000,31200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-04,3.290000,3.350000,3.250000,3.350000,3.350000,55700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-05,3.370000,3.419800,3.350000,3.370000,3.370000,11200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-06,3.340000,3.380000,3.290000,3.350000,3.350000,10100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-07,3.340000,3.350000,3.290000,3.290000,3.290000,19800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-08,3.290000,3.430000,3.290000,3.360000,3.360000,11900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-11,3.330000,3.360000,3.310000,3.330000,3.330000,3500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-12,3.310000,3.400000,3.310000,3.380000,3.380000,7300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-13,3.361900,3.400000,3.360000,3.380000,3.380000,14200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-14,3.380000,3.390000,3.340000,3.350000,3.350000,6200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-15,3.360000,3.420000,3.320000,3.400000,3.400000,16800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-18,3.390000,3.390000,3.330000,3.360000,3.360000,14500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-19,3.330000,3.420000,3.211900,3.420000,3.420000,17700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-20,3.400000,3.550000,3.370000,3.530000,3.530000,62100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-21,3.500000,3.590000,3.360000,3.440000,3.440000,16400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-22,3.460800,3.620000,3.420000,3.560000,3.560000,25700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-25,3.590000,3.790000,3.590000,3.740400,3.740400,52400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-26,3.750000,3.910000,3.720100,3.900000,3.900000,143700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-27,3.810000,3.902000,3.810000,3.900000,3.900000,17700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-28,3.940000,3.940000,3.830000,3.870000,3.870000,13600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-10-29,3.830000,3.900000,3.790000,3.880000,3.880000,38000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-01,3.900000,3.900000,3.760000,3.870000,3.870000,19700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-02,3.858800,3.880000,3.750000,3.820000,3.820000,31300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-03,3.820000,3.820000,3.670000,3.670000,3.670000,10100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-04,3.680000,3.680000,3.440000,3.580000,3.580000,68700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-05,3.540000,3.710000,3.530000,3.710000,3.710000,23700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-08,3.700000,3.750000,3.520000,3.620000,3.620000,38300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-09,3.610000,3.610000,3.450000,3.520000,3.520000,48100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-10,3.575000,3.810000,3.540000,3.780000,3.780000,30200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-11,3.730000,3.770000,3.650000,3.770000,3.770000,14400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-12,3.660000,3.840000,3.660000,3.840000,3.840000,37700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-15,3.829900,3.980000,3.790000,3.980000,3.980000,45600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-16,3.980000,3.980000,3.840000,3.850000,3.850000,35000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-17,3.880000,3.920000,3.620000,3.710000,3.710000,43600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-18,3.690000,3.849400,3.690000,3.790000,3.790000,26400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-19,3.830000,3.920000,3.760000,3.920000,3.920000,18400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-22,3.900000,3.980000,3.860300,3.940000,3.940000,37700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-23,3.980000,4.000000,3.850000,3.959900,3.959900,51300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-24,3.960000,3.960000,3.610000,3.720000,3.720000,95700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-26,3.500000,3.810000,3.500000,3.800000,3.800000,55500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-29,3.800000,3.800000,3.660000,3.700000,3.700000,21900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-11-30,3.740000,3.740000,3.650000,3.720000,3.720000,23600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-01,3.830000,3.860000,3.690000,3.799900,3.799900,34700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-02,3.760000,3.930000,3.760000,3.849900,3.849900,39800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-03,3.850000,3.989900,3.830000,3.960000,3.960000,62200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-06,3.900000,4.060000,3.850000,4.000000,4.000000,89800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-07,4.070000,4.070000,3.890000,3.900000,3.900000,51200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-08,3.940000,3.940000,3.830000,3.880000,3.880000,33000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-09,3.900000,4.000000,3.880000,3.940000,3.940000,51600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-10,3.990000,4.040000,3.920000,3.930000,3.930000,54800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-13,3.880000,4.020000,3.880000,3.920000,3.920000,36200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-14,3.900000,4.010000,3.900000,3.970000,3.970000,42600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-15,4.040000,4.040000,3.880000,3.960000,3.960000,33400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-16,3.960000,4.020000,3.920000,3.990000,3.990000,46900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-17,3.950000,4.020000,3.950000,3.950000,3.950000,35000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-20,4.000000,4.050000,3.900000,4.020000,4.020000,53200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-21,4.060000,4.150000,3.990000,4.108000,4.108000,91300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-22,4.140000,4.340000,4.090600,4.210000,4.210000,155000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-23,4.300000,4.400000,4.250000,4.280000,4.280000,58800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-27,4.350000,4.750000,4.319900,4.670000,4.670000,189700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-28,4.740000,4.790000,4.590000,4.750000,4.750000,103200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-29,4.780000,4.850000,4.580000,4.650000,4.650000,55300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-30,4.730000,4.740000,4.650000,4.727000,4.727000,67400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2010-12-31,4.750000,4.750000,4.630000,4.690000,4.690000,66800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-03,4.700000,4.720000,4.350000,4.520000,4.520000,195400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-04,4.470000,4.479400,4.280000,4.400000,4.400000,98200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-05,4.370000,4.480000,4.370000,4.450000,4.450000,46700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-06,4.450000,4.560000,4.370000,4.470000,4.470000,43100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-07,4.520000,4.549900,4.370000,4.370000,4.370000,79500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-10,4.380000,4.460000,4.370000,4.440000,4.440000,27600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-11,4.490000,4.530000,4.380800,4.500100,4.500100,43400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-12,4.560000,4.700000,4.420000,4.620000,4.620000,73000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-13,4.670000,4.670000,4.530000,4.650000,4.650000,33800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-14,4.690000,4.690000,4.470000,4.520000,4.520000,60800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-18,4.450000,4.740000,4.430100,4.740000,4.740000,88500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-19,4.680000,4.860000,4.650000,4.780000,4.780000,71500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-20,5.000000,5.080000,4.870000,5.044800,5.044800,342900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-21,5.050000,5.140000,4.782000,4.800000,4.800000,136700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-24,4.960000,5.220000,4.780000,5.160000,5.160000,128200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-25,5.210000,5.350000,5.086000,5.210000,5.210000,123600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-26,5.260000,5.320000,5.160000,5.245000,5.245000,79200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-27,5.250000,5.330000,5.210200,5.250000,5.250000,57600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-28,5.280000,5.280000,5.080000,5.100000,5.100000,48200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-01-31,5.170000,5.200000,5.040000,5.170000,5.170000,48000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-01,5.200000,5.280000,5.090000,5.200000,5.200000,73400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-02,5.160000,5.280000,5.160000,5.220000,5.220000,55500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-03,5.220000,5.280000,5.180000,5.280000,5.280000,35000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-04,5.300000,5.340000,5.180000,5.340000,5.340000,49600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-07,5.360000,5.360000,5.180600,5.210000,5.210000,38900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-08,5.240000,5.240000,5.080000,5.160000,5.160000,104800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-09,5.220000,5.310000,4.860000,5.050000,5.050000,118000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-10,4.990000,4.990000,4.800000,4.970000,4.970000,52900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-11,4.910000,4.910000,4.700000,4.760000,4.760000,68400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-14,4.610000,4.900000,4.610000,4.880000,4.880000,49400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-15,4.840000,4.930000,4.830100,4.850000,4.850000,28900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-16,4.820000,4.870000,4.750000,4.780000,4.780000,22500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-17,4.790000,4.800000,4.640000,4.790000,4.790000,43200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-18,4.790000,4.790000,4.700000,4.780000,4.780000,37700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-22,4.720000,4.780000,4.680100,4.710000,4.710000,31800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-23,4.740000,4.740000,4.650000,4.685000,4.685000,23700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-24,4.660000,4.900000,4.660000,4.850000,4.850000,32100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-25,4.850000,4.900000,4.760000,4.840000,4.840000,29700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-02-28,4.840000,4.920000,4.770000,4.820000,4.820000,26600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-01,4.870000,4.900000,4.760000,4.900000,4.900000,23300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-02,4.850000,4.900000,4.770000,4.890000,4.890000,25400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-03,4.852800,4.870000,4.800000,4.850000,4.850000,17800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-04,4.880000,4.910000,4.760000,4.910000,4.910000,33600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-07,3.910000,3.930000,3.400100,3.540000,3.540000,1430200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-08,3.540000,3.730000,3.440000,3.450000,3.450000,649600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-09,3.440000,3.510000,3.350000,3.360000,3.360000,308400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-10,3.380000,3.520000,3.310000,3.494800,3.494800,135800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-11,3.500000,3.690000,3.500000,3.650000,3.650000,147000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-14,3.680000,4.070000,3.330000,3.640000,3.640000,1089800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-15,3.500000,3.700000,3.500000,3.560000,3.560000,222300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-16,3.630000,3.630000,3.530000,3.530000,3.530000,114900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-17,3.550000,3.850000,3.550000,3.710000,3.710000,1186100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-18,3.770000,3.910000,3.640000,3.680000,3.680000,94700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-21,3.740000,3.790000,3.710000,3.750000,3.750000,64700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-22,3.780000,3.840000,3.780000,3.800000,3.800000,79100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-23,3.810000,3.910000,3.810000,3.870000,3.870000,54100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-24,3.910000,3.950000,3.850000,3.910000,3.910000,51300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-25,3.940000,3.940000,3.700000,3.740000,3.740000,185800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-28,3.730000,3.801600,3.640000,3.710000,3.710000,112900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-29,3.690000,3.780000,3.690000,3.710000,3.710000,253400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-30,3.710000,3.760000,3.669000,3.700000,3.700000,50400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-03-31,3.670000,3.750000,3.640100,3.740000,3.740000,52700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-01,3.650000,3.880000,3.650000,3.880000,3.880000,71600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-04,3.880000,3.890000,3.740000,3.890000,3.890000,63500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-05,3.850000,3.890000,3.777400,3.890000,3.890000,37200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-06,3.880000,3.900000,3.780000,3.900000,3.900000,50100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-07,3.880000,4.100000,3.800000,3.980000,3.980000,1022000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-08,4.020000,4.200000,4.000100,4.060000,4.060000,86900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-11,4.080000,4.080000,3.980000,4.010000,4.010000,45300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-12,4.000000,4.150000,4.000000,4.010000,4.010000,58800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-13,4.060000,4.060000,3.950000,4.000000,4.000000,38500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-14,4.020000,4.140000,3.900000,4.120000,4.120000,60400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-15,4.160000,4.190000,4.060000,4.100000,4.100000,50200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-18,4.040000,4.050000,3.980000,4.020000,4.020000,26900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-19,4.020000,4.140000,4.000000,4.030000,4.030000,51800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-20,4.100000,4.100000,4.011000,4.070000,4.070000,20600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-21,3.950000,4.080000,3.950000,3.990000,3.990000,155500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-25,4.000000,4.070000,3.950000,3.960000,3.960000,44800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-26,3.960400,3.990000,3.810000,3.820000,3.820000,97900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-27,3.810000,4.010000,3.810000,4.010000,4.010000,67000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-28,3.970000,4.060000,3.970000,4.030000,4.030000,12000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-04-29,4.000000,4.040000,3.910000,4.000000,4.000000,26000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-02,3.970000,4.050000,3.930000,4.050000,4.050000,77000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-03,4.000000,4.030000,3.950000,4.020000,4.020000,34000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-04,3.990000,4.030000,3.940000,3.990000,3.990000,20900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-05,3.960000,4.000000,3.840100,4.000000,4.000000,88700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-06,4.000000,4.040000,3.930000,4.030000,4.030000,27000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-09,3.950000,4.000000,3.860000,3.880000,3.880000,37000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-10,3.850000,3.920000,3.660000,3.830000,3.830000,132200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-11,3.800000,3.840000,3.790000,3.810000,3.810000,6400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-12,3.742800,3.910000,3.720000,3.880000,3.880000,21400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-13,3.880000,3.930000,3.770000,3.830000,3.830000,20000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-16,3.772000,3.830000,3.730000,3.770000,3.770000,20100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-17,3.740000,3.760000,3.670000,3.700000,3.700000,30400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-18,3.670000,3.720000,3.650000,3.690000,3.690000,47100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-19,3.840000,3.870000,3.720000,3.790000,3.790000,81900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-20,3.780000,3.830000,3.710000,3.770000,3.770000,40500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-23,3.770000,3.800000,3.671000,3.780000,3.780000,36900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-24,3.780000,3.780000,3.710000,3.710000,3.710000,12500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-25,3.710000,3.760000,3.684500,3.720000,3.720000,10400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-26,3.690000,3.739900,3.671000,3.710000,3.710000,6500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-27,3.750000,3.920000,3.680800,3.830000,3.830000,35700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-05-31,3.870000,3.930000,3.710000,3.810000,3.810000,76700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-01,3.790000,3.900000,3.770000,3.780000,3.780000,41000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-02,3.770000,3.820000,3.680000,3.800000,3.800000,32900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-03,3.740000,3.800000,3.740000,3.790000,3.790000,16000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-06,3.780000,3.790000,3.720000,3.720000,3.720000,19400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-07,3.704000,3.750000,3.660000,3.710000,3.710000,35800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-08,3.670000,3.800000,3.660000,3.755000,3.755000,49300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-09,3.740000,3.740000,3.600000,3.660000,3.660000,58900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-10,3.690000,3.700000,3.610000,3.660000,3.660000,24700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-13,3.670000,3.890000,3.530000,3.570000,3.570000,94900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-14,3.560000,3.620000,3.470000,3.550000,3.550000,93100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-15,3.510000,3.650000,3.460000,3.520000,3.520000,90200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-16,3.510000,3.600000,3.500000,3.530000,3.530000,11000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-17,3.540000,3.670000,3.500000,3.560000,3.560000,87500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-20,3.540000,3.570000,3.490000,3.510000,3.510000,48300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-21,3.530000,3.610000,3.480000,3.500000,3.500000,58800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-22,3.500000,3.570000,3.300000,3.390000,3.390000,965200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-23,3.590000,3.700000,3.410000,3.560000,3.560000,184000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-24,3.570000,3.649100,3.520000,3.550000,3.550000,77900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-27,3.540000,3.590000,3.540000,3.580000,3.580000,15200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-28,3.570000,3.630000,3.530000,3.600000,3.600000,30800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-29,3.590000,3.630000,3.590000,3.620000,3.620000,17400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-06-30,3.590000,3.710000,3.590000,3.640000,3.640000,25000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-01,3.630000,3.700000,3.580000,3.600000,3.600000,37900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-05,3.630000,3.670000,3.520000,3.530000,3.530000,50300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-06,3.540000,3.550000,3.500000,3.510000,3.510000,57200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-07,3.509900,3.510000,3.430000,3.500000,3.500000,73400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-08,3.480000,3.534800,3.470000,3.530000,3.530000,40300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-11,3.530000,3.580000,3.520000,3.560000,3.560000,80300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-12,3.560000,3.630000,3.470000,3.600000,3.600000,104400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-13,3.590000,3.740000,3.550000,3.710000,3.710000,77200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-14,3.720000,3.740000,3.550000,3.710000,3.710000,20000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-15,3.720000,3.740000,3.690000,3.710000,3.710000,19600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-18,3.690000,3.779000,3.680000,3.700000,3.700000,34300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-19,3.710000,3.710000,3.670000,3.680000,3.680000,20100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-20,3.690000,3.700000,3.650000,3.650000,3.650000,5100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-21,3.640000,3.700000,3.640000,3.690000,3.690000,41700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-22,3.665000,3.720000,3.665000,3.700000,3.700000,40100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-25,3.650000,3.760000,3.650000,3.690000,3.690000,30100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-26,3.680000,3.769000,3.680000,3.745000,3.745000,100600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-27,3.760000,3.770000,3.680000,3.720000,3.720000,70800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-28,3.680000,3.727100,3.590000,3.610000,3.610000,32000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-07-29,3.590000,3.590000,3.500000,3.530000,3.530000,21300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-01,3.550000,3.580000,3.452000,3.480000,3.480000,57500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-02,3.480000,3.490000,3.430000,3.430000,3.430000,60000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-03,3.470000,3.470000,3.400000,3.400000,3.400000,36100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-04,3.410000,3.450000,3.370000,3.410000,3.410000,94400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-05,3.350000,3.510000,3.310000,3.510000,3.510000,130600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-08,3.450000,3.450000,3.310000,3.380000,3.380000,76000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-09,3.350000,3.470000,3.260000,3.320000,3.320000,85900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-10,3.320000,3.480000,3.320000,3.450000,3.450000,37700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-11,3.450000,3.480000,3.310000,3.320000,3.320000,110400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-12,3.330000,3.560000,3.330000,3.440000,3.440000,30200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-15,3.450000,3.600000,3.390000,3.500000,3.500000,80300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-16,3.510000,3.510000,3.340000,3.430000,3.430000,32500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-17,3.400000,3.410000,3.340000,3.370000,3.370000,12800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-18,3.350000,3.350000,3.290000,3.310000,3.310000,42200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-19,3.300000,3.360000,3.300000,3.300000,3.300000,15600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-22,3.320000,3.350000,3.290000,3.290000,3.290000,58400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-23,3.290000,3.320000,3.280000,3.300000,3.300000,64700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-24,3.290000,3.350000,3.280000,3.300000,3.300000,38800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-25,3.280000,3.330000,3.270000,3.300000,3.300000,14100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-26,3.290000,3.320000,3.290000,3.315000,3.315000,7900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-29,3.320000,3.320000,3.280000,3.280000,3.280000,14300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-30,3.280000,3.300000,3.280000,3.290000,3.290000,9700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-08-31,3.280100,3.320500,3.270000,3.310000,3.310000,41300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-01,3.270000,3.375000,3.270000,3.360000,3.360000,18300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-02,3.350000,3.360000,3.280000,3.310000,3.310000,14700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-06,3.280000,3.310000,3.270000,3.280000,3.280000,17500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-07,3.290000,3.340000,3.210000,3.240000,3.240000,40600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-08,3.250000,3.330000,3.250000,3.320000,3.320000,55300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-09,3.370000,3.410000,3.300000,3.330000,3.330000,23400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-12,3.260000,3.380000,3.250000,3.250000,3.250000,15400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-13,3.260000,3.360000,3.230000,3.320000,3.320000,15400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-14,3.330000,3.400000,3.330000,3.340000,3.340000,14600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-15,3.310000,3.360100,3.270000,3.280000,3.280000,21700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-16,3.290000,3.300000,3.240000,3.290000,3.290000,35500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-19,3.260000,3.320000,3.260000,3.270000,3.270000,8600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-20,3.260000,3.330000,3.260000,3.320000,3.320000,9800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-21,3.280000,3.360000,3.270000,3.305000,3.305000,10600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-22,3.370000,3.370000,3.220000,3.220000,3.220000,25600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-23,3.220000,3.290000,3.210000,3.240000,3.240000,35800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-26,3.220000,3.290000,3.200000,3.200000,3.200000,30000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-27,3.210000,3.325000,3.200000,3.210000,3.210000,18300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-28,3.210000,3.250000,3.170000,3.220000,3.220000,37700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-29,3.240000,3.270000,3.200000,3.240000,3.240000,8600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-09-30,3.230000,3.270000,3.200000,3.260000,3.260000,52900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-03,3.230000,3.270000,2.920000,3.110000,3.110000,283700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-04,3.110000,3.400000,3.050000,3.220000,3.220000,67700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-05,3.210000,3.270000,3.210000,3.270000,3.270000,8100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-06,3.220800,3.320000,3.180000,3.250000,3.250000,126700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-07,3.220000,3.290000,3.090000,3.140000,3.140000,119500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-10,3.180000,3.190000,2.900000,3.110000,3.110000,707600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-11,3.120000,3.280000,3.120000,3.250000,3.250000,10700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-12,3.190000,3.350000,3.150000,3.160000,3.160000,22700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-13,3.210000,3.230000,3.100000,3.150000,3.150000,16300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-14,3.190000,3.240000,3.120000,3.225000,3.225000,5800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-17,3.190000,3.230000,3.170000,3.230000,3.230000,4400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-18,3.150000,3.220000,3.150000,3.200000,3.200000,5100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-19,3.190000,3.240000,3.190000,3.190000,3.190000,6500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-20,3.190000,3.230000,3.180000,3.180000,3.180000,10400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-21,3.200000,3.240000,3.200000,3.210000,3.210000,4100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-24,3.180000,3.240000,3.180000,3.220000,3.220000,16600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-25,3.200000,3.230000,3.180000,3.210000,3.210000,9400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-26,3.220000,3.220000,3.180000,3.200000,3.200000,15000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-27,3.240000,3.260000,3.180000,3.260000,3.260000,33400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-28,3.510000,3.720000,3.330000,3.390000,3.390000,75000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-10-31,3.350000,3.460000,3.330000,3.430000,3.430000,24600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-01,3.450000,3.450000,3.280000,3.370000,3.370000,46600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-02,3.360000,3.370000,3.230000,3.340000,3.340000,69300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-03,3.350000,3.350000,3.280000,3.300000,3.300000,27700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-04,3.280000,3.400000,3.280000,3.390000,3.390000,27100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-07,3.370000,3.410000,3.300000,3.366000,3.366000,84500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-08,3.350000,3.410000,3.300000,3.350000,3.350000,185700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-09,3.368000,3.370000,3.310000,3.360000,3.360000,8000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-10,3.370000,3.390000,3.300000,3.345000,3.345000,23200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-11,3.360100,3.460000,3.350000,3.380000,3.380000,27300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-14,3.310000,3.360000,3.300000,3.300000,3.300000,10600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-15,3.320000,3.430000,3.320000,3.330000,3.330000,22400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-16,3.310000,3.410000,3.310000,3.350000,3.350000,10600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-17,3.350000,3.400000,3.290000,3.290000,3.290000,31500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-18,3.350000,3.350000,3.290000,3.309600,3.309600,3400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-21,3.300000,3.340000,3.270000,3.270000,3.270000,31100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-22,3.260000,3.320000,3.240000,3.250000,3.250000,20200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-23,3.240000,3.310000,3.230000,3.230000,3.230000,5300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-25,3.240000,3.255000,3.190000,3.255000,3.255000,19600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-28,3.300000,3.350000,3.260000,3.340000,3.340000,79700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-29,3.300000,3.390000,3.210000,3.330000,3.330000,12900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-11-30,3.250000,3.380000,3.240000,3.380000,3.380000,51800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-01,3.340000,3.340000,3.240000,3.320000,3.320000,17900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-02,3.280000,3.330000,3.240000,3.310000,3.310000,12900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-05,3.300000,3.350000,3.260000,3.310000,3.310000,9500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-06,3.250000,3.310000,3.250000,3.270000,3.270000,18700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-07,3.250000,3.332500,3.250000,3.300000,3.300000,5100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-08,3.270000,3.320000,3.240000,3.250000,3.250000,10500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-09,3.250000,3.340000,3.250000,3.300000,3.300000,3900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-12,3.230000,3.280000,3.230000,3.250000,3.250000,6200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-13,3.360000,3.360000,3.230000,3.230000,3.230000,13700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-14,3.220000,3.315000,3.200000,3.315000,3.315000,3500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-15,3.340000,3.340000,3.220000,3.220000,3.220000,21400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-16,3.200000,3.300000,3.190000,3.290000,3.290000,31900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-19,3.280000,3.316000,3.250000,3.300000,3.300000,283600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-20,3.330000,3.340000,3.290000,3.330000,3.330000,8100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-21,3.349300,3.389300,3.349000,3.370000,3.370000,65200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-22,3.350000,3.480000,3.350000,3.470000,3.470000,109500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-23,3.510000,3.510000,3.430000,3.510000,3.510000,12800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-27,3.500000,3.520100,3.470000,3.470000,3.470000,12600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-28,3.470000,3.540000,3.440000,3.500000,3.500000,75400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-29,3.490000,3.550000,3.429000,3.510000,3.510000,27300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2011-12-30,3.510000,3.550000,3.400000,3.470000,3.470000,39200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-03,3.460000,3.579200,3.410000,3.500000,3.500000,10800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-04,3.500000,3.510000,3.420000,3.420000,3.420000,7600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-05,3.401600,3.520000,3.401600,3.455000,3.455000,22000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-06,3.460000,3.500000,3.450000,3.450000,3.450000,1400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-09,3.410000,3.490000,3.400000,3.440000,3.440000,24200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-10,3.430000,3.580000,3.430000,3.550000,3.550000,30100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-11,3.460000,3.579000,3.420000,3.560000,3.560000,6500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-12,3.590000,3.600000,3.530000,3.570000,3.570000,11700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-13,3.590000,3.600000,3.540000,3.550000,3.550000,18700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-17,3.580000,3.599000,3.490000,3.520000,3.520000,2400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-18,3.540000,3.630000,3.535000,3.630000,3.630000,31900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-19,3.640000,3.640000,3.530000,3.555000,3.555000,13000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-20,3.560000,3.619900,3.510000,3.610000,3.610000,10900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-23,3.614000,3.614000,3.546000,3.570000,3.570000,16000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-24,3.520000,3.567500,3.510000,3.510000,3.510000,11900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-25,3.510000,3.910000,3.510000,3.890000,3.890000,381800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-26,3.970000,3.990000,3.880100,3.990000,3.990000,31200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-27,3.950000,3.950200,3.901000,3.940000,3.940000,45800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-30,4.000000,4.040000,3.950100,4.000000,4.000000,45100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-01-31,4.000000,4.010000,3.970100,4.010000,4.010000,20900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-01,4.040000,4.080000,4.000000,4.040000,4.040000,29300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-02,4.058800,4.090000,3.990000,3.990000,3.990000,14800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-03,4.030000,4.150000,3.990700,4.140000,4.140000,46200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-06,4.140000,4.150000,4.030000,4.130000,4.130000,18600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-07,4.190000,4.210000,4.130000,4.200000,4.200000,30800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-08,4.160000,4.200000,4.150000,4.200000,4.200000,20100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-09,4.210000,4.250000,4.180000,4.220000,4.220000,14800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-10,4.225100,4.250000,4.200000,4.210000,4.210000,12100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-13,4.250000,4.250000,4.150000,4.150000,4.150000,24700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-14,4.200000,4.210000,3.760000,4.070000,4.070000,48700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-15,4.010000,4.050400,3.980700,4.040000,4.040000,9500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-16,4.030000,4.130000,4.010100,4.130000,4.130000,16400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-17,4.140000,4.300000,4.130000,4.210000,4.210000,37600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-21,4.250000,4.350000,4.221000,4.308400,4.308400,78400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-22,4.310000,4.310000,4.180000,4.260000,4.260000,10000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-23,4.190000,4.300000,4.190000,4.250000,4.250000,28600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-24,4.250000,4.330000,4.191000,4.290000,4.290000,57000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-27,4.350000,4.450000,4.304000,4.380000,4.380000,42300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-28,4.360000,4.410000,4.310000,4.320000,4.320000,41000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-02-29,4.320000,4.410000,4.320000,4.410000,4.410000,32100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-01,4.490000,4.650000,4.490000,4.630000,4.630000,108900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-02,4.600000,4.700000,4.600000,4.690000,4.690000,39700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-05,4.700000,4.750000,4.650000,4.680000,4.680000,55100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-06,4.700000,4.750000,4.650000,4.680000,4.680000,27800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-07,4.710000,4.780000,4.700000,4.780000,4.780000,26000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-08,4.800000,5.120000,4.800000,4.990000,4.990000,211200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-09,5.000000,5.030000,4.830000,4.850000,4.850000,96900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-12,4.850000,4.850000,4.700000,4.700000,4.700000,64600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-13,4.730000,4.839200,4.540700,4.670000,4.670000,94300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-14,4.680000,4.810000,4.680000,4.810000,4.810000,41500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-15,4.810000,4.920000,4.760000,4.870000,4.870000,42100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-16,4.890000,4.890000,4.653700,4.740000,4.740000,36100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-19,4.770000,4.820000,4.650000,4.700000,4.700000,83600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-20,4.652100,4.760000,4.652100,4.720000,4.720000,33300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-21,4.740000,4.830000,4.740000,4.810000,4.810000,39700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-22,4.830000,5.129900,4.800000,4.990000,4.990000,166900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-23,5.010000,5.100000,4.930000,4.930000,4.930000,164500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-26,5.010000,5.120000,5.000000,5.050000,5.050000,120000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-27,5.050000,5.439900,5.045100,5.370000,5.370000,331500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-28,5.460000,5.750000,5.409900,5.730000,5.730000,505800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-29,5.770000,5.990000,5.650000,5.890000,5.890000,516300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-03-30,5.950000,6.000000,5.750000,5.900000,5.900000,324300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-02,5.880000,6.200000,5.860000,6.180000,6.180000,315200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-03,6.200000,6.410000,6.160000,6.370000,6.370000,278800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-04,6.450000,6.450000,5.780000,6.220000,6.220000,382100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-05,6.120000,6.270000,6.050100,6.250000,6.250000,134100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-09,6.140000,6.350000,6.100000,6.220000,6.220000,135800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-10,6.250000,6.260000,5.950000,6.100000,6.100000,176600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-11,6.100000,6.150000,5.920000,6.130000,6.130000,186400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-12,6.170000,6.260000,6.130000,6.170000,6.170000,249300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-13,6.110000,6.250000,6.100000,6.220000,6.220000,101400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-16,6.250000,6.350000,6.210000,6.350000,6.350000,239700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-17,6.390000,6.480000,6.330000,6.370000,6.370000,174300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-18,6.360000,6.400000,6.000000,6.150000,6.150000,207400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-19,6.200000,6.310000,6.110000,6.240000,6.240000,167100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-20,6.340000,6.370000,6.040000,6.180000,6.180000,185600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-23,6.080000,6.290000,6.010000,6.290000,6.290000,170600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-24,6.280000,6.360000,6.240000,6.360000,6.360000,74800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-25,6.360000,7.290000,6.360000,7.260000,7.260000,1262900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-26,4.500000,5.000000,4.000000,4.340000,4.340000,2239400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-27,4.260000,4.520000,4.250000,4.500000,4.500000,403500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-04-30,4.450000,4.500000,4.280000,4.410000,4.410000,278000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-01,4.420000,4.620000,4.410000,4.610000,4.610000,151000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-02,4.620000,4.665000,4.560000,4.660000,4.660000,146900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-03,4.600000,4.890000,4.480000,4.870000,4.870000,400300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-04,4.860000,5.140000,4.830100,4.860000,4.860000,346600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-07,4.870000,5.010000,4.710000,4.940000,4.940000,119000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-08,4.910000,4.915000,4.460000,4.730000,4.730000,230900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-09,4.670000,4.670000,4.510000,4.660000,4.660000,148000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-10,4.670000,4.750000,4.660000,4.700000,4.700000,94000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-11,4.670000,4.900000,4.670000,4.870000,4.870000,83100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-14,4.850000,4.850000,4.610000,4.690000,4.690000,61000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-15,4.690000,4.720000,4.590000,4.710000,4.710000,61000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-16,4.700000,4.740000,4.650000,4.680000,4.680000,33200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-17,4.670000,4.690000,4.410000,4.440000,4.440000,100100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-18,4.460000,4.520000,4.440000,4.480000,4.480000,36300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-21,4.490000,4.650000,4.400000,4.590000,4.590000,110700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-22,4.640000,4.720000,4.530000,4.540000,4.540000,49000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-23,4.520000,4.620000,4.460000,4.530000,4.530000,82000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-24,4.530000,4.590000,4.420000,4.530000,4.530000,34300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-25,4.510000,4.600000,4.360000,4.370000,4.370000,136400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-29,4.410000,4.440000,4.360000,4.390000,4.390000,70400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-30,4.380000,4.400000,4.200000,4.270000,4.270000,89900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-05-31,4.250000,4.290000,4.050000,4.090000,4.090000,203800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-01,3.990000,4.220000,3.990000,4.090000,4.090000,148100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-04,4.120000,4.180000,4.000000,4.050000,4.050000,82700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-05,4.050000,4.179900,4.010000,4.040000,4.040000,68500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-06,4.080000,4.160000,3.990000,4.030000,4.030000,67800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-07,4.060000,4.060000,3.890000,4.040000,4.040000,97200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-08,4.010100,4.070000,4.000000,4.030000,4.030000,86200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-11,4.070000,4.120000,3.890000,3.910000,3.910000,137200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-12,3.870000,4.020000,3.730000,3.920000,3.920000,151300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-13,3.930000,3.930000,3.720000,3.800000,3.800000,138600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-14,3.850000,4.150000,3.810000,4.140000,4.140000,171000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-15,4.120000,4.220000,4.070000,4.150000,4.150000,186000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-18,4.120000,4.370100,4.110000,4.270000,4.270000,198000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-19,4.290000,4.390000,4.260000,4.390000,4.390000,190800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-20,4.400000,4.419900,4.300000,4.390000,4.390000,212800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-21,4.390000,4.430000,4.340000,4.380000,4.380000,228900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-22,3.970000,4.119900,3.850000,3.950000,3.950000,4312900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-25,3.920000,4.090000,3.860000,4.080000,4.080000,254700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-26,4.100000,4.210000,4.051900,4.180000,4.180000,171200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-27,4.200000,4.410000,4.180000,4.370000,4.370000,159500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-28,4.340000,4.350000,4.220000,4.270000,4.270000,74900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-06-29,4.330000,4.330000,4.260000,4.300000,4.300000,101900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-02,4.300000,4.340000,4.250000,4.330000,4.330000,113300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-03,4.320000,4.390000,4.285000,4.390000,4.390000,143800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-05,4.390000,4.420000,4.340000,4.420000,4.420000,116200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-06,4.360000,4.410000,4.350000,4.390000,4.390000,67900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-09,4.380000,4.550000,4.380000,4.530000,4.530000,162200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-10,4.530000,4.570000,4.390000,4.420000,4.420000,93600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-11,4.420000,4.430000,4.240000,4.270000,4.270000,77500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-12,4.240000,4.240000,4.080000,4.180000,4.180000,81500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-13,4.180000,4.400000,4.000000,4.320000,4.320000,71700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-16,4.320000,4.320000,4.210000,4.250000,4.250000,39900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-17,4.260000,4.310000,4.150000,4.170000,4.170000,55300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-18,4.180000,4.180000,4.050000,4.060000,4.060000,81500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-19,4.060000,4.060000,3.970000,3.990000,3.990000,90300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-20,3.960000,3.960000,3.880000,3.890000,3.890000,164800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-23,3.850000,4.230000,3.850000,4.000000,4.000000,174000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-24,4.000000,4.060000,3.890000,3.910000,3.910000,118600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-25,3.920000,3.920000,3.780000,3.810000,3.810000,197400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-26,3.840000,3.900000,3.785000,3.820000,3.820000,91000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-27,3.820000,4.010000,3.820000,3.990000,3.990000,90400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-30,4.000000,4.159900,4.000000,4.050000,4.050000,60200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-07-31,4.030000,4.140000,4.005000,4.020000,4.020000,138800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-01,4.040000,4.170000,3.900000,3.920000,3.920000,226000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-02,4.040000,4.590000,4.020000,4.540000,4.540000,416300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-03,4.560000,4.820000,4.560000,4.680000,4.680000,391300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-06,4.680000,4.750000,4.630000,4.710000,4.710000,203200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-07,4.710000,4.730000,4.690000,4.710000,4.710000,209100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-08,4.700000,4.729900,4.660000,4.670000,4.670000,258300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-09,4.660000,4.730000,4.620500,4.710000,4.710000,84400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-10,4.710000,4.721000,4.640100,4.650000,4.650000,145500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-13,4.650000,4.740000,4.500000,4.710000,4.710000,66000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-14,4.750000,4.790000,4.672000,4.750000,4.750000,88700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-15,4.720000,4.740000,4.610000,4.720000,4.720000,113000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-16,4.700000,4.980000,4.700000,4.960000,4.960000,106200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-17,4.970000,5.050000,4.900000,5.050000,5.050000,221300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-20,5.050000,5.110100,5.020000,5.110000,5.110000,152000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-21,5.110000,5.170000,5.050000,5.130000,5.130000,160500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-22,5.140000,5.220000,5.130000,5.170000,5.170000,147500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-23,5.170000,5.250000,5.150000,5.230000,5.230000,162300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-24,5.220000,5.260000,5.180000,5.250000,5.250000,126900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-27,5.280000,5.860000,5.100000,5.620000,5.620000,376700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-28,5.640000,5.640000,5.390000,5.500000,5.500000,145400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-29,5.480000,5.550000,5.300000,5.510000,5.510000,224300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-30,5.510000,5.600000,5.469000,5.490000,5.490000,120500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-08-31,5.500000,5.700000,5.500000,5.690000,5.690000,200900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-04,5.700000,5.729900,5.520000,5.610000,5.610000,139300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-05,5.620000,5.640000,5.460000,5.470000,5.470000,130200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-06,5.510000,5.648300,5.460000,5.520000,5.520000,101300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-07,5.570000,5.599900,5.321800,5.370000,5.370000,84200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-10,5.840000,6.180000,5.800000,6.020000,6.020000,608000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-11,6.040000,6.150000,5.940000,5.980000,5.980000,233400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-12,5.980000,6.149900,5.960000,6.010000,6.010000,168000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-13,6.010000,6.120000,5.950000,5.970000,5.970000,200500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-14,5.980000,5.980000,5.800000,5.830000,5.830000,198900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-17,5.890000,5.970000,5.800000,5.820000,5.820000,166600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-18,5.840000,5.940000,5.810000,5.860000,5.860000,92800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-19,5.870000,5.940000,5.830000,5.880000,5.880000,99400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-20,5.890000,6.100000,5.810000,5.980000,5.980000,79700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-21,6.050000,6.200000,5.940000,5.990000,5.990000,298500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-24,5.990000,6.110000,5.990000,6.100000,6.100000,109200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-25,6.180000,6.360000,6.140000,6.300000,6.300000,324600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-26,6.330000,6.330000,6.010000,6.070000,6.070000,123600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-27,6.110000,6.155000,5.910000,5.950000,5.950000,199400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-09-28,5.920000,6.000000,5.880000,5.960000,5.960000,142000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-01,5.960000,6.170000,5.960000,6.050000,6.050000,128000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-02,6.050000,6.190000,6.050000,6.120000,6.120000,90500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-03,6.010000,6.200000,6.000000,6.150000,6.150000,104700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-04,6.200000,6.210000,5.940000,5.980000,5.980000,86000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-05,6.000000,6.080000,5.860000,5.920000,5.920000,106600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-08,5.920000,5.920000,5.680000,5.810000,5.810000,186700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-09,5.800000,5.810000,5.590000,5.590000,5.590000,112800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-10,5.610000,5.620000,5.450000,5.490000,5.490000,130200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-11,5.530000,5.840000,5.530000,5.790000,5.790000,139500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-12,5.810000,5.840000,5.710000,5.820000,5.820000,111100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-15,5.850000,5.850000,5.720000,5.790000,5.790000,89600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-16,5.830000,5.850000,5.630000,5.660000,5.660000,56200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-17,5.640000,5.790000,5.620100,5.720000,5.720000,44400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-18,5.730000,5.730000,5.450000,5.560000,5.560000,124600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-19,5.540000,5.620000,5.320000,5.380000,5.380000,146900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-22,5.380000,5.420000,5.190000,5.230000,5.230000,128100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-23,5.210000,5.270000,5.170000,5.200000,5.200000,44100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-24,5.200000,5.350000,5.200000,5.320000,5.320000,94900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-25,5.360000,5.430000,5.350000,5.430000,5.430000,58100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-26,5.440000,5.470000,5.180000,5.200000,5.200000,72600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-10-31,5.190000,5.369900,5.010000,5.100000,5.100000,114600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-01,5.100000,5.119900,5.000000,5.020400,5.020400,86600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-02,5.060000,5.090000,5.000000,5.020000,5.020000,112400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-05,5.000000,5.190000,5.000000,5.070000,5.070000,62100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-06,5.110000,5.220000,5.010000,5.070000,5.070000,67100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-07,5.040000,5.040000,4.900000,4.980000,4.980000,104400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-08,5.590000,5.590000,5.250100,5.480000,5.480000,290400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-09,5.480000,5.580000,5.450000,5.490000,5.490000,150800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-12,5.520000,5.550000,5.260000,5.330000,5.330000,143400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-13,5.290000,5.370000,5.180000,5.290000,5.290000,100200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-14,5.280000,5.390000,5.230000,5.300000,5.300000,142400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-15,5.290000,5.300000,5.130000,5.280000,5.280000,162000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-16,5.350000,5.530000,5.260000,5.480000,5.480000,185100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-19,5.530000,5.840000,5.530000,5.840000,5.840000,210000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-20,5.850000,5.850000,5.610000,5.680000,5.680000,110800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-21,5.660000,5.980000,5.660000,5.980000,5.980000,163100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-23,5.980000,5.990000,5.850000,5.870000,5.870000,58200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-26,5.940000,6.190000,5.920000,6.190000,6.190000,306900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-27,6.190000,6.476500,6.170000,6.380000,6.380000,488600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-28,6.340000,6.360000,6.020000,6.330000,6.330000,272200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-29,6.360000,6.800000,6.331500,6.520000,6.520000,379200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-11-30,6.550000,6.560000,6.330000,6.450000,6.450000,273500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-03,6.500000,6.590000,6.210000,6.270000,6.270000,286600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-04,6.290000,6.330000,6.060000,6.130000,6.130000,167000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-05,6.160000,6.160000,6.040000,6.070000,6.070000,207800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-06,6.070000,6.150100,5.910000,6.020000,6.020000,217300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-07,6.080000,6.140000,5.990000,6.040000,6.040000,148100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-10,6.060000,6.160000,6.010000,6.100000,6.100000,126700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-11,6.140000,6.390000,6.140000,6.380000,6.380000,192300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-12,6.400000,6.400000,6.200000,6.250000,6.250000,190500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-13,6.270000,6.340000,6.200000,6.230000,6.230000,222500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-14,6.300000,6.390000,6.290000,6.380000,6.380000,192000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-17,6.380000,6.520000,6.295000,6.490000,6.490000,174600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-18,6.490000,6.600000,6.320000,6.470000,6.470000,228000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-19,6.450000,6.459900,6.230000,6.380000,6.380000,172900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-20,6.360000,6.540000,6.270000,6.470000,6.470000,183400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-21,6.420000,6.420000,6.300000,6.390000,6.390000,252000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-24,6.410000,6.410000,6.280000,6.360000,6.360000,76400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-26,6.390000,6.520000,6.180000,6.203300,6.203300,119500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-27,6.230000,6.400000,6.133900,6.190000,6.190000,77200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-28,6.160000,6.240000,6.080000,6.080000,6.080000,95000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2012-12-31,6.100000,6.380000,6.070000,6.280000,6.280000,189900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-02,6.400000,6.660000,6.390000,6.630000,6.630000,270300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-03,6.750000,6.959000,6.500000,6.880000,6.880000,384000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-04,6.910000,7.040000,6.880100,6.930000,6.930000,182200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-07,6.890000,6.899900,6.720000,6.810000,6.810000,149500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-08,6.840000,7.040000,6.750000,7.020000,7.020000,149500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-09,7.070000,7.310000,7.040100,7.060000,7.060000,217000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-10,7.130000,7.169900,6.900000,7.140000,7.140000,108300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-11,7.150000,7.150000,6.840000,6.910000,6.910000,226100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-14,6.920000,6.920000,6.760000,6.810000,6.810000,88100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-15,6.770000,6.940000,6.770000,6.920000,6.920000,49600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-16,6.890000,6.980000,6.800000,6.870000,6.870000,66700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-17,6.900000,6.970000,6.810000,6.880000,6.880000,68800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-18,6.860000,6.940000,6.810000,6.830000,6.830000,100100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-22,6.850000,7.040000,6.780000,7.040000,7.040000,128000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-23,7.050000,7.050000,6.820000,6.850000,6.850000,93200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-24,6.870000,6.970000,6.825000,6.950000,6.950000,93700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-25,6.950000,7.100000,6.930000,7.100000,7.100000,99200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-28,7.110000,7.130000,6.970000,7.080000,7.080000,202500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-29,7.100000,7.100000,6.970000,7.000000,7.000000,87900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-30,6.990000,7.050000,6.830000,6.890000,6.890000,93800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-01-31,6.860000,6.990000,6.840000,6.900000,6.900000,75300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-01,6.940000,7.030000,6.850000,6.950000,6.950000,150400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-04,6.950000,6.950000,6.720000,6.730000,6.730000,91400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-05,6.720000,6.790000,6.650000,6.700000,6.700000,85800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-06,6.680000,6.790000,6.570000,6.660000,6.660000,93800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-07,6.640000,6.640000,6.250000,6.510000,6.510000,236400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-08,6.490000,6.790000,6.220000,6.770000,6.770000,93700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-11,6.780000,6.780000,6.390000,6.450000,6.450000,125300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-12,6.470000,6.580000,6.450000,6.570000,6.570000,61300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-13,6.570000,6.570000,6.380800,6.500000,6.500000,114700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-14,6.510000,6.610000,6.400000,6.530000,6.530000,66300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-15,6.500000,6.515000,6.385000,6.500000,6.500000,142100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-19,6.470000,6.490000,6.305000,6.480000,6.480000,94800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-20,6.450000,6.500000,5.990000,6.020000,6.020000,159900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-21,5.980000,6.023000,5.730000,5.980000,5.980000,190700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-22,6.010000,6.320000,6.010000,6.280000,6.280000,129200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-25,6.240000,6.310000,6.130000,6.150000,6.150000,101700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-26,6.180000,6.290000,6.080000,6.200000,6.200000,114300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-27,6.190000,6.310000,6.150000,6.250000,6.250000,80200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-02-28,6.260000,6.440000,6.150000,6.230000,6.230000,70200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-01,6.230000,6.310000,6.050000,6.280000,6.280000,77000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-04,6.270000,6.330000,6.180000,6.330000,6.330000,75200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-05,6.310000,6.378000,6.170000,6.370000,6.370000,98500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-06,6.370000,6.475800,6.060000,6.400000,6.400000,116500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-07,6.480000,6.800000,6.230000,6.720000,6.720000,177300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-08,6.800000,6.870000,6.660000,6.770000,6.770000,207200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-11,6.730000,6.780000,6.570000,6.680000,6.680000,106400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-12,6.660000,6.709900,6.440000,6.540000,6.540000,60800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-13,6.560000,6.569000,6.380000,6.560000,6.560000,57200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-14,6.550000,6.665500,6.510000,6.620000,6.620000,97100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-15,6.600000,6.790000,6.435000,6.470000,6.470000,148600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-18,6.410000,6.510000,6.230000,6.290000,6.290000,128100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-19,6.340000,6.510000,6.310000,6.440000,6.440000,97200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-20,6.450000,6.460000,6.250000,6.300000,6.300000,82800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-21,6.260000,6.470000,6.260000,6.450000,6.450000,61300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-22,6.490000,6.510000,6.420000,6.460000,6.460000,79900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-25,6.460000,6.710000,6.430000,6.680000,6.680000,66100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-26,6.750000,6.900000,6.655000,6.890000,6.890000,83400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-27,6.840000,6.900000,6.750000,6.900000,6.900000,64300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-03-28,6.920000,6.970000,6.820000,6.910000,6.910000,83500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-01,6.920000,6.920000,6.650000,6.790000,6.790000,135600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-02,6.900000,7.149000,6.850000,7.070000,7.070000,294900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-03,7.060000,7.370000,7.040000,7.310000,7.310000,307200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-04,7.400000,8.090000,7.354500,8.060000,8.060000,1029700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-05,8.070000,8.210000,7.810100,8.180000,8.180000,1039100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-08,8.220000,8.640000,8.180000,8.600000,8.600000,779000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-09,8.690000,8.800000,8.440000,8.650000,8.650000,531300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-10,8.650000,9.320000,8.590000,9.100000,9.100000,849400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-11,9.390000,9.440000,8.480000,8.760000,8.760000,753400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-12,8.740000,8.860000,8.500000,8.820000,8.820000,344500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-15,8.820000,8.820000,8.390000,8.480000,8.480000,372900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-16,8.520000,8.690000,8.350000,8.670000,8.670000,378300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-17,8.600000,8.600000,8.280000,8.410000,8.410000,329900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-18,8.410000,8.520000,8.260000,8.380000,8.380000,229000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-19,8.350000,8.890000,8.310000,8.860000,8.860000,374300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-22,8.870000,9.000000,8.610000,8.790000,8.790000,472900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-23,8.840000,9.080000,8.820400,9.080000,9.080000,308800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-24,9.100000,9.170000,8.680000,8.870000,8.870000,424300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-25,8.910000,9.020000,8.750000,8.970000,8.970000,259000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-26,8.980000,8.980000,8.760000,8.840000,8.840000,175500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-29,8.910000,9.020000,8.840000,8.960000,8.960000,198200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-04-30,8.950000,9.010000,8.880000,8.960000,8.960000,180900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-01,8.950000,8.980000,8.660000,8.680000,8.680000,315400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-02,8.790000,8.910000,8.291000,8.800000,8.800000,506400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-03,8.960000,9.000000,8.810000,8.930000,8.930000,376800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-06,8.910000,9.410000,8.800000,8.840000,8.840000,613300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-07,8.840000,9.290000,8.810000,9.230000,9.230000,542500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-08,9.400000,9.650000,9.254600,9.360000,9.360000,398000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-09,9.400000,9.450000,9.310000,9.360000,9.360000,221200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-10,9.400000,9.440000,8.850000,8.980000,8.980000,457000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-13,9.000000,9.090000,8.820000,9.090000,9.090000,431800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-14,9.090000,9.090000,8.820000,8.890000,8.890000,431400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-15,8.840000,9.050000,8.820100,8.990000,8.990000,270800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-16,8.990000,9.000000,8.800000,8.880000,8.880000,191000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-17,8.940000,9.100000,8.750000,8.850000,8.850000,989700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-20,8.860000,8.989000,8.510100,8.700000,8.700000,330400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-21,8.690000,8.770000,8.530000,8.610000,8.610000,262100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-22,8.600000,8.860000,8.000000,8.230000,8.230000,723300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-23,8.090000,8.570000,8.040000,8.500000,8.500000,341200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-24,8.490000,8.569900,8.420000,8.480000,8.480000,115000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-28,8.660000,8.780000,8.460000,8.500000,8.500000,185700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-29,8.390000,8.585000,8.270000,8.440000,8.440000,136600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-30,8.460000,8.560000,8.460000,8.490000,8.490000,222400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-05-31,8.420000,8.500000,8.270000,8.280000,8.280000,223800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-03,8.270000,8.420000,8.030000,8.220000,8.220000,317900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-04,8.200000,8.340000,8.074000,8.110000,8.110000,205200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-05,8.060000,8.180000,7.700000,7.860000,7.860000,417000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-06,7.840000,8.110000,7.700100,8.110000,8.110000,278800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-07,8.170000,8.260000,8.080000,8.090000,8.090000,207700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-10,8.170000,8.350000,8.060000,8.140000,8.140000,379700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-11,8.110000,8.290000,7.980000,8.040000,8.040000,195800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-12,8.090000,8.090000,7.690000,7.740000,7.740000,207800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-13,7.700000,7.780000,7.500000,7.690000,7.690000,249800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-14,7.800000,7.905000,7.540000,7.610000,7.610000,379500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-17,7.720000,7.786000,7.540000,7.640000,7.640000,269800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-18,7.670000,8.030000,7.580000,7.920000,7.920000,243100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-19,7.910000,7.939900,7.600000,7.690000,7.690000,195900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-20,7.580000,7.679900,7.370000,7.580000,7.580000,249100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-21,7.580000,8.100000,7.550000,7.990000,7.990000,359700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-24,7.860000,7.900000,7.710000,7.840000,7.840000,217800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-25,7.920000,7.920000,7.520000,7.630000,7.630000,194200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-26,7.690000,7.830000,7.580000,7.760000,7.760000,189700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-27,7.820000,7.970000,7.800000,7.920000,7.920000,194200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-06-28,7.910000,8.330000,7.690000,8.240000,8.240000,617300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-01,8.310000,8.440000,8.250000,8.400000,8.400000,364700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-02,8.440000,8.620000,8.440000,8.580000,8.580000,353800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-03,8.510000,8.690000,8.510000,8.680000,8.680000,100600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-05,8.830000,8.899900,8.690000,8.870000,8.870000,262400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-08,8.900000,9.140000,8.880000,9.130000,9.130000,319100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-09,9.160000,9.450000,9.120000,9.280000,9.280000,431100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-10,9.300000,9.520000,9.240000,9.500000,9.500000,361600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-11,9.660000,9.840000,9.300000,9.670000,9.670000,1110600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-12,9.670000,9.740000,9.430000,9.610000,9.610000,231200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-15,9.590000,9.950000,9.530000,9.920000,9.920000,361300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-16,9.970000,9.970000,9.600000,9.810000,9.810000,256100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-17,9.890000,9.950000,9.760000,9.950000,9.950000,337600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-18,9.990000,10.000000,9.810000,9.890000,9.890000,246600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-19,9.850000,9.909900,9.680000,9.780000,9.780000,174000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-22,9.770000,9.840000,9.690000,9.710000,9.710000,159300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-23,9.810000,9.840000,9.540000,9.740000,9.740000,151600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-24,9.810000,9.840000,9.595000,9.770000,9.770000,234100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-25,9.700000,9.979000,9.480100,9.940000,9.940000,413900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-26,9.910000,10.440000,9.850000,10.190000,10.190000,368500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-29,10.200000,10.289900,9.900000,10.010000,10.010000,315600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-30,10.070000,10.199900,9.960000,10.100000,10.100000,175300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-07-31,10.100000,10.290000,10.030000,10.170000,10.170000,149400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-01,10.460000,10.680000,10.100000,10.230000,10.230000,372200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-02,10.200000,10.250000,10.100000,10.160000,10.160000,292300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-05,10.060000,10.129900,9.930000,10.040000,10.040000,382300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-06,9.990000,10.040000,9.800000,9.885000,9.885000,298100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-07,9.860000,9.900000,9.630000,9.830000,9.830000,587400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-08,9.880000,10.120000,9.860000,10.010000,10.010000,355700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-09,10.010000,10.220000,9.940000,10.040000,10.040000,180600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-12,10.010000,10.280000,10.010000,10.250000,10.250000,244100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-13,10.290000,10.345000,10.050000,10.270000,10.270000,195700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-14,10.240000,10.280000,9.920000,10.050000,10.050000,373300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-15,9.880000,10.030000,9.650000,9.830000,9.830000,270100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-16,9.770000,9.980000,9.720000,9.870000,9.870000,273700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-19,9.910000,9.980000,9.780000,9.910000,9.910000,256500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-20,9.960000,10.100000,9.880000,10.040000,10.040000,276700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-21,10.030000,10.250000,9.920000,10.070000,10.070000,231800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-22,10.070000,10.280000,10.070000,10.270000,10.270000,245300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-23,10.270000,10.290000,10.130000,10.180000,10.180000,233100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-26,10.180000,10.240000,9.990000,10.190000,10.190000,310200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-27,10.060000,10.090000,9.810000,9.950000,9.950000,262000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-28,9.920000,10.040000,9.820000,9.920000,9.920000,188900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-29,9.900000,10.040000,9.770000,9.830000,9.830000,521400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-08-30,9.820000,9.920000,9.650000,9.760000,9.760000,222800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-03,9.890000,9.980000,9.570000,9.710000,9.710000,431100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-04,9.840000,9.840000,9.585000,9.680000,9.680000,296400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-05,9.680000,9.820000,9.410000,9.770000,9.770000,394800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-06,9.850000,9.970000,9.640000,9.940000,9.940000,359700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-09,9.950000,10.080000,9.930000,10.040000,10.040000,227300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-10,10.100000,10.170000,9.920800,10.040000,10.040000,366700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-11,10.050000,10.050000,9.730000,10.000000,10.000000,330600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-12,10.010000,10.055100,9.765000,9.790000,9.790000,186700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-13,9.840000,9.980000,9.660000,9.900000,9.900000,245300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-16,10.040000,10.090000,9.922500,9.970000,9.970000,305800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-17,10.000000,10.120000,9.980000,10.070000,10.070000,212500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-18,10.100000,10.330000,10.020000,10.210000,10.210000,475300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-19,10.270000,10.390000,10.064000,10.200000,10.200000,234500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-20,10.210000,10.270000,9.840000,10.140000,10.140000,455500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-23,10.120000,10.370000,10.040000,10.330000,10.330000,272600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-24,10.350000,11.100000,10.350000,10.940000,10.940000,789700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-25,11.010000,11.360000,10.940000,11.130000,11.130000,607400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-26,11.170000,11.340000,11.050000,11.260000,11.260000,332700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-27,11.220000,11.440000,11.070000,11.360000,11.360000,203100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-09-30,11.260000,11.380000,11.010000,11.090000,11.090000,253900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-01,11.110000,11.390000,11.050000,11.330000,11.330000,185200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-02,11.290000,11.350000,11.010000,11.280000,11.280000,196600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-03,11.250000,11.400000,10.800000,10.930000,10.930000,383200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-04,10.920000,11.320000,10.920000,11.110000,11.110000,173400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-07,11.030000,11.030000,10.610000,10.730000,10.730000,265700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-08,10.710000,10.750000,10.010000,10.220000,10.220000,556800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-09,10.210000,10.410000,9.890000,10.310000,10.310000,525800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-10,10.400000,10.560000,10.290000,10.440000,10.440000,240800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-11,10.410000,10.620000,10.250000,10.460000,10.460000,284800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-14,10.360000,10.660000,10.250000,10.620000,10.620000,183500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-15,10.610000,10.640000,10.257700,10.380000,10.380000,162100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-16,10.440000,10.680000,10.370000,10.480000,10.480000,435400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-17,10.450000,10.539900,10.220100,10.490000,10.490000,232200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-18,10.610000,10.610000,10.130000,10.340000,10.340000,297800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-21,10.340000,10.340000,10.220000,10.250000,10.250000,201000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-22,10.320000,10.420000,10.130000,10.190000,10.190000,165200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-23,10.100000,10.215000,9.970000,10.000000,10.000000,308900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-24,10.030000,10.370000,10.000000,10.240000,10.240000,304000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-25,10.280000,10.390000,10.100000,10.160000,10.160000,152400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-28,10.260000,10.410000,10.150000,10.360000,10.360000,432600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-29,10.420000,11.080000,10.350000,11.060000,11.060000,778700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-30,11.080000,11.230000,10.830000,10.960000,10.960000,382500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-10-31,10.940000,11.050000,10.810000,10.940000,10.940000,352500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-01,10.950000,11.230000,10.870000,11.150000,11.150000,360400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-04,11.200000,11.380000,11.050000,11.150000,11.150000,230300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-05,11.280000,11.400000,11.010000,11.360000,11.360000,353300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-06,11.430000,11.440000,10.890000,10.980000,10.980000,391400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-07,11.650000,11.650000,10.870000,11.510000,11.510000,624700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-08,11.570000,12.170000,11.350000,11.950000,11.950000,875100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-11,12.020000,12.580000,12.020000,12.480000,12.480000,948000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-12,12.540000,12.690000,12.500000,12.580000,12.580000,644300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-13,12.610000,12.790000,12.320000,12.780000,12.780000,381400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-14,12.850000,12.860000,12.610000,12.640000,12.640000,404500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-15,12.620000,12.970000,12.603200,12.910000,12.910000,403300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-18,12.990000,13.120000,12.820000,12.900000,12.900000,405600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-19,12.900000,13.040000,12.700000,12.780000,12.780000,254300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-20,12.850000,13.149900,12.730000,13.090000,13.090000,303200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-21,13.120000,13.620000,13.120000,13.620000,13.620000,423100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-22,13.700000,14.050000,12.920000,13.180000,13.180000,931500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-25,13.270000,13.619000,13.180700,13.500000,13.500000,411400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-26,13.500000,13.530000,13.372100,13.500000,13.500000,278100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-27,13.490000,13.509900,13.030000,13.420000,13.420000,305800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-11-29,13.500000,13.580000,13.380000,13.470000,13.470000,92800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-02,13.530000,13.570000,13.430000,13.450000,13.450000,253300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-03,13.420000,13.440000,13.210000,13.310000,13.310000,240000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-04,13.220000,13.330000,13.050000,13.240000,13.240000,401400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-05,13.220000,13.230000,12.710100,12.830000,12.830000,414100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-06,12.870000,12.980000,12.590000,12.700000,12.700000,477400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-09,12.740000,12.750000,12.101000,12.470000,12.470000,1106000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-10,12.420000,12.840000,12.420000,12.690000,12.690000,529400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-11,12.700000,12.827200,12.405000,12.490000,12.490000,533900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-12,12.480000,12.980000,12.460000,12.720000,12.720000,390900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-13,12.790000,12.970000,12.660000,12.720000,12.720000,214300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-16,12.740000,13.010000,12.720000,12.810000,12.810000,262300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-17,12.840000,12.920000,12.560000,12.620000,12.620000,187400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-18,12.680000,12.880000,12.490000,12.840000,12.840000,210500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-19,12.760000,12.860000,12.500000,12.650000,12.650000,235600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-20,12.710000,12.836500,12.520000,12.690000,12.690000,1505700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-23,12.710000,12.930000,12.680000,12.890000,12.890000,290000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-24,12.850000,12.980000,12.650000,12.760000,12.760000,99100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-26,12.790000,12.990000,12.770000,12.880000,12.880000,198700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-27,12.940000,12.940000,12.510000,12.660000,12.660000,186500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-30,12.650000,12.844000,12.500000,12.790000,12.790000,214500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2013-12-31,12.890000,13.840000,12.890000,13.640000,13.640000,1240800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-02,13.740000,13.740000,11.700000,12.630000,12.630000,1654700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-03,12.630000,12.930000,12.560000,12.770000,12.770000,368600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-06,12.750000,12.910000,12.512300,12.760000,12.760000,409200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-07,12.810000,12.990000,12.660000,12.860000,12.860000,323100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-08,12.810000,12.870000,12.560900,12.770000,12.770000,281500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-09,12.760000,12.800000,12.120000,12.300000,12.300000,645400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-10,12.240000,12.480000,12.010000,12.460000,12.460000,320000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-13,12.390000,12.575000,12.060000,12.340000,12.340000,348100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-14,12.340000,12.430000,12.175000,12.370000,12.370000,178300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-15,12.420000,12.490000,12.150000,12.300000,12.300000,299100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-16,12.290000,12.610000,12.290000,12.600000,12.600000,344800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-17,12.640000,12.710000,12.567500,12.650000,12.650000,192900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-21,12.900000,13.320000,12.810000,12.980000,12.980000,589200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-22,13.050000,14.520000,13.050000,14.130000,14.130000,906100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-23,14.150000,14.590000,13.830000,14.570000,14.570000,664500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-24,14.500000,14.520000,13.240000,14.280000,14.280000,776700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-27,14.280000,14.720000,13.600000,14.040000,14.040000,504600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-28,14.130000,14.749000,14.100000,14.490000,14.490000,715400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-29,14.460000,14.530000,14.250000,14.410000,14.410000,344200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-30,14.740000,16.200000,14.700000,15.820000,15.820000,894600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-01-31,15.580000,15.690000,15.070000,15.480000,15.480000,413900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-03,15.370000,15.470000,14.340000,14.630000,14.630000,579800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-04,14.600000,14.830000,14.251000,14.430000,14.430000,333200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-05,14.280000,14.390000,13.320000,14.030000,14.030000,530800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-06,14.150000,14.390000,13.770000,13.850000,13.850000,326100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-07,13.950000,15.070000,13.850000,14.830000,14.830000,464800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-10,14.760000,15.320000,14.600000,14.700000,14.700000,296600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-11,14.760000,14.932500,14.292500,14.780000,14.780000,250700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-12,14.850000,14.990000,14.460000,14.590000,14.590000,248000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-13,14.500000,15.170000,14.250000,15.090000,15.090000,221500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-14,15.110000,15.930000,15.110000,15.860000,15.860000,476600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-18,16.010000,16.620000,15.871500,16.070000,16.070000,539200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-19,16.050000,16.220000,15.470000,15.550000,15.550000,340500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-20,15.550000,16.159900,15.400000,16.000000,16.000000,272900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-21,16.110000,16.650000,16.060000,16.220000,16.220000,424300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-24,16.460000,17.260000,16.272200,16.430000,16.430000,498700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-25,16.350000,16.789000,16.300000,16.570000,16.570000,409100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-26,16.730000,16.900000,16.150000,16.340000,16.340000,337000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-27,16.260000,16.549900,15.410100,15.910000,15.910000,354100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-02-28,16.000000,16.210000,14.500000,14.970000,14.970000,697500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-03,14.520000,15.446000,14.300100,15.020000,15.020000,556800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-04,15.270000,15.710000,15.040000,15.130000,15.130000,484900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-05,15.230000,15.539900,14.898000,15.490000,15.490000,555600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-06,14.650000,14.977000,13.060000,14.170000,14.170000,2263500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-07,14.170000,14.400000,13.790000,14.120000,14.120000,494300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-10,14.090000,14.400000,13.990000,14.210000,14.210000,506100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-11,14.400000,14.930000,14.210100,14.920000,14.920000,792800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-12,14.930000,15.230000,14.741000,15.140000,15.140000,354100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-13,15.170000,15.460000,14.810000,14.920000,14.920000,492800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-14,14.830000,15.100000,14.540000,14.980000,14.980000,298300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-17,15.080000,15.390000,14.580000,14.730000,14.730000,339700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-18,14.750000,15.730000,14.750000,15.530000,15.530000,593300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-19,15.560000,15.729000,15.310000,15.450000,15.450000,209800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-20,15.350000,15.690000,15.160000,15.570000,15.570000,270300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-21,15.610000,15.690000,14.610000,14.920000,14.920000,1485300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-24,14.960000,14.960000,13.880000,13.950000,13.950000,612400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-25,14.060000,14.440000,13.390000,13.470000,13.470000,627000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-26,13.730000,14.000000,12.880000,12.945000,12.945000,639900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-27,12.960000,12.970000,12.040000,12.820000,12.820000,823100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-28,12.840000,13.090000,12.180000,12.480000,12.480000,572100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-03-31,12.530000,12.895300,12.310000,12.860000,12.860000,588500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-01,12.890000,13.610000,12.890000,13.550000,13.550000,530600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-02,13.650000,13.810000,13.360000,13.570000,13.570000,375200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-03,13.540000,13.760000,12.740000,13.160000,13.160000,473900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-04,13.260000,13.440000,12.600000,13.260000,13.260000,573500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-07,13.200000,14.339000,13.040000,14.100000,14.100000,1116100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-08,14.050000,14.270000,13.490000,13.550000,13.550000,749800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-09,13.670000,14.430000,13.644000,14.250000,14.250000,482600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-10,14.310000,14.310000,13.540000,13.680000,13.680000,712300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-11,13.610000,13.930000,13.390000,13.650000,13.650000,636500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-14,13.780000,14.039400,13.280000,13.670000,13.670000,569000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-15,13.960000,14.830000,13.420000,14.370000,14.370000,857400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-16,15.610000,15.610000,14.750000,15.400000,15.400000,1215000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-17,15.300000,16.220000,15.220000,15.840000,15.840000,5367300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-21,15.840000,15.840000,15.470000,15.660000,15.660000,900700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-22,15.600000,16.230000,15.420000,15.990000,15.990000,806600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-23,15.930000,16.060000,15.650000,15.840000,15.840000,455300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-24,15.960000,15.960000,14.920000,15.660000,15.660000,451800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-25,15.520000,15.720000,15.400000,15.610000,15.610000,405100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-28,15.720000,15.990000,15.393000,15.840000,15.840000,501700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-29,15.910000,16.320000,15.820000,15.980000,15.980000,626700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-04-30,15.960000,16.080000,15.300000,15.850000,15.850000,557400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-01,15.830000,16.150000,15.450000,15.680000,15.680000,485300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-02,15.680000,16.340000,15.492600,16.300000,16.300000,455800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-05,16.180000,16.660000,15.915000,16.550000,16.550000,549000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-06,16.470000,16.860000,16.260000,16.330000,16.330000,493800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-07,16.320000,17.000000,15.950000,16.980000,16.980000,598700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-08,17.030000,19.970000,16.700000,17.290000,17.290000,1313100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-09,17.200000,18.020000,16.720000,17.830000,17.830000,573600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-12,17.860000,18.720000,17.830000,18.540000,18.540000,913500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-13,18.580000,18.690000,18.050000,18.150000,18.150000,795000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-14,18.060000,18.370000,17.790000,17.980000,17.980000,431200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-15,18.000000,18.300000,17.630000,18.120000,18.120000,621200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-16,18.090000,18.107000,17.490000,17.720000,17.720000,590200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-19,17.700000,18.240000,17.700000,18.210000,18.210000,339100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-20,18.210000,18.480000,18.010000,18.150000,18.150000,458300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-21,18.280000,18.750000,18.150000,18.580000,18.580000,290600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-22,18.590000,19.179600,18.520000,19.060000,19.060000,535900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-23,18.980000,19.220000,18.840000,19.080000,19.080000,316000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-27,19.100000,19.360000,18.620000,19.000000,19.000000,493500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-28,19.140000,19.140000,18.420000,18.510000,18.510000,345900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-29,18.600000,19.460000,18.600000,19.370000,19.370000,450700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-05-30,19.390000,19.775000,19.160400,19.240000,19.240000,658200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-02,19.380000,19.430000,18.920000,19.160000,19.160000,550600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-03,19.260000,19.430000,18.780000,19.160000,19.160000,632100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-04,19.310000,21.130000,19.010100,20.480000,20.480000,910400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-05,20.480000,21.150000,20.210000,20.300000,20.300000,643900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-06,20.460000,20.900000,20.308000,20.410000,20.410000,479800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-09,20.380000,20.730000,19.920000,20.030000,20.030000,763900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-10,20.060000,20.500000,20.040000,20.370000,20.370000,562000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-11,20.370000,20.390000,19.781000,19.820000,19.820000,446900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-12,19.830000,20.194000,19.420000,19.540000,19.540000,359200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-13,19.620000,19.860000,19.150000,19.760000,19.760000,417800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-16,19.640000,19.990000,19.390000,19.990000,19.990000,414600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-17,20.000000,20.660000,19.880000,20.315000,20.315000,420500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-18,20.290000,21.000000,20.260000,20.640000,20.640000,301500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-19,20.660000,20.900000,20.370000,20.760000,20.760000,183600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-20,20.920000,22.170000,20.790000,21.980000,21.980000,1386300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-23,21.980000,22.070000,21.210000,21.600000,21.600000,696800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-24,21.520000,22.000000,21.500000,21.910000,21.910000,408700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-25,21.750000,22.210000,21.460000,22.010000,22.010000,358000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-26,22.310000,22.980000,22.050000,22.710000,22.710000,704800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-27,22.600000,22.700000,22.220000,22.640000,22.640000,677600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-06-30,22.640000,23.140000,22.360000,22.790000,22.790000,505400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-01,23.010000,24.099900,23.010000,23.850000,23.850000,640400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-02,23.800000,23.960000,23.430000,23.470000,23.470000,344700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-03,23.600000,23.980000,23.355300,23.780000,23.780000,239100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-07,23.980000,23.990000,22.690000,22.700000,22.700000,629900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-08,22.580000,22.787500,21.171000,22.720000,22.720000,907100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-09,22.820000,23.460000,22.370000,23.450000,23.450000,340000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-10,22.990000,23.980000,22.760100,23.770000,23.770000,494300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-11,23.760000,24.340000,23.750000,24.100000,24.100000,341100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-14,24.410000,24.680000,24.100000,24.500000,24.500000,383200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-15,24.580000,24.580000,23.150000,23.370000,23.370000,424200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-16,23.440000,23.737500,22.720000,22.740000,22.740000,328600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-17,22.690000,23.050000,22.030100,22.210000,22.210000,431400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-18,22.140000,23.370000,21.810000,23.200000,23.200000,404600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-21,23.040000,23.310000,22.530000,23.160000,23.160000,303500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-22,23.300000,23.560000,23.150000,23.490000,23.490000,270900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-23,23.480000,23.980000,23.200000,23.680000,23.680000,240700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-24,23.700000,23.700000,22.920000,23.000000,23.000000,282200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-25,22.830000,22.950000,22.330000,22.680000,22.680000,271400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-28,22.690000,22.800000,21.860000,22.060000,22.060000,336000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-29,22.030000,22.540000,21.230000,22.220000,22.220000,271700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-30,22.550000,23.090000,22.190000,22.410000,22.410000,222400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-07-31,22.190000,22.190000,20.940100,20.970000,20.970000,432600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-01,20.890000,21.320000,20.550000,21.130000,21.130000,360200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-04,21.140000,21.500000,20.720000,21.280000,21.280000,448300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-05,21.160000,21.650000,20.850000,21.230000,21.230000,339300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-06,20.990000,21.700000,20.990000,21.470000,21.470000,240000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-07,21.640000,21.920000,21.160000,21.210000,21.210000,204200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-08,21.220000,21.690000,21.000000,21.290000,21.290000,360500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-11,23.520000,23.694700,22.020000,22.340000,22.340000,441600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-12,22.220000,22.570000,20.440000,20.530000,20.530000,572900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-13,20.580000,20.730000,19.900000,20.310000,20.310000,508900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-14,20.020000,20.380000,19.100000,19.180000,19.180000,549800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-15,19.330000,19.730000,18.840000,19.180000,19.180000,480600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-18,19.310000,20.500000,19.310000,20.470000,20.470000,639800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-19,20.460000,20.804000,20.210100,20.370000,20.370000,329400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-20,20.240000,20.350000,19.900000,19.920000,19.920000,237100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-21,19.950000,20.530000,19.800000,20.370000,20.370000,347600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-22,20.430000,20.430000,20.080000,20.270000,20.270000,209900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-25,20.500000,20.790000,20.490000,20.690000,20.690000,308200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-26,20.720000,20.930000,20.645000,20.660000,20.660000,243400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-27,20.630000,20.730000,20.090000,20.200000,20.200000,204300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-28,20.020000,20.220000,19.540000,19.630000,19.630000,221200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-08-29,19.610000,19.690000,19.040000,19.060000,19.060000,264900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-02,19.390000,20.447000,19.340000,19.800000,19.800000,855600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-03,19.890000,20.500000,19.730000,20.380000,20.380000,1055700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-04,20.500000,20.548900,19.650000,19.690000,19.690000,271000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-05,19.610000,19.640000,18.570000,18.750000,18.750000,335700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-08,18.700000,19.750000,18.520000,19.640000,19.640000,304900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-09,19.540000,19.540000,18.660000,18.690000,18.690000,191400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-10,18.690000,19.420000,18.600000,19.100000,19.100000,181900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-11,18.970000,19.280000,18.610000,19.190000,19.190000,226800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-12,19.240000,19.480000,18.620000,18.680000,18.680000,351400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-15,18.680000,18.840000,18.230000,18.580000,18.580000,306400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-16,18.490000,19.300000,18.280000,19.200000,19.200000,197100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-17,19.090000,19.680000,19.060000,19.570000,19.570000,279600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-18,19.720000,19.880000,19.430000,19.650000,19.650000,315700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-19,19.700000,20.060000,19.500000,19.710000,19.710000,803200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-22,19.630000,19.780000,19.357500,19.700000,19.700000,319400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-23,19.600000,19.970000,19.470000,19.660000,19.660000,337800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-24,19.650000,20.080000,19.340000,20.050000,20.050000,275345,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-25,20.040000,20.160000,19.090000,19.340000,19.340000,647730,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-26,19.300000,19.370000,18.550000,19.280000,19.280000,441169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-29,18.980000,20.145000,18.570000,20.100000,20.100000,369849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-09-30,20.140000,20.360000,19.710000,19.910000,19.910000,753815,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-01,19.920000,20.980000,19.860000,20.800000,20.800000,558214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-02,20.840000,20.870000,19.920000,20.250000,20.250000,491486,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-03,20.540000,20.840000,20.060000,20.780000,20.780000,279177,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-06,20.780000,20.870000,20.520000,20.730000,20.730000,341164,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-07,20.560000,20.880000,19.895000,20.710000,20.710000,548468,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-08,20.620000,21.880000,20.550000,21.830000,21.830000,551115,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-09,21.750000,21.889900,20.940000,21.500000,21.500000,377294,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-10,21.400000,21.980000,21.110000,21.640000,21.640000,431824,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-13,21.520000,21.890000,20.970000,21.280000,21.280000,433676,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-14,21.580000,21.830000,21.030000,21.520000,21.520000,320712,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-15,20.950000,21.670000,20.460000,21.330000,21.330000,609234,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-16,20.690000,22.540000,20.500000,22.280000,22.280000,466054,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-17,22.860000,22.999500,22.340000,22.500000,22.500000,526170,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-20,22.840000,22.960000,22.340000,22.750000,22.750000,244763,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-21,22.870000,22.950000,22.550000,22.720000,22.720000,296668,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-22,22.690000,23.430000,22.530000,23.090000,23.090000,256708,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-23,23.450000,24.380000,23.150000,23.980000,23.980000,331761,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-24,24.030000,24.430000,23.790000,24.110000,24.110000,275817,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-27,23.970000,24.310000,23.610000,24.180000,24.180000,227200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-28,24.350000,25.180000,24.080100,25.130000,25.130000,467888,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-29,25.110000,25.320000,24.021000,24.730000,24.730000,521221,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-30,24.520000,25.940000,24.474200,25.490000,25.490000,376649,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-10-31,26.220000,26.750000,25.145000,25.220000,25.220000,530391,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-03,25.350000,25.630000,25.080000,25.460000,25.460000,409050,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-04,25.240000,26.000000,25.030000,25.110000,25.110000,398695,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-05,25.410000,25.480000,24.450000,24.600000,24.600000,427024,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-06,24.350000,24.350000,22.080000,23.350000,23.350000,861835,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-07,23.410000,23.410000,22.550000,22.970000,22.970000,378288,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-10,22.860000,23.680000,22.330000,23.580000,23.580000,284530,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-11,23.500000,23.900000,23.090000,23.560000,23.560000,264950,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-12,23.350000,23.980000,23.140000,23.890000,23.890000,168148,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-13,23.840000,24.190000,23.610000,23.870000,23.870000,205617,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-14,23.890000,23.890000,22.930000,23.300000,23.300000,212469,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-17,23.300000,23.930000,23.180000,23.400000,23.400000,214019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-18,23.460000,23.900000,23.020000,23.170000,23.170000,257796,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-19,23.030000,23.180000,22.640000,23.070000,23.070000,226308,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-20,23.060000,23.310000,22.730000,22.870000,22.870000,143193,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-21,23.250000,23.570000,22.770000,22.890000,22.890000,222135,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-24,22.900000,23.650000,22.440000,22.880000,22.880000,335951,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-25,23.060000,23.100000,22.111500,22.740000,22.740000,289966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-26,22.620000,23.270000,22.470000,23.170000,23.170000,249018,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-11-28,23.000000,23.680000,22.690000,22.870000,22.870000,167491,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-01,22.700000,22.720000,21.170000,21.310000,21.310000,451466,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-02,20.750000,21.880000,20.750000,21.590000,21.590000,429084,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-03,21.540000,22.180000,21.350000,22.050000,22.050000,253485,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-04,22.050000,22.260000,21.660000,22.060000,22.060000,198174,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-05,21.950000,22.520000,21.950000,22.390000,22.390000,187735,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-08,22.390000,23.210000,22.380000,22.830000,22.830000,266997,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-09,22.640000,23.630000,22.190000,23.580000,23.580000,249711,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-10,24.000000,24.000000,22.100000,22.140000,22.140000,331257,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-11,22.350000,22.810000,21.837000,22.350000,22.350000,220420,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-12,22.050000,22.510000,21.610000,22.120000,22.120000,248750,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-15,21.240000,21.895000,19.900000,19.930000,19.930000,732475,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-16,20.000000,20.900000,19.970000,20.310000,20.310000,316221,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-17,20.310000,20.950000,20.000000,20.920000,20.920000,299167,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-18,21.020000,21.740000,20.890000,21.550000,21.550000,360911,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-19,21.490000,22.000000,21.170000,21.420000,21.420000,811177,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-22,21.400000,21.610000,20.624300,20.770000,20.770000,221059,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-23,20.780000,21.090000,19.020000,19.450000,19.450000,558693,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-24,19.350000,20.110000,19.149200,19.840000,19.840000,201148,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-26,20.000000,20.510000,19.795100,20.240000,20.240000,166388,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-29,19.970000,20.440000,19.230000,19.440000,19.440000,381762,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-30,19.540000,19.920000,19.130000,19.470000,19.470000,212637,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2014-12-31,19.640000,20.320000,19.510000,19.800000,19.800000,344533,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-02,19.830000,20.410000,19.660000,20.100000,20.100000,266905,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-05,19.860000,20.980000,19.840000,20.470000,20.470000,329036,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-06,20.470000,20.660000,19.530000,19.860000,19.860000,322443,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-07,19.800000,20.100000,19.720000,19.920000,19.920000,405242,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-08,20.160000,24.810000,20.106000,24.520000,24.520000,1218374,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-09,24.680000,24.740000,23.590000,24.240000,24.240000,456476,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-12,24.540000,25.990000,24.140000,25.300000,25.300000,539423,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-13,25.610000,25.915000,24.680000,25.030000,25.030000,371676,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-14,24.650000,25.340000,24.320000,24.600000,24.600000,300276,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-15,24.710000,25.050000,24.190000,24.770000,24.770000,336651,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-16,24.700000,25.870000,24.580000,25.830000,25.830000,280968,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-20,25.950000,26.000000,24.642500,25.780000,25.780000,461669,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-21,25.300000,25.430000,24.150000,24.590000,24.590000,403031,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-22,24.810000,24.810000,23.631000,24.400000,24.400000,273270,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-23,24.330000,25.000000,24.280000,24.790000,24.790000,206787,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-26,24.710000,25.305000,24.630000,25.210000,25.210000,264615,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-27,24.870000,25.790000,24.810000,25.470000,25.470000,217258,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-28,25.500000,25.500000,24.400000,24.560000,24.560000,212183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-29,24.600000,25.110000,24.200000,24.960000,24.960000,205307,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-01-30,21.450000,24.810000,21.450000,24.290000,24.290000,375005,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-02,24.400000,24.650000,23.690000,23.990000,23.990000,252007,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-03,24.010000,24.110000,22.439000,23.010000,23.010000,463971,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-04,22.680000,24.020000,22.030000,23.730000,23.730000,295140,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-05,23.790000,24.160000,23.460000,23.790000,23.790000,191940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-06,23.860000,24.400000,23.600000,23.790000,23.790000,208404,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-09,23.590000,23.960000,23.320000,23.370000,23.370000,179462,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-10,23.640000,24.260000,23.240000,24.040000,24.040000,222849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-11,24.090000,25.000000,23.932000,24.860000,24.860000,343841,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-12,25.020000,25.750000,24.350000,25.500000,25.500000,323754,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-13,25.430000,25.430000,24.440000,24.770000,24.770000,192558,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-17,24.860000,25.070000,24.350000,24.930000,24.930000,316740,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-18,24.810000,25.700000,24.810000,25.510000,25.510000,330065,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-19,25.550000,25.630000,25.088400,25.470000,25.470000,322786,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-20,25.480000,25.560000,25.110000,25.450000,25.450000,233378,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-23,25.450000,26.700000,25.320000,25.740000,25.740000,444984,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-24,25.700000,26.060000,24.680000,24.980000,24.980000,264400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-25,24.980000,26.130000,24.800000,25.880000,25.880000,162319,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-26,25.830000,26.250000,25.450000,26.200000,26.200000,170275,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-02-27,26.060000,26.180000,25.380000,25.710000,25.710000,274500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-02,25.790000,26.889000,25.450000,25.470000,25.470000,367403,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-03,25.450000,25.655000,24.620000,24.910000,24.910000,422943,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-04,24.750000,25.560000,24.240000,25.110000,25.110000,293232,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-05,25.340000,26.590000,24.990900,25.780000,25.780000,332090,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-06,26.820000,26.820000,25.010000,25.070000,25.070000,168155,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-09,25.220000,25.790000,24.800000,25.520000,25.520000,205970,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-10,25.210000,26.040000,24.750000,25.480000,25.480000,156153,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-11,24.990000,25.950000,24.960000,25.830000,25.830000,257282,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-12,26.050000,26.990000,25.660000,26.820000,26.820000,354466,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-13,26.550000,32.190000,26.550000,31.310000,31.310000,2227118,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-16,31.550000,31.980000,30.680000,30.810000,30.810000,859473,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-17,30.950000,31.550000,29.870000,31.350000,31.350000,685421,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-18,31.380000,33.240000,30.860000,32.290000,32.290000,716500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-19,32.400000,33.640000,32.360000,33.410000,33.410000,564295,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-20,33.660000,34.150000,31.900000,32.320000,32.320000,966306,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-23,32.240000,32.270000,30.810000,31.750000,31.750000,407523,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-24,31.730000,31.900000,30.528800,30.600000,30.600000,291062,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-25,30.510000,30.940000,28.480000,28.580000,28.580000,407496,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-26,28.450000,29.390000,27.500000,28.570000,28.570000,433936,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-27,28.600000,30.820000,28.290000,30.570000,30.570000,326720,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-30,30.810000,31.250000,30.440000,30.810000,30.810000,283200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-03-31,30.740000,30.880000,30.020000,30.360000,30.360000,456560,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-01,30.240000,30.500000,28.880000,29.390000,29.390000,587180,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-02,29.320000,30.590000,29.020000,30.250000,30.250000,291763,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-06,30.240000,30.240000,28.950000,29.120000,29.120000,397944,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-07,29.210000,30.670000,29.210000,29.610000,29.610000,408582,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-08,29.720000,30.780000,29.410000,30.710000,30.710000,382741,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-09,30.560000,31.050000,29.800000,30.350000,30.350000,388783,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-10,30.090000,30.740000,30.040000,30.500000,30.500000,306822,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-13,30.500000,33.190000,30.480000,32.120000,32.120000,539134,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-14,32.160000,32.670000,31.110000,31.400000,31.400000,380572,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-15,31.540000,32.330000,31.340000,32.050000,32.050000,270316,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-16,32.050000,32.580000,31.600000,32.300000,32.300000,236694,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-17,32.040000,32.400000,31.680000,32.090000,32.090000,333984,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-20,32.200000,33.280000,31.770000,33.180000,33.180000,363942,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-21,33.410000,33.490000,32.830000,32.860000,32.860000,362569,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-22,32.740000,33.550000,32.610000,33.370000,33.370000,270842,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-23,33.740000,35.470000,33.380000,35.000000,35.000000,597069,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-24,35.160000,35.160000,34.460000,34.750000,34.750000,273883,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-27,34.930000,35.040000,32.420000,32.570000,32.570000,433966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-28,32.700000,33.100000,31.500000,31.870000,31.870000,437253,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-29,31.830000,32.240000,30.720000,31.300000,31.300000,345780,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-04-30,31.110000,31.420000,29.420000,29.510000,29.510000,461658,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-01,30.040000,31.610000,29.770000,31.490000,31.490000,330920,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-04,30.920000,32.129000,30.760000,31.120000,31.120000,348014,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-05,31.030000,31.320000,30.110000,31.100000,31.100000,330031,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-06,31.540000,32.100000,30.890000,31.980000,31.980000,400506,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-07,32.100000,37.550000,32.100000,37.550000,37.550000,1026296,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-08,37.500000,38.729000,36.640300,37.390000,37.390000,635092,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-11,37.500000,39.405300,37.500000,38.660000,38.660000,461551,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-12,38.950000,40.450000,38.000000,39.880000,39.880000,790733,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-13,40.130000,40.740000,39.390000,40.010000,40.010000,480357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-14,40.050000,41.480000,39.770000,41.370000,41.370000,352619,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-15,41.500000,41.730000,40.930000,41.630000,41.630000,308528,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-18,41.680000,42.250000,41.190000,41.730000,41.730000,374377,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-19,41.890000,42.406400,41.530000,41.710000,41.710000,390170,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-20,41.670000,42.430000,41.100000,41.990000,41.990000,438119,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-21,41.980000,41.990000,40.660000,41.190000,41.190000,427382,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-22,40.970000,41.710000,40.600000,40.880000,40.880000,248668,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-26,40.770000,41.350000,39.722000,40.510000,40.510000,440316,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-27,40.540000,41.070000,39.910000,40.380000,40.380000,310608,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-28,41.000000,41.000000,39.932500,40.740000,40.740000,268144,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-05-29,40.470000,41.870000,40.270000,40.760000,40.760000,386073,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-01,40.540000,40.650000,39.210000,40.070000,40.070000,395467,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-02,40.280000,40.560000,39.410000,40.160000,40.160000,765313,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-03,40.380000,40.750000,39.640000,40.110000,40.110000,506941,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-04,39.890000,39.940000,37.910000,38.190000,38.190000,546077,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-05,38.290000,39.070000,37.980000,38.610000,38.610000,449525,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-08,38.430000,38.810000,37.920000,38.220000,38.220000,279981,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-09,38.330000,38.330000,37.170000,37.310000,37.310000,291865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-10,37.320000,38.640000,37.060000,38.390000,38.390000,346112,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-11,38.290000,38.500000,37.600000,38.460000,38.460000,228097,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-12,38.200000,38.320000,37.440000,38.220000,38.220000,209954,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-15,38.020000,38.870000,37.540000,38.750000,38.750000,269662,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-16,39.230000,39.360000,37.590000,37.660000,37.660000,302051,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-17,37.930000,38.560000,37.740000,38.330000,38.330000,157195,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-18,38.500000,40.100000,38.440000,40.000000,40.000000,368386,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-19,40.000000,40.000000,38.970000,39.750000,39.750000,488436,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-22,40.000000,41.550000,39.710000,41.510000,41.510000,306559,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-23,41.390000,41.750000,40.470000,40.700000,40.700000,310468,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-24,40.300000,41.250000,40.270000,41.140000,41.140000,306274,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-25,41.320000,41.740000,40.590000,41.360000,41.360000,285179,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-26,41.610000,42.350000,41.050000,42.120000,42.120000,691978,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-29,41.850000,42.480000,41.190000,41.310000,41.310000,353499,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-06-30,41.510000,42.010000,40.800100,41.270000,41.270000,441454,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-01,41.710000,41.850000,40.770000,41.210000,41.210000,203681,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-02,41.240000,41.640000,39.960000,40.040000,40.040000,218334,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-06,39.810000,41.900000,39.662000,41.760000,41.760000,204805,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-07,41.730000,42.220000,40.380000,42.140000,42.140000,237851,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-08,41.720000,41.962000,39.279000,39.730000,39.730000,397829,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-09,40.260000,40.430000,38.520000,38.630000,38.630000,319222,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-10,39.340000,40.439900,38.890000,40.280000,40.280000,335357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-13,40.450000,41.730000,40.440000,41.300000,41.300000,202186,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-14,41.400000,42.000000,40.940000,41.400000,41.400000,281248,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-15,41.600000,41.820000,39.460000,39.680000,39.680000,458366,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-16,40.190000,41.900000,39.950000,41.720000,41.720000,367525,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-17,42.000000,42.100000,39.920000,40.460000,40.460000,324050,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-20,40.520000,40.522100,39.310000,40.090000,40.090000,215189,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-21,39.770000,39.940000,37.400000,37.470000,37.470000,596094,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-22,37.070000,38.610000,35.890000,38.530000,38.530000,653064,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-23,38.400000,38.600000,37.320000,37.530000,37.530000,262962,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-24,37.310000,37.820000,35.610000,35.820000,35.820000,483020,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-27,35.610000,36.700000,35.010100,36.100000,36.100000,355587,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-28,36.410000,37.340000,35.640100,36.650000,36.650000,375397,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-29,36.630000,36.963100,34.800000,35.190000,35.190000,306097,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-30,34.900000,35.720000,34.050000,34.980000,34.980000,221566,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-07-31,35.220000,35.940000,34.700000,35.010000,35.010000,297279,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-03,34.950000,36.120000,34.950000,35.480000,35.480000,210737,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-04,35.780000,35.780000,34.750000,35.350000,35.350000,414405,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-05,35.800000,37.010000,35.450000,36.530000,36.530000,448053,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-06,38.000000,39.170000,33.690000,36.000000,36.000000,921048,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-07,35.680000,38.000000,34.430000,36.470000,36.470000,373958,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-10,36.690000,37.820000,36.670000,37.110000,37.110000,324041,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-11,37.020000,37.980000,35.980000,36.310000,36.310000,230422,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-12,36.410000,37.280000,35.550000,37.030000,37.030000,209120,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-13,36.950000,37.170000,34.880000,35.150000,35.150000,231647,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-14,35.030000,35.590000,33.900000,34.780000,34.780000,219998,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-17,34.250000,36.310000,33.770000,36.250000,36.250000,198675,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-18,35.990000,36.033800,34.750000,35.000000,35.000000,225914,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-19,34.770000,35.170000,34.100000,34.320000,34.320000,152339,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-20,33.760000,34.390000,32.010000,32.170000,32.170000,354912,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-21,31.240000,34.460000,30.753300,33.655000,33.655000,384983,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-24,31.970000,34.259900,29.250000,32.160000,32.160000,419194,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-25,34.070000,34.070000,31.469600,32.210000,32.210000,346927,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-26,32.970000,33.960000,31.980000,33.790000,33.790000,316990,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-27,34.230000,34.430000,33.090000,34.380000,34.380000,312854,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-28,34.040000,34.540000,33.210000,34.290000,34.290000,182916,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-08-31,34.430000,35.520000,33.610000,34.080000,34.080000,320940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-01,33.510000,34.610000,33.050000,33.370000,33.370000,361826,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-02,33.700000,34.970000,33.210100,34.920000,34.920000,218224,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-03,35.280000,35.470000,33.370000,33.510000,33.510000,251635,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-04,32.960000,34.220000,32.250000,33.100000,33.100000,147906,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-08,33.930000,35.330000,33.390000,35.240000,35.240000,252760,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-09,35.760000,35.790000,34.400100,34.560000,34.560000,250065,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-10,34.490000,35.800000,34.470000,35.530000,35.530000,197153,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-11,35.190000,36.490000,35.110000,36.490000,36.490000,171822,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-14,36.570000,37.000000,35.560000,36.290000,36.290000,213417,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-15,36.540000,37.250000,35.990000,37.110000,37.110000,124089,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-16,36.980000,37.500000,35.020000,36.110000,36.110000,222657,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-17,35.960000,37.880000,35.960000,37.650000,37.650000,226849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-18,37.160000,37.870000,36.430000,36.530000,36.530000,492808,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-21,37.140000,37.880000,33.900000,35.150000,35.150000,367245,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-22,34.800000,35.440000,33.820000,34.660000,34.660000,332929,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-23,34.660000,36.590000,33.380000,36.260000,36.260000,242965,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-24,36.020000,37.010000,34.870000,36.850000,36.850000,265689,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-25,37.250000,37.250000,32.410000,33.870000,33.870000,426724,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-28,33.520000,33.810000,30.160000,31.620000,31.620000,581123,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-29,31.750000,32.260000,27.250000,27.900000,27.900000,805096,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-09-30,27.840000,29.235000,27.250000,27.850000,27.850000,746557,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-01,27.810000,28.410000,27.000000,27.010000,27.010000,451856,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-02,26.780000,28.010000,25.960000,27.200000,27.200000,681652,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-05,27.360000,28.740000,27.240000,28.550000,28.550000,507131,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-06,28.300000,28.300000,25.030000,25.660000,25.660000,533044,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-07,25.750000,26.550000,24.750000,25.110000,25.110000,594846,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-08,24.740000,25.130000,24.030000,24.520000,24.520000,404028,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-09,24.640000,25.644000,24.075000,25.280000,25.280000,209861,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-12,25.390000,25.890000,25.000000,25.300000,25.300000,273868,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-13,25.410000,26.160000,24.570000,24.620000,24.620000,288725,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-14,24.700000,25.755000,24.350000,24.770000,24.770000,276017,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-15,24.680000,27.930000,24.490000,27.470000,27.470000,418739,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-16,27.590000,30.380000,27.360000,30.270000,30.270000,820192,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-19,30.110000,33.000000,29.620000,30.660000,30.660000,970600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-20,30.480000,31.700000,30.050000,30.710000,30.710000,533470,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-21,31.000000,31.900000,30.310000,30.650000,30.650000,480852,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-22,30.950000,31.700000,30.180000,31.570000,31.570000,406475,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-23,31.810000,32.980000,31.800000,32.800000,32.800000,392659,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-26,32.560000,33.300000,31.800000,32.010000,32.010000,328944,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-27,32.060000,32.720000,31.700000,32.640000,32.640000,260828,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-28,32.770000,34.460000,31.960000,34.400000,34.400000,430417,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-29,34.110000,34.920000,32.721000,32.920000,32.920000,331293,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-10-30,32.910000,33.890000,32.730000,33.240000,33.240000,214179,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-02,33.490000,34.560000,33.210000,34.510000,34.510000,258411,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-03,34.260000,35.120000,33.950000,34.390000,34.390000,238781,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-04,34.500000,35.570000,33.610000,34.810000,34.810000,266076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-05,35.070000,36.000000,31.310000,32.380000,32.380000,506314,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-06,30.400000,30.860000,21.690000,26.810000,26.810000,2829387,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-09,26.800000,27.500000,26.290000,26.700000,26.700000,520779,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-10,26.700000,27.140000,25.810000,26.850000,26.850000,340777,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-11,27.020000,27.390000,26.060000,26.110000,26.110000,318840,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-12,26.250000,26.860000,25.740000,25.950000,25.950000,427231,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-13,25.760000,26.940000,25.630000,26.420000,26.420000,283282,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-16,26.340000,26.490000,25.360000,26.180000,26.180000,328152,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-17,26.200000,27.920000,25.970000,27.680000,27.680000,250919,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-18,27.520000,28.440000,27.200000,28.360000,28.360000,262230,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-19,28.250000,28.727000,27.080000,27.840000,27.840000,294145,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-20,28.020000,29.490000,27.910000,28.540000,28.540000,291286,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-23,28.360000,28.500000,27.000000,27.710000,27.710000,271096,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-24,27.650000,27.910000,26.960000,27.550000,27.550000,150349,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-25,27.480000,28.840000,27.480000,28.540000,28.540000,259691,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-27,28.670000,29.290000,28.350000,28.960000,28.960000,115434,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-11-30,29.000000,29.500000,28.060000,28.430000,28.430000,215695,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-01,28.490000,28.990000,27.750000,28.670000,28.670000,231239,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-02,28.600000,29.570000,28.340000,28.530000,28.530000,156017,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-03,28.680000,28.840000,27.070000,27.740000,27.740000,188092,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-04,27.730000,28.900000,27.530000,28.570000,28.570000,232349,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-07,28.600000,28.630000,27.800000,28.090000,28.090000,311692,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-08,27.610000,29.250000,27.310000,29.070000,29.070000,293598,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-09,28.880000,28.880000,27.000000,27.440000,27.440000,225614,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-10,27.480000,28.540000,27.410000,28.380000,28.380000,372881,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-11,27.610000,28.810000,27.610000,28.100000,28.100000,263800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-14,28.210000,28.660000,27.440000,28.180000,28.180000,351527,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-15,28.610000,29.690000,28.610000,29.080000,29.080000,277132,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-16,29.270000,30.150000,28.910000,30.080000,30.080000,237366,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-17,30.170000,30.409900,28.640000,28.930000,28.930000,279625,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-18,28.760000,29.630000,28.694000,29.190000,29.190000,1292940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-21,29.310000,29.440000,28.280000,29.430000,29.430000,205583,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-22,29.500000,29.500000,28.020000,28.780000,28.780000,212232,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-23,28.930000,29.760000,28.400000,29.670000,29.670000,173904,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-24,29.540000,29.590000,28.780000,29.120000,29.120000,94085,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-28,29.060000,29.700000,28.380000,29.040000,29.040000,225627,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-29,29.380000,30.300000,29.310000,30.130000,30.130000,175675,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-30,30.110000,30.300000,29.040000,29.070000,29.070000,251478,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2015-12-31,28.810000,29.265000,28.200000,28.290000,28.290000,396260,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-04,27.900000,28.230000,26.790000,28.100000,28.100000,343000,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-05,28.230000,28.853200,27.060000,27.650000,27.650000,336281,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-06,27.140000,27.350000,25.010000,25.400000,25.400000,411647,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-07,24.860000,25.810000,24.170000,25.540000,25.540000,376245,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-08,25.820000,26.010000,23.880000,23.980000,23.980000,387278,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-11,24.220000,24.250000,22.710000,23.260000,23.260000,374441,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-12,23.580000,24.490000,23.500000,24.440000,24.440000,319103,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-13,24.590000,24.790000,22.900000,23.020000,23.020000,246618,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-14,23.270000,23.910000,22.320000,23.140000,23.140000,316977,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-15,22.420000,23.040000,21.755000,22.440000,22.440000,427912,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-19,22.860000,22.860000,20.870000,21.410000,21.410000,395534,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-20,21.030000,24.720000,20.540000,24.060000,24.060000,699191,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-21,24.000000,24.165000,22.440000,22.580000,22.580000,277076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-22,23.230000,24.040000,22.460000,23.910000,23.910000,316172,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-25,23.640000,25.590000,23.450000,24.040000,24.040000,586545,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-26,23.900000,23.900000,22.145000,23.690000,23.690000,390264,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-27,23.630000,23.920000,22.014200,22.230000,22.230000,337197,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-28,22.530000,22.550000,21.020000,21.410000,21.410000,368914,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-01-29,21.440000,22.330000,21.290000,22.150000,22.150000,404413,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-01,22.040000,22.760000,21.480000,22.450000,22.450000,301443,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-02,22.000000,22.440000,21.640000,21.960000,21.960000,234772,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-03,22.080000,22.120000,20.910000,22.050000,22.050000,233921,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-04,21.980000,22.930000,21.450000,21.870000,21.870000,322689,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-05,21.720000,22.550000,20.970000,21.040000,21.040000,353071,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-08,20.710000,21.350000,20.450000,20.930000,20.930000,341588,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-09,20.750000,22.120000,20.070000,21.350000,21.350000,201298,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-10,21.500000,22.640000,21.270000,21.980000,21.980000,378267,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-11,21.500000,22.050000,21.070000,21.730000,21.730000,344854,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-12,22.220000,23.030000,21.400000,22.970000,22.970000,379664,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-16,23.200000,23.600000,22.810000,23.140000,23.140000,353225,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-17,23.290000,24.560000,23.000000,24.010000,24.010000,328097,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-18,24.060000,24.570000,23.640000,24.300000,24.300000,407736,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-19,24.190000,24.940000,23.910000,24.770000,24.770000,279995,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-22,25.830000,26.450000,25.110000,26.190000,26.190000,405697,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-23,26.010000,26.400000,25.165000,25.190000,25.190000,362994,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-24,24.900000,25.770000,24.350000,25.440000,25.440000,416215,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-25,25.500000,25.920000,24.380000,25.780000,25.780000,390382,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-26,25.920000,27.270000,25.870100,26.050000,26.050000,468621,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-02-29,25.890000,26.381700,25.210000,25.730000,25.730000,629758,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-01,25.940000,27.480000,25.010000,27.240000,27.240000,509020,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-02,27.130000,27.460000,26.240000,26.900000,26.900000,562238,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-03,26.840000,27.330000,26.485000,27.100000,27.100000,310312,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-04,26.740000,27.245000,26.300000,26.820000,26.820000,346949,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-07,26.660000,27.590000,26.320000,27.190000,27.190000,333254,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-08,27.060000,27.330000,25.980000,26.090000,26.090000,236923,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-09,26.250000,26.780000,25.080000,26.620000,26.620000,316708,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-10,26.890000,27.470000,26.195000,26.400000,26.400000,391863,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-11,26.600000,27.850000,26.400000,27.370000,27.370000,304627,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-14,27.250000,28.500000,25.970000,26.330000,26.330000,254699,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-15,26.090000,26.090000,24.690000,25.010000,25.010000,366007,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-16,25.000000,25.830000,24.880000,25.450000,25.450000,250076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-17,25.250000,25.570000,24.130000,24.550000,24.550000,304635,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-18,24.690000,24.760000,23.666800,24.080000,24.080000,679126,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-21,24.090000,24.800000,23.940000,24.350000,24.350000,313713,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-22,24.320000,25.660000,24.320000,25.500000,25.500000,300832,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-23,25.360000,25.970000,24.990000,25.290000,25.290000,430620,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-24,25.230000,26.330000,24.963000,26.130000,26.130000,312731,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-28,26.270000,26.400000,24.630000,24.720000,24.720000,257614,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-29,24.720000,24.795000,24.030000,24.610000,24.610000,639906,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-30,24.930000,26.960000,24.740000,26.770000,26.770000,347699,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-03-31,27.120000,27.660000,26.670000,26.820000,26.820000,257441,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-01,26.620000,27.180000,26.240000,26.920000,26.920000,236392,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-04,27.260000,27.570000,26.810000,26.890000,26.890000,225183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-05,26.710000,27.430000,26.280100,27.030000,27.030000,276901,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-06,26.990000,28.720000,26.990000,28.630000,28.630000,373681,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-07,28.350000,28.830000,26.930000,27.220000,27.220000,319240,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-08,27.510000,27.780000,26.920000,27.700000,27.700000,256560,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-11,27.750000,28.110000,27.110000,27.200000,27.200000,228968,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-12,27.110000,27.950000,27.030000,27.420000,27.420000,287642,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-13,27.710000,28.920000,27.360000,28.840000,28.840000,266714,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-14,28.720000,28.970000,28.200000,28.440000,28.440000,206886,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-15,28.270000,28.780000,27.750000,28.010000,28.010000,142357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-18,27.760000,28.320000,27.670000,28.220000,28.220000,173748,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-19,28.160000,28.190000,26.950000,27.270000,27.270000,172339,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-20,27.370000,27.980000,27.010100,27.260000,27.260000,174821,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-21,27.230000,28.120000,27.155000,27.830000,27.830000,185941,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-22,27.790000,28.180000,27.300000,27.990000,27.990000,211038,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-25,27.950000,28.240000,27.040100,27.180000,27.180000,199678,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-26,27.300000,27.310000,26.010000,27.000000,27.000000,211353,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-27,26.880000,27.270000,26.100000,26.990000,26.990000,128078,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-28,26.810000,27.770000,26.330000,26.970000,26.970000,220234,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-04-29,26.740000,27.080000,26.210000,26.640000,26.640000,163782,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-02,26.640000,27.470000,26.390000,27.380000,27.380000,216027,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-03,27.070000,27.670000,26.630000,26.740000,26.740000,151439,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-04,26.650000,27.290000,25.640000,25.710000,25.710000,314709,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-05,26.250000,26.760000,24.700000,25.920000,25.920000,424214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-06,25.910000,26.650000,25.425000,26.250000,26.250000,277505,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-09,26.180000,27.460000,26.180000,26.950000,26.950000,246273,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-10,27.200000,27.380000,26.290000,26.860000,26.860000,234924,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-11,26.840000,27.090000,26.060000,26.120000,26.120000,278425,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-12,26.220000,26.540000,25.459200,26.310000,26.310000,191394,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-13,26.310000,26.700000,26.030000,26.190000,26.190000,208640,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-16,26.000000,26.520000,26.000000,26.330000,26.330000,316609,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-17,26.140000,26.450000,25.230000,25.360000,25.360000,235559,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-18,25.290000,26.360000,25.100000,26.180000,26.180000,244136,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-19,24.770000,24.770000,23.311200,23.950000,23.950000,1189868,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-20,24.070000,24.450000,23.822000,24.385000,24.385000,477993,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-23,24.390000,24.730000,23.305400,23.500000,23.500000,465510,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-24,23.630000,24.370000,23.490000,24.120000,24.120000,362415,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-25,24.210000,24.800000,24.120000,24.610000,24.610000,534224,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-26,24.550000,24.550000,23.660000,23.670000,23.670000,180304,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-27,23.610000,24.280000,23.330000,24.240000,24.240000,141411,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-05-31,24.430000,24.680000,23.690000,23.960000,23.960000,280777,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-01,23.940000,24.310000,23.680000,24.160000,24.160000,270568,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-02,24.070000,25.060000,24.070000,25.060000,25.060000,210964,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-03,25.000000,25.450000,24.260000,24.820000,24.820000,211379,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-06,24.760000,25.300000,24.360000,25.110000,25.110000,403129,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-07,25.000000,25.000000,24.280000,24.540000,24.540000,257247,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-08,24.620000,24.890000,24.050000,24.750000,24.750000,168014,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-09,24.580000,24.915000,23.670000,23.750000,23.750000,292996,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-10,23.460000,23.850000,23.000000,23.260000,23.260000,223805,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-13,23.120000,23.240000,22.410000,22.500000,22.500000,242743,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-14,22.490000,22.660000,21.790000,22.090000,22.090000,267261,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-15,22.230000,22.550000,22.020000,22.350000,22.350000,289131,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-16,22.190000,22.460000,21.710000,22.440000,22.440000,249254,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-17,22.390000,22.420000,21.110000,21.160000,21.160000,566249,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-20,21.450000,22.980000,21.450000,22.470000,22.470000,430752,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-21,22.590000,22.590000,21.945000,22.520000,22.520000,267209,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-22,22.500000,23.789900,22.460000,23.250000,23.250000,282634,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-23,23.510000,23.850000,23.260000,23.840000,23.840000,227805,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-24,22.760000,23.880000,22.450000,23.670000,23.670000,533845,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-27,23.370000,23.860000,23.310000,23.460000,23.460000,400411,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-28,23.860000,24.960000,23.640000,24.920000,24.920000,485410,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-29,25.120000,27.129900,24.859000,26.630000,26.630000,672262,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-06-30,26.700000,27.360000,25.960000,27.360000,27.360000,532497,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-01,27.420000,28.000000,26.640000,27.970000,27.970000,440480,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-05,27.740000,27.900000,27.055000,27.220000,27.220000,367349,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-06,27.020000,27.770000,26.740000,27.730000,27.730000,166698,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-07,27.850000,27.860000,26.680000,27.270000,27.270000,211309,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-08,27.410000,27.750000,27.210000,27.750000,27.750000,290428,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-11,27.810000,28.430000,27.760000,27.950000,27.950000,297453,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-12,28.290000,28.290000,27.215000,27.460000,27.460000,320187,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-13,27.610000,27.750000,26.480000,26.560000,26.560000,285618,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-14,26.840000,27.000000,26.450000,26.660000,26.660000,181918,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-15,26.920000,27.220000,26.830000,27.060000,27.060000,140380,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-18,27.030000,27.310000,26.590000,26.980000,26.980000,115732,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-19,26.950000,26.950000,25.930000,26.060000,26.060000,176414,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-20,26.270000,27.120000,26.230000,27.020000,27.020000,265625,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-21,27.110000,27.590000,27.100000,27.320000,27.320000,150147,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-22,27.260000,27.690000,27.140000,27.500000,27.500000,150264,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-25,27.490000,27.820000,26.940000,26.990000,26.990000,137725,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-26,26.870000,27.680000,26.580000,27.480000,27.480000,272776,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-27,27.530000,28.330000,27.497300,28.310000,28.310000,218075,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-28,28.180000,28.310000,27.690000,27.850000,27.850000,199322,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-07-29,27.860000,29.030000,27.780000,28.600000,28.600000,231311,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-01,28.590000,30.000000,28.590000,29.870000,29.870000,417678,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-02,29.810000,30.060000,29.330000,29.700000,29.700000,369233,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-03,29.690000,30.290000,29.260000,30.240000,30.240000,310085,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-04,30.850000,31.250000,29.020000,29.950000,29.950000,431018,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-05,29.970000,30.405000,29.790000,30.070000,30.070000,260333,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-08,30.030000,30.315000,28.950000,30.000000,30.000000,247731,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-09,30.050000,30.440000,29.785000,29.900000,29.900000,131389,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-10,29.880000,29.880000,29.210000,29.490000,29.490000,182838,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-11,29.590000,30.810000,29.150000,30.630000,30.630000,244413,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-12,30.620000,31.250000,30.480000,31.130000,31.130000,179393,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-15,31.240000,31.480000,30.960000,31.200000,31.200000,181726,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-16,31.060000,31.650000,30.850000,31.370000,31.370000,269091,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-17,31.390000,31.740000,31.085000,31.590000,31.590000,280012,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-18,31.640000,31.690000,31.000000,31.450000,31.450000,213300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-19,31.350000,31.540000,31.150000,31.460000,31.460000,153964,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-22,31.530000,31.910000,31.415000,31.780000,31.780000,222230,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-23,31.850000,31.980000,31.560000,31.680000,31.680000,137330,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-24,31.560000,32.160000,30.770000,31.110000,31.110000,344758,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-25,31.070000,31.750000,30.390000,31.010000,31.010000,264508,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-26,30.940000,31.570000,30.000000,31.350000,31.350000,226948,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-29,31.350000,32.200000,30.610000,31.140000,31.140000,240407,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-30,31.170000,31.480000,30.780000,30.890000,30.890000,202552,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-08-31,30.920000,31.400000,30.610000,30.990000,30.990000,191075,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-01,31.040000,31.210000,30.780000,31.040000,31.040000,217966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-02,31.200000,31.410000,30.830000,31.410000,31.410000,274604,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-06,31.440000,31.750000,31.230100,31.610000,31.610000,173280,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-07,31.620000,33.390000,31.620000,33.380000,33.380000,308462,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-08,33.250000,33.400000,32.740000,33.260000,33.260000,212067,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-09,32.860000,33.310000,32.180000,32.190000,32.190000,426891,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-12,32.030000,32.800000,32.010000,32.750000,32.750000,286058,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-13,32.440000,32.440000,31.920000,32.120000,32.120000,281896,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-14,32.260000,33.290000,32.240000,32.830000,32.830000,352454,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-15,32.540000,33.060000,31.950000,33.060000,33.060000,396070,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-16,33.030000,33.510000,32.650000,33.200000,33.200000,403452,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-19,33.300000,33.390000,32.916000,33.240000,33.240000,216398,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-20,33.540000,33.550000,32.580000,33.320000,33.320000,224013,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-21,33.550000,33.790000,32.720000,33.420000,33.420000,361597,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-22,33.480000,33.480000,32.110000,32.800000,32.800000,319216,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-23,32.470000,32.775000,32.060000,32.110000,32.110000,351874,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-26,31.990000,31.990000,30.760000,31.010000,31.010000,291874,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-27,31.050000,31.740000,30.840000,31.710000,31.710000,218960,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-28,31.620000,31.880000,31.030000,31.410000,31.410000,291510,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-29,31.360000,31.400000,29.500000,29.540000,29.540000,374175,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-09-30,29.800000,30.600000,29.310000,30.190000,30.190000,410713,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-03,30.000000,30.430000,29.750000,30.300000,30.300000,326918,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-04,30.460000,30.640000,29.960000,30.140000,30.140000,138635,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-05,30.350000,30.710000,30.000000,30.290000,30.290000,149813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-06,30.100000,30.300000,29.840000,30.240000,30.240000,286131,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-07,30.190000,31.070000,30.110000,30.980000,30.980000,274956,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-10,31.220000,31.720000,31.220000,31.640000,31.640000,147585,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-11,31.310000,31.740000,30.190000,30.310000,30.310000,241537,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-12,30.410000,30.565000,29.790000,29.900000,29.900000,163521,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-13,29.590000,30.160000,29.590000,29.690000,29.690000,269942,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-14,29.750000,29.900000,29.270000,29.320000,29.320000,170619,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-17,29.290000,29.420000,28.810000,28.830000,28.830000,202266,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-18,29.150000,29.410000,28.899000,29.210000,29.210000,246833,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-19,29.160000,29.160000,28.250000,28.400000,28.400000,302119,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-20,28.380000,29.400000,28.120000,29.150000,29.150000,237644,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-21,28.870000,29.320000,28.770000,29.250000,29.250000,157607,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-24,29.370000,29.680000,28.980000,29.270000,29.270000,254974,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-25,29.200000,29.412000,28.655000,28.730000,28.730000,240872,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-26,28.790000,28.940000,28.455000,28.820000,28.820000,158148,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-27,29.040000,29.252000,28.570000,28.640000,28.640000,135445,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-28,28.520000,28.770000,27.590000,28.580000,28.580000,168806,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-10-31,28.620000,28.850000,28.240000,28.570000,28.570000,160564,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-01,28.580000,28.800000,27.920000,28.570000,28.570000,196794,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-02,28.520000,28.610000,27.910000,28.240000,28.240000,227902,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-03,29.850000,29.940000,26.160000,26.640000,26.640000,615748,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-04,26.430000,27.490000,26.189400,27.070000,27.070000,311351,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-07,27.660000,27.660000,26.610000,27.480000,27.480000,307313,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-08,27.270000,28.120000,27.110000,27.930000,27.930000,161329,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-09,29.400000,31.040000,29.020000,30.910000,30.910000,520813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-10,31.200000,32.220000,30.100000,31.410000,31.410000,475675,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-11,31.350000,32.400000,30.610000,32.290000,32.290000,356962,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-14,32.570000,33.130000,31.820000,33.050000,33.050000,326590,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-15,33.010000,33.290000,32.290000,33.110000,33.110000,236464,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-16,32.850000,33.060000,31.925000,32.025000,32.025000,185696,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-17,32.220000,33.060000,31.900000,33.040000,33.040000,198614,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-18,33.060000,33.190000,32.300000,32.960000,32.960000,204079,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-21,32.960000,33.320000,32.067000,32.500000,32.500000,474664,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-22,32.510000,32.930000,31.810000,32.150000,32.150000,311232,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-23,31.740000,34.060000,31.440000,33.980000,33.980000,559694,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-25,34.000000,34.020000,33.620000,33.860000,33.860000,170097,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-28,33.570000,33.570000,32.770000,33.000000,33.000000,259856,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-29,33.120000,33.790000,32.860000,33.420000,33.420000,311965,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-11-30,33.690000,33.935000,31.850000,32.200000,32.200000,246418,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-01,32.320000,32.500000,30.860000,30.910000,30.910000,261052,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-02,30.920000,31.555000,30.810000,31.050000,31.050000,164848,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-05,31.490000,32.310000,31.030000,32.250000,32.250000,242021,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-06,32.210000,32.770000,31.610000,32.470000,32.470000,201396,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-07,32.080000,32.660000,30.480000,31.270000,31.270000,238258,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-08,31.200000,31.760000,30.660000,31.720000,31.720000,194747,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-09,31.990000,32.240000,31.340000,31.540000,31.540000,149616,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-12,31.460000,31.970000,31.110000,31.900000,31.900000,179263,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-13,32.090000,33.020000,32.070000,32.590000,32.590000,200837,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-14,32.620000,33.090000,32.230000,33.050000,33.050000,244594,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-15,33.260000,33.580000,32.840000,33.530000,33.530000,259872,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-16,33.640000,34.030000,32.270000,32.390000,32.390000,614903,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-19,32.470000,33.200000,32.060000,32.190000,32.190000,201928,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-20,32.570000,32.900000,32.400000,32.810000,32.810000,157526,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-21,32.890000,32.940000,32.210000,32.520000,32.520000,146368,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-22,32.470000,32.630000,31.790000,31.850000,31.850000,163776,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-23,31.930000,32.540000,31.740000,32.450000,32.450000,115056,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-27,32.660000,33.340000,32.020000,32.060000,32.060000,145744,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-28,32.180000,32.270000,31.420000,31.530000,31.530000,151943,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-29,31.570000,32.190000,31.339000,31.510000,31.510000,142164,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2016-12-30,31.310000,31.575000,30.620000,30.820000,30.820000,221220,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-03,30.800000,31.520000,30.710000,31.150000,31.150000,257207,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-04,31.230000,32.440000,31.020000,32.300000,32.300000,248098,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-05,32.470000,33.250000,31.870000,33.110000,33.110000,320874,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-06,32.810000,33.705000,32.585000,33.100000,33.100000,201778,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-09,33.220000,33.220000,32.300000,32.340000,32.340000,241608,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-10,32.300000,32.760000,31.830000,32.190000,32.190000,245010,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-11,32.110000,32.480000,30.380000,30.940000,30.940000,267811,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-12,30.710000,31.350000,30.440000,31.100000,31.100000,161435,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-13,31.150000,31.650000,30.800000,30.930000,30.930000,162150,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-17,30.740000,31.810000,29.590000,29.710000,29.710000,160518,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-18,29.910000,30.600000,29.610000,30.560000,30.560000,185196,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-19,30.560000,30.560000,29.900000,30.310000,30.310000,119058,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-20,30.350000,30.589900,29.970000,30.520000,30.520000,166293,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-23,30.310000,30.820000,29.330000,29.530000,29.530000,246142,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-24,29.570000,29.820000,28.530000,29.780000,29.780000,257933,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-25,29.990000,30.040000,28.475000,28.820000,28.820000,493666,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-26,28.850000,29.240000,28.650000,29.020000,29.020000,202573,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-27,28.990000,29.420000,28.830000,29.080000,29.080000,117410,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-30,28.940000,29.310000,28.610000,28.900000,28.900000,240710,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-01-31,28.690000,30.140000,28.690000,30.040000,30.040000,267308,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-01,30.140000,30.280000,29.330000,29.720000,29.720000,150366,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-02,29.510000,29.940000,29.300000,29.480000,29.480000,133390,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-03,29.700000,29.870000,29.500000,29.690000,29.690000,115066,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-06,29.570000,29.590000,29.010000,29.110000,29.110000,107955,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-07,29.120000,29.470000,28.920000,29.240000,29.240000,244430,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-08,29.110000,29.380000,28.880000,29.090000,29.090000,211052,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-09,29.090000,30.320000,29.090000,30.270000,30.270000,326241,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-10,30.240000,30.380000,29.860000,30.070000,30.070000,97028,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-13,30.540000,30.550000,29.940000,30.110000,30.110000,142380,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-14,29.920000,30.410000,29.920000,30.350000,30.350000,132668,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-15,30.320000,30.860000,29.980000,30.810000,30.810000,152310,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-16,30.800000,30.930000,30.440000,30.890000,30.890000,215860,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-17,30.920000,31.150000,30.530000,31.020000,31.020000,281596,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-21,31.170000,31.170000,30.260000,30.480000,30.480000,260654,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-22,30.750000,32.420000,30.750000,32.320000,32.320000,539077,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-23,32.450000,32.660000,31.670000,32.400000,32.400000,300362,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-24,32.010000,32.320000,31.410000,32.130000,32.130000,132756,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-27,32.080000,32.550000,31.840000,32.430000,32.430000,231642,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-02-28,32.350000,32.800000,30.840000,31.510000,31.510000,578565,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-01,32.060000,32.770000,31.790000,32.030000,32.030000,258149,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-02,31.840000,32.270000,31.590000,31.850000,31.850000,192179,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-03,31.940000,32.180000,31.390000,31.660000,31.660000,88819,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-06,31.550000,31.800000,31.230000,31.230000,31.230000,115134,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-07,30.940000,31.870000,30.700000,30.970000,30.970000,182779,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-08,31.100000,31.980000,31.060000,31.670000,31.670000,145330,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-09,31.820000,32.140000,31.630000,32.020000,32.020000,123249,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-10,32.230000,32.370000,31.920000,32.240000,32.240000,166337,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-13,32.230000,32.660000,31.870000,32.610000,32.610000,138351,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-14,32.520000,33.070000,32.360000,33.000000,33.000000,253456,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-15,33.080000,33.810000,32.900000,33.690000,33.690000,245592,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-16,33.700000,33.780000,33.350000,33.750000,33.750000,125693,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-17,33.630000,35.360000,33.000000,34.930000,34.930000,729445,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-20,34.920000,35.610000,34.460000,34.970000,34.970000,300760,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-21,35.030000,35.030000,33.810000,33.870000,33.870000,287907,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-22,33.860000,34.440000,33.560000,34.060000,34.060000,184433,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-23,34.000000,35.170000,33.420000,34.710000,34.710000,426471,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-24,34.800000,34.910000,34.140000,34.640000,34.640000,200546,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-27,34.160000,34.820000,33.380000,34.670000,34.670000,156693,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-28,34.540000,35.000000,34.280000,34.750000,34.750000,140153,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-29,34.790000,35.570000,34.650000,35.100000,35.100000,253732,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-30,35.160000,35.460000,34.730000,35.070000,35.070000,165465,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-03-31,35.000000,35.320000,34.440000,35.200000,35.200000,214192,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-03,35.220000,35.230000,33.820000,33.830000,33.830000,261786,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-04,33.810000,35.470000,33.680000,33.880000,33.880000,202542,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-05,33.760000,34.220000,33.400000,33.640000,33.640000,241974,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-06,33.770000,33.850000,32.730000,33.810000,33.810000,204295,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-07,33.720000,34.350000,33.400000,34.290000,34.290000,223101,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-10,34.250000,34.710000,34.120000,34.470000,34.470000,156766,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-11,34.300000,34.760000,34.240000,34.740000,34.740000,167558,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-12,34.780000,35.350000,34.190000,35.140000,35.140000,221661,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-13,35.080000,35.750000,34.920000,35.350000,35.350000,186994,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-17,35.510000,35.730000,35.130000,35.640000,35.640000,104301,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-18,35.590000,35.800000,35.290000,35.670000,35.670000,179586,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-19,35.790000,36.020000,35.420000,35.890000,35.890000,291340,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-20,36.030000,36.100000,35.320000,35.840000,35.840000,349067,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-21,35.780000,35.780000,34.710000,35.060000,35.060000,224107,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-24,35.330000,35.730000,35.040000,35.110000,35.110000,146940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-25,35.300000,35.690000,34.600000,34.630000,34.630000,367775,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-26,34.630000,35.850000,34.630000,35.790000,35.790000,300005,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-27,35.810000,37.290000,35.780000,36.890000,36.890000,489239,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-04-28,36.960000,37.590000,36.130000,36.790000,36.790000,313096,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-01,36.790000,37.400000,36.420000,37.260000,37.260000,269407,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-02,37.260000,37.290000,36.120000,36.290000,36.290000,249463,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-03,36.040000,36.320000,35.750000,35.800000,35.800000,217941,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-04,36.300000,38.110000,35.530000,38.010000,38.010000,407224,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-05,38.250000,38.610000,37.570000,37.670000,37.670000,360625,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-08,37.680000,38.270000,37.430000,37.710000,37.710000,380201,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-09,37.710000,38.090000,37.080000,38.060000,38.060000,291434,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-10,38.090000,38.480000,37.730000,38.360000,38.360000,270404,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-11,38.350000,38.780000,37.840000,38.620000,38.620000,255628,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-12,38.560000,38.970000,38.360000,38.840000,38.840000,291650,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-15,39.060000,39.230000,38.370000,38.450000,38.450000,179826,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-16,38.450000,39.740000,38.330000,39.720000,39.720000,272500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-17,39.130000,39.960000,39.050000,39.390000,39.390000,514375,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-18,39.390000,39.840000,38.330000,38.760000,38.760000,256915,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-19,38.620000,39.490000,38.120000,38.310000,38.310000,181207,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-22,38.410000,39.180000,38.150000,39.160000,39.160000,182244,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-23,39.390000,39.460000,38.500000,38.620000,38.620000,299151,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-24,38.750000,39.370000,38.560000,38.900000,38.900000,342709,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-25,38.950000,38.950000,38.330000,38.860000,38.860000,130900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-26,38.860000,39.460000,38.310000,39.260000,39.260000,122723,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-30,39.190000,39.510000,39.040000,39.280000,39.280000,131498,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-05-31,39.540000,39.670000,38.550000,39.240000,39.240000,315990,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-01,39.510000,39.780000,38.890000,39.360000,39.360000,356068,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-02,39.360000,40.310000,39.360000,39.980000,39.980000,340158,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-05,40.050000,40.480000,39.680000,39.750000,39.750000,303935,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-06,39.650000,40.060000,38.520000,38.880000,38.880000,283972,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-07,39.060000,39.690000,38.340000,39.060000,39.060000,231076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-08,39.060000,39.810000,38.970000,39.340000,39.340000,168705,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-09,39.240000,39.910000,38.970000,39.230000,39.230000,225722,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-12,39.280000,39.280000,37.430000,37.860000,37.860000,383968,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-13,38.140000,38.360000,37.400000,38.010000,38.010000,375837,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-14,38.080000,39.230000,38.080000,38.990000,38.990000,193795,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-15,38.450000,38.650000,37.990000,38.530000,38.530000,172147,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-16,38.110000,38.800000,37.880000,38.230000,38.230000,219862,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-19,38.390000,39.510000,37.980000,39.260000,39.260000,177814,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-20,39.180000,40.170000,39.020000,39.150000,39.150000,215609,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-21,39.300000,40.270000,39.230000,39.840000,39.840000,253139,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-22,39.710000,40.580000,39.600000,40.090000,40.090000,161065,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-23,40.390000,46.810000,39.270000,44.200000,44.200000,879657,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-26,44.410000,46.640000,44.030000,45.340000,45.340000,724455,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-27,44.400000,45.140000,42.620000,43.250000,43.250000,758153,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-28,42.630000,43.240000,41.450000,41.600000,41.600000,2558151,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-29,41.800000,42.420000,40.970000,41.640000,41.640000,391375,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-06-30,41.450000,41.810000,41.160000,41.440000,41.440000,304888,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-03,41.400000,41.810000,40.980000,41.370000,41.370000,133990,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-05,41.680000,42.170000,41.180000,41.740000,41.740000,297961,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-06,41.390000,41.880000,41.000000,41.100000,41.100000,295387,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-07,41.360000,42.000000,40.750000,41.390000,41.390000,212502,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-10,41.180000,41.650000,40.590000,41.460000,41.460000,235832,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-11,41.500000,41.980000,41.120000,41.420000,41.420000,433794,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-12,41.730000,42.790000,41.010000,42.630000,42.630000,344739,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-13,42.730000,42.750000,41.901000,42.600000,42.600000,454004,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-14,42.580000,42.720000,42.180000,42.300000,42.300000,273435,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-17,42.160000,42.550000,41.590000,41.890000,41.890000,135940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-18,41.720000,41.930000,41.140000,41.370000,41.370000,147214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-19,41.630000,42.170000,41.430000,42.040000,42.040000,148761,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-20,42.000000,42.240000,41.670000,42.170000,42.170000,192852,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-21,42.720000,42.900000,41.820000,42.450000,42.450000,298184,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-24,42.320000,42.870000,42.270000,42.730000,42.730000,134234,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-25,42.870000,42.870000,41.990000,42.290000,42.290000,343242,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-26,42.570000,42.680000,41.390000,41.760000,41.760000,399730,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-27,41.900000,42.110000,40.600000,40.720000,40.720000,371593,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-28,40.650000,41.070000,40.300000,40.390000,40.390000,319144,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-07-31,40.490000,40.810000,40.120000,40.270000,40.270000,149709,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-01,40.370000,41.800000,40.230000,40.990000,40.990000,593294,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-02,41.280000,41.690000,40.330000,40.990000,40.990000,352828,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-03,42.000000,43.000000,41.130000,41.440000,41.440000,554169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-04,41.750000,41.950000,40.290000,41.530000,41.530000,333824,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-07,41.880000,42.680000,41.590000,42.530000,42.530000,189921,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-08,42.410000,43.340000,42.360000,42.780000,42.780000,741720,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-09,42.590000,43.250000,42.250000,42.710000,42.710000,351492,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-10,42.500000,42.500000,40.670000,41.070000,41.070000,225626,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-11,41.220000,41.990000,40.720000,41.180000,41.180000,215269,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-14,41.400000,41.680000,41.070000,41.610000,41.610000,150520,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-15,41.640000,41.680000,40.960000,41.080000,41.080000,107513,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-16,41.360000,41.860000,40.800000,41.270000,41.270000,135152,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-17,41.020000,41.180000,39.690000,39.710000,39.710000,263703,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-18,39.420000,40.480000,39.340000,40.210000,40.210000,234773,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-21,40.030000,40.530000,39.990000,40.310000,40.310000,160952,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-22,40.390000,42.110000,40.030000,41.940000,41.940000,234714,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-23,41.520000,41.930000,41.180000,41.440000,41.440000,143146,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-24,41.500000,41.990000,41.130000,41.850000,41.850000,158712,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-25,42.010000,42.240000,41.120000,41.320000,41.320000,157862,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-28,41.670000,42.970000,41.410000,42.470000,42.470000,303412,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-29,42.170000,42.610000,41.910100,42.390000,42.390000,188514,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-30,42.250000,42.770000,42.250000,42.420000,42.420000,149321,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-08-31,42.640000,43.720000,42.640000,43.670000,43.670000,242294,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-01,43.910000,43.930000,43.240000,43.480000,43.480000,197722,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-05,43.560000,43.660000,42.340000,42.950000,42.950000,225570,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-06,43.140000,43.450000,42.510000,42.940000,42.940000,184019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-07,43.050000,43.300000,42.580000,43.030000,43.030000,141131,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-08,42.980000,43.640000,42.980000,43.450000,43.450000,184171,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-11,43.760000,44.140000,43.240000,43.660000,43.660000,185270,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-12,43.650000,43.880000,42.840000,42.910000,42.910000,197970,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-13,42.800000,43.300000,42.530000,43.000000,43.000000,362375,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-14,43.090000,43.450000,42.700000,43.130000,43.130000,370439,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-15,43.260000,44.330000,42.910000,44.320000,44.320000,1076234,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-18,44.640000,46.120000,44.380000,46.060000,46.060000,571251,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-19,45.890000,45.890000,43.990000,44.430000,44.430000,576114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-20,44.180000,44.690000,43.750000,44.210000,44.210000,197841,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-21,44.040000,44.600000,43.500000,44.150000,44.150000,141168,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-22,44.060000,44.130000,43.650000,43.760000,43.760000,162468,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-25,43.780000,44.020000,42.960000,43.220000,43.220000,210567,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-26,41.100000,41.100000,36.190000,36.980000,36.980000,1927969,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-27,36.990000,38.140000,35.730000,37.920000,37.920000,1041228,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-28,37.670000,37.950000,37.000000,37.690000,37.690000,345144,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-09-29,37.800000,38.530000,37.730000,38.320000,38.320000,386526,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-02,40.050000,40.050000,37.430000,37.650000,37.650000,788436,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-03,37.710000,38.140000,37.290000,38.080000,38.080000,365371,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-04,38.160000,38.470000,37.690000,38.270000,38.270000,201100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-05,38.200000,38.530000,37.900000,38.220000,38.220000,392197,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-06,38.000000,38.690000,37.990000,38.330000,38.330000,269033,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-09,38.330000,38.330000,37.480000,37.830000,37.830000,243910,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-10,37.830000,37.930000,37.210000,37.470000,37.470000,225191,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-11,37.510000,38.110000,37.130000,37.920000,37.920000,297089,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-12,37.840000,38.670000,37.250000,38.270000,38.270000,302861,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-13,38.350000,38.700000,37.930000,38.500000,38.500000,152214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-16,38.500000,38.920000,38.140000,38.200000,38.200000,465587,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-17,38.050000,38.140000,34.910000,36.230000,36.230000,1386196,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-18,36.590000,36.960000,35.920000,36.270000,36.270000,602973,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-19,36.040000,37.170000,35.660000,37.110000,37.110000,518739,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-20,37.380000,38.470000,37.180000,37.920000,37.920000,366911,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-23,37.920000,38.040000,37.340000,37.420000,37.420000,247480,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-24,37.690000,38.080000,37.080000,37.110000,37.110000,490245,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-25,37.110000,37.400000,36.660000,37.000000,37.000000,194182,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-26,36.920000,37.650000,36.060000,37.620000,37.620000,272278,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-27,37.590000,38.200000,36.880000,38.120000,38.120000,287307,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-30,37.900000,38.620000,37.160000,38.570000,38.570000,429500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-10-31,38.580000,38.720000,37.140000,37.200000,37.200000,429301,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-01,37.600000,37.870000,36.680000,37.540000,37.540000,412117,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-02,37.750000,38.630000,37.400000,38.490000,38.490000,258532,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-03,38.410000,39.000000,37.950000,38.920000,38.920000,200208,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-06,38.720000,39.000000,38.230000,38.300000,38.300000,359236,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-07,38.430000,38.470000,37.400000,37.910000,37.910000,296641,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-08,37.700000,38.050000,37.250000,37.390000,37.390000,477847,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-09,38.660000,38.700000,32.050000,36.180000,36.180000,1401717,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-10,35.850000,36.050000,34.080000,34.730000,34.730000,535119,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-13,34.730000,34.730000,33.280000,33.530000,33.530000,510755,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-14,33.500000,33.500000,31.960000,32.530000,32.530000,556416,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-15,32.580000,33.030000,32.080000,32.610000,32.610000,398940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-16,32.660000,34.040000,32.640000,33.730000,33.730000,418575,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-17,33.440000,33.830000,33.070000,33.400000,33.400000,311223,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-20,33.520000,33.740000,33.120000,33.260000,33.260000,233340,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-21,33.580000,34.530000,32.970000,34.500000,34.500000,624434,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-22,34.460000,34.660000,33.690000,33.910000,33.910000,171848,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-24,34.130000,34.600000,33.850000,34.550000,34.550000,131144,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-27,34.420000,34.820000,34.420000,34.590000,34.590000,266053,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-28,34.730000,35.135000,34.490000,35.040000,35.040000,309176,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-29,34.980000,35.480000,34.880000,35.050000,35.050000,213101,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-11-30,34.970000,35.540000,34.590000,35.450000,35.450000,247980,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-01,35.480000,35.530000,34.210000,35.510000,35.510000,321560,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-04,35.950000,35.970000,34.300000,34.340000,34.340000,412439,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-05,34.830000,37.000000,34.830000,35.100000,35.100000,370751,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-06,34.960000,35.075000,34.560000,34.740000,34.740000,325927,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-07,34.850000,35.445000,34.500000,34.580000,34.580000,393222,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-08,35.230000,36.225000,35.230000,35.560000,35.560000,235808,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-11,35.600000,36.270000,35.100000,35.350000,35.350000,247072,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-12,35.490000,35.760000,35.210000,35.570000,35.570000,226283,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-13,35.510000,35.820000,35.190000,35.360000,35.360000,281278,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-14,35.370000,35.870000,35.180000,35.230000,35.230000,291683,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-15,35.340000,36.490000,35.130000,36.080000,36.080000,805912,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-18,36.190000,36.610000,35.950000,36.350000,36.350000,183681,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-19,36.320000,36.590000,35.310000,35.330000,35.330000,231446,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-20,35.290000,35.930000,35.230000,35.340000,35.340000,211190,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-21,35.460000,35.730000,35.060000,35.440000,35.440000,244669,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-22,35.450000,36.020000,35.140000,35.720000,35.720000,205680,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-26,35.670000,35.790000,35.380000,35.510000,35.510000,175183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-27,35.650000,36.450000,35.485000,36.130000,36.130000,191331,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-28,36.100000,36.460000,35.660000,36.080000,36.080000,163843,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2017-12-29,36.280000,36.780000,36.170000,36.280000,36.280000,223657,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-02,36.360000,37.080000,36.050000,37.060000,37.060000,244016,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-03,37.130000,37.230000,36.473200,37.020000,37.020000,199921,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-04,37.150000,37.360000,36.700000,37.110000,37.110000,148006,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-05,37.170000,37.500000,36.890000,37.130000,37.130000,193124,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-08,37.150000,37.150000,36.290000,36.890000,36.890000,189443,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-09,36.920000,37.250000,36.440000,36.490000,36.490000,254115,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-10,36.300000,36.530000,35.820000,36.470000,36.470000,139266,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-11,36.380000,37.100000,36.250000,36.640000,36.640000,195046,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-12,36.740000,37.130000,36.440000,36.610000,36.610000,118965,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-16,36.900000,36.990000,34.840000,34.870000,34.870000,285325,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-17,35.050000,35.330000,34.660000,35.290000,35.290000,292379,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-18,35.320000,35.320000,34.500000,34.880000,34.880000,185200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-19,34.820000,35.900000,34.670100,35.780000,35.780000,189627,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-22,35.980000,36.400000,35.520000,36.290000,36.290000,280419,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-23,36.370000,36.900000,36.180000,36.830000,36.830000,153934,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-24,36.840000,37.355000,36.280000,36.660000,36.660000,190741,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-25,36.960000,37.170000,36.300000,36.860000,36.860000,178304,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-26,37.070000,37.230000,36.730000,36.890000,36.890000,190925,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-29,36.850000,37.820000,36.335000,37.150000,37.150000,221290,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-30,36.740000,36.870000,35.880000,35.940000,35.940000,288481,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-01-31,36.040000,36.100000,35.210000,35.370000,35.370000,293749,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-01,35.110000,35.650000,34.570000,35.120000,35.120000,224266,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-02,34.790000,35.250000,33.730000,33.820000,33.820000,222016,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-05,33.520000,33.945000,31.240000,31.290000,31.290000,382509,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-06,30.540000,33.040000,30.200000,32.880000,32.880000,341753,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-07,32.760000,33.070000,32.470000,32.660000,32.660000,279674,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-08,32.810000,32.810000,30.900000,30.920000,30.920000,322595,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-09,31.390000,31.410000,29.560000,30.920000,30.920000,267580,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-12,31.090000,32.120000,30.680000,31.950000,31.950000,359816,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-13,31.710000,32.490000,31.390000,32.320000,32.320000,153648,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-14,31.950000,33.110000,31.383700,32.990000,32.990000,179544,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-15,33.370000,33.690000,31.520000,32.860000,32.860000,191897,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-16,32.760000,33.380000,32.710000,32.750000,32.750000,152382,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-20,32.480000,33.010000,31.630000,31.760000,31.760000,215519,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-21,31.770000,32.750000,31.460000,32.400000,32.400000,346143,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-22,35.470000,36.150000,33.700000,34.980000,34.980000,627823,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-23,35.590000,35.590000,34.320000,35.370000,35.370000,335677,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-26,35.200000,35.990000,34.320000,35.710000,35.710000,359778,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-27,35.830000,35.900000,35.320000,35.470000,35.470000,288919,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-02-28,35.490000,35.530000,34.250000,34.290000,34.290000,279198,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-01,34.250000,34.250000,33.280000,33.870000,33.870000,212680,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-02,33.560000,34.630000,33.510000,34.500000,34.500000,273225,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-05,34.260000,35.050000,33.970000,35.010000,35.010000,142451,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-06,35.150000,35.850000,34.240000,35.810000,35.810000,553038,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-07,35.510000,36.450000,35.310500,36.410000,36.410000,413932,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-08,36.550000,36.765600,35.950000,36.360000,36.360000,466600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-09,36.530000,37.450000,36.130000,37.270000,37.270000,193263,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-12,37.480000,37.480000,36.190000,37.010000,37.010000,231543,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-13,37.090000,37.190000,35.760000,36.030000,36.030000,281530,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-14,36.500000,36.520000,35.880000,36.410000,36.410000,218920,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-15,36.430000,36.620000,36.100000,36.500000,36.500000,253681,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-16,36.500000,36.830000,36.300000,36.750000,36.750000,734073,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-19,36.690000,36.710000,35.190000,35.770000,35.770000,197449,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-20,35.790000,35.930000,35.170000,35.550000,35.550000,153632,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-21,35.600000,36.340000,35.340000,36.010000,36.010000,159135,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-22,35.560000,36.190000,35.270000,35.270000,35.270000,156579,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-23,35.360000,35.580000,34.410000,34.420000,34.420000,224232,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-26,34.990000,35.974400,34.050000,35.340000,35.340000,212176,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-27,35.530000,35.790000,34.290000,34.570000,34.570000,178618,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-28,34.560000,35.630000,34.160000,35.460000,35.460000,332232,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-03-29,35.600000,36.680000,34.910000,36.180000,36.180000,325588,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-02,36.030000,36.255000,34.750000,35.290000,35.290000,402390,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-03,35.440000,35.490000,34.685000,35.260000,35.260000,242453,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-04,34.610000,36.150000,34.610000,36.050000,36.050000,177787,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-05,36.270000,36.610000,35.720000,36.470000,36.470000,176718,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-06,36.200000,36.650000,35.780000,36.470000,36.470000,273680,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-09,36.750000,37.220000,36.200000,36.540000,36.540000,241286,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-10,37.020000,37.870000,36.770000,37.820000,37.820000,208061,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-11,37.610000,37.820000,37.070000,37.490000,37.490000,325821,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-12,37.820000,38.249900,37.170100,37.760000,37.760000,244155,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-13,37.970000,38.140000,36.100000,37.350000,37.350000,124581,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-16,37.650000,37.650000,37.070000,37.150000,37.150000,114370,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-17,37.370000,38.110000,36.980000,37.900000,37.900000,160544,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-18,38.110000,38.670000,37.700100,38.530000,38.530000,189867,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-19,38.330000,38.710000,37.310000,37.440000,37.440000,137207,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-20,37.250000,37.720000,37.140000,37.630000,37.630000,135243,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-23,37.640000,38.450000,37.510000,37.900000,37.900000,213696,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-24,38.190000,38.190000,36.920000,37.530000,37.530000,200888,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-25,37.640000,38.290000,37.420000,37.630000,37.630000,177239,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-26,37.720000,38.170000,37.285000,37.850000,37.850000,524796,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-27,37.970000,37.970000,37.270000,37.300000,37.300000,165548,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-04-30,37.490000,37.595000,36.410000,37.000000,37.000000,252067,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-01,36.940000,37.150000,36.590000,37.120000,37.120000,149786,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-02,37.060000,37.780000,36.780000,37.080000,37.080000,238810,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-03,37.020000,37.320000,36.440000,36.760000,36.760000,237774,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-04,36.620000,37.380000,36.430000,37.130000,37.130000,105030,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-07,37.280000,38.430000,37.190000,38.350000,38.350000,323972,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-08,38.290000,41.280000,38.080000,40.520000,40.520000,1444109,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-09,40.720000,40.820000,40.110000,40.300000,40.300000,521402,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-10,40.250000,40.970000,39.510000,40.900000,40.900000,259836,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-11,40.610000,42.860000,40.610000,42.250000,42.250000,522238,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-14,42.470000,42.470000,41.850000,42.120000,42.120000,242884,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-15,42.010000,42.150000,41.660000,41.790000,41.790000,179026,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-16,41.920000,42.280000,41.620000,42.070000,42.070000,231216,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-17,42.140000,42.220000,41.360000,42.060000,42.060000,138832,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-18,42.100000,42.660000,41.580000,42.580000,42.580000,247922,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-21,42.630000,42.880000,42.290000,42.600000,42.600000,234524,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-22,42.590000,42.590000,42.130000,42.210000,42.210000,183245,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-23,41.880000,42.820000,41.880000,42.800000,42.800000,166377,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-24,42.860000,43.455000,42.760000,43.030000,43.030000,184743,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-25,42.960000,43.555000,42.720000,43.460000,43.460000,263809,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-29,43.220000,43.500000,42.800000,43.270000,43.270000,214004,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-30,43.550000,43.850000,43.250000,43.390000,43.390000,219046,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-05-31,43.290000,43.950000,43.100000,43.680000,43.680000,226329,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-01,43.690000,44.580000,43.480000,43.600000,43.600000,325966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-04,43.690000,44.220000,43.170000,43.910000,43.910000,1844134,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-05,43.920000,44.080000,43.330000,43.910000,43.910000,309078,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-06,43.920000,44.610000,43.750000,44.140000,44.140000,289760,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-07,44.330000,44.330000,43.690000,44.080000,44.080000,473492,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-08,44.070000,44.730000,44.070000,44.240000,44.240000,206678,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-11,44.200000,45.210000,44.200000,44.390000,44.390000,316296,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-12,44.440000,44.750000,44.100000,44.680000,44.680000,165994,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-13,44.840000,44.840000,44.200000,44.470000,44.470000,289236,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-14,44.690000,44.780000,44.480000,44.780000,44.780000,247433,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-15,44.480000,45.585000,43.020000,45.220000,45.220000,712642,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-18,45.030000,45.420000,44.560000,45.400000,45.400000,179734,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-19,45.180000,45.460000,45.040000,45.380000,45.380000,197971,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-20,45.410000,46.030000,45.100000,45.980000,45.980000,178534,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-21,46.110000,46.110000,45.390000,45.600000,45.600000,254670,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-22,46.000000,46.480000,45.480000,46.290000,46.290000,725761,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-25,46.140000,46.590000,45.560000,46.060000,46.060000,408365,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-26,46.200000,47.260000,46.070000,46.970000,46.970000,298158,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-27,46.990000,47.100000,45.335000,45.430000,45.430000,444271,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-28,45.560000,46.970000,45.061000,46.800000,46.800000,301691,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-06-29,47.080000,47.870000,46.500000,47.040000,47.040000,468508,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-02,46.870000,47.100000,46.163000,47.020000,47.020000,212449,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-03,47.260000,48.160000,46.970000,47.780000,47.780000,115507,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-05,47.860000,48.520000,47.760000,48.480000,48.480000,242375,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-06,48.700000,49.230000,48.300000,48.950000,48.950000,346974,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-09,49.210000,49.210000,47.920000,48.070000,48.070000,287389,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-10,48.420000,48.467500,47.860000,47.910000,47.910000,380010,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-11,47.690000,48.620000,47.545000,48.030000,48.030000,306078,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-12,48.230000,48.705700,47.870000,48.000000,48.000000,217707,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-13,47.820000,48.320000,47.770000,47.860000,47.860000,111329,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-16,47.920000,47.920000,47.350000,47.770000,47.770000,132978,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-17,47.710000,48.270000,47.710000,47.970000,47.970000,223900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-18,48.000000,48.040000,47.590000,47.920000,47.920000,182007,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-19,47.770000,49.330000,47.510000,48.790000,48.790000,396044,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-20,49.060000,49.327500,48.340000,48.790000,48.790000,196398,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-23,48.790000,49.280000,48.600000,48.980000,48.980000,153261,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-24,49.280000,49.430000,48.000000,48.270000,48.270000,273913,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-25,48.410000,49.095000,48.230000,49.050000,49.050000,225769,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-26,48.760000,49.420000,48.260000,48.820000,48.820000,212287,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-27,49.010000,49.010000,47.460000,47.560000,47.560000,238552,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-30,47.630000,48.000000,46.470000,46.800000,46.800000,434113,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-07-31,46.920000,48.755000,46.680000,48.330000,48.330000,345955,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-01,48.340000,48.510000,47.640000,48.050000,48.050000,261817,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-02,46.000000,47.760000,45.000000,47.280000,47.280000,664401,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-03,47.650000,48.226000,47.230000,47.570000,47.570000,282764,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-06,47.590000,49.260000,47.590000,48.930000,48.930000,471154,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-07,49.180000,49.720000,48.450000,49.010000,49.010000,330563,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-08,48.960000,49.060000,48.540000,48.760000,48.760000,130110,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-09,49.030000,50.000000,49.000000,49.500000,49.500000,438252,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-10,49.180000,49.630000,48.760000,49.270000,49.270000,196487,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-13,49.430000,49.810000,48.900000,49.310000,49.310000,201353,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-14,49.280000,49.950000,48.930000,49.500000,49.500000,189998,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-15,49.290000,49.580000,48.760000,49.080000,49.080000,297584,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-16,49.330000,49.355000,48.870000,48.900000,48.900000,211870,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-17,48.780000,49.530000,48.690000,49.520000,49.520000,249956,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-20,49.630000,49.730000,48.525000,49.630000,49.630000,174821,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-21,49.860000,51.320000,49.840000,51.250000,51.250000,369575,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-22,51.210000,51.785000,50.815000,51.610000,51.610000,159561,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-23,51.600000,52.380000,51.260000,52.200000,52.200000,242298,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-24,52.450000,53.460000,52.405600,52.950000,52.950000,464149,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-27,53.120000,54.069000,52.800000,53.030000,53.030000,668432,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-28,53.120000,53.590000,52.480000,53.310000,53.310000,267354,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-29,53.470000,54.740000,53.470000,54.340000,54.340000,442636,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-30,54.150000,54.820000,53.940000,54.410000,54.410000,260503,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-08-31,54.310000,55.310000,54.060000,54.880000,54.880000,211435,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-04,54.690000,55.390000,54.010000,55.360000,55.360000,289040,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-05,55.410000,57.310000,55.190000,57.020000,57.020000,500967,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-06,57.320000,58.120000,56.720000,57.720000,57.720000,399046,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-07,57.580000,58.500000,57.330000,57.550000,57.550000,216771,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-10,57.660000,58.200000,57.160000,57.900000,57.900000,443177,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-11,57.810000,58.400000,57.270000,57.320000,57.320000,227242,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-12,57.070000,57.930000,56.340000,57.000000,57.000000,615680,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-13,57.120000,57.730000,56.760000,57.460000,57.460000,322707,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-14,57.690000,58.990000,57.580000,58.970000,58.970000,592914,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-17,58.800000,58.800000,57.140000,57.290000,57.290000,420184,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-18,57.450000,58.120000,57.140000,57.420000,57.420000,547354,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-19,57.530000,57.900000,56.990000,57.680000,57.680000,326552,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-20,58.040000,58.170000,56.800000,56.830000,56.830000,325689,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-21,56.940000,57.530000,55.130000,55.240000,55.240000,866138,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-24,55.310000,55.550000,54.440000,55.070000,55.070000,402807,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-25,54.990000,55.260000,54.100000,54.380000,54.380000,440685,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-26,54.420000,54.420000,53.560000,53.650000,53.650000,468417,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-27,53.620000,54.480000,52.820000,54.200000,54.200000,354374,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-09-28,54.200000,55.700000,53.720000,55.460000,55.460000,683899,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-01,55.700000,56.495000,55.120000,55.530000,55.530000,641214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-02,55.440000,56.370000,55.000000,55.690000,55.690000,472283,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-03,56.210000,56.570000,55.690000,55.950000,55.950000,196414,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-04,55.710000,55.710000,53.240000,53.420000,53.420000,662834,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-05,53.610000,54.720000,53.140000,54.480000,54.480000,296395,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-08,54.335000,54.800000,53.347400,54.690000,54.690000,468319,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-09,54.470000,54.970000,53.880000,54.030000,54.030000,490066,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-10,54.030000,55.220000,53.460000,53.570000,53.570000,329425,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-11,53.300000,54.490000,52.750000,53.160000,53.160000,308513,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-12,54.050000,54.715000,53.280000,54.010000,54.010000,243813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-15,53.950000,54.310000,53.130000,53.840000,53.840000,285063,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-16,54.350000,56.800000,53.990000,56.590000,56.590000,317085,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-17,56.720000,57.620000,55.600000,57.480000,57.480000,365984,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-18,57.400000,58.330000,55.590000,56.510000,56.510000,382088,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-19,56.540000,57.770000,54.530000,55.150000,55.150000,304440,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-22,54.870000,56.240000,54.870000,56.080000,56.080000,309206,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-23,55.330000,57.450000,55.330000,56.140000,56.140000,353497,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-24,56.320000,57.000000,52.600000,52.660000,52.660000,620887,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-25,52.990000,54.910000,52.560000,53.340000,53.340000,559544,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-26,52.630000,54.970000,52.620000,54.620000,54.620000,234859,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-29,55.160000,56.170000,54.140000,54.880000,54.880000,408010,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-30,54.670000,55.700000,53.820000,54.580000,54.580000,257291,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-10-31,55.140000,55.850000,54.220000,54.220000,54.220000,592184,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-01,55.890000,63.980000,55.890000,63.550000,63.550000,1384600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-02,64.710000,68.120000,64.350000,66.220000,66.220000,2256811,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-05,64.650000,67.718600,64.500000,67.290000,67.290000,1145903,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-06,67.300000,68.505000,66.580000,67.910000,67.910000,801698,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-07,68.720000,70.500000,67.120000,67.980000,67.980000,1048855,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-08,67.990000,69.180000,67.569800,68.880000,68.880000,726182,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-09,68.950000,69.230000,67.670000,67.740000,67.740000,428578,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-12,66.150000,68.430000,65.180000,65.290000,65.290000,381083,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-13,65.220000,66.660000,65.140000,65.390000,65.390000,306069,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-14,65.820000,67.150000,63.710000,63.780000,63.780000,418717,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-15,63.260000,64.660000,62.110000,64.050000,64.050000,920215,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-16,63.890000,66.590000,63.740000,65.450000,65.450000,557357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-19,65.500000,66.000000,62.090000,62.180000,62.180000,371609,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-20,61.400000,62.810000,61.050000,61.500000,61.500000,373205,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-21,61.530000,63.770000,61.530000,63.410000,63.410000,187545,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-23,62.920000,64.690000,62.920000,63.940000,63.940000,70305,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-26,64.710000,64.710000,63.170000,64.230000,64.230000,289523,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-27,63.740000,65.020000,63.340000,64.140000,64.140000,225109,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-28,64.550000,65.200000,63.800100,64.900000,64.900000,377178,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-29,64.560000,66.420000,64.523000,65.900000,65.900000,257142,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-11-30,65.690000,66.280000,64.180000,64.670000,64.670000,367768,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-03,65.880000,65.990000,63.900000,64.330000,64.330000,1042774,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-04,63.740000,65.080000,62.630000,62.880000,62.880000,605924,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-06,62.300000,62.850000,60.890000,61.730000,61.730000,485423,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-07,61.720000,62.350000,60.870000,61.260000,61.260000,328517,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-10,61.120000,62.350000,60.480500,61.920000,61.920000,406336,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-11,62.390000,62.999000,61.340000,61.860000,61.860000,317938,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-12,62.050000,63.260000,60.110000,60.650000,60.650000,830339,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-13,60.500000,61.730000,58.830000,59.080000,59.080000,364322,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-14,58.750000,59.850000,57.170000,57.300000,57.300000,467139,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-17,57.210000,57.210000,53.580000,54.210000,54.210000,1410737,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-18,54.770000,55.360000,53.730000,54.010000,54.010000,624538,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-19,54.160000,54.550000,51.830000,52.350000,52.350000,499666,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-20,52.490000,52.630000,50.250000,50.800000,50.800000,533173,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-21,50.770000,50.810000,48.460000,48.970000,48.970000,1595773,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-24,48.590000,49.510000,48.260000,48.260000,48.260000,157905,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-26,48.290000,51.660000,48.290000,51.580000,51.580000,373963,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-27,50.670000,51.310000,49.250000,50.520000,50.520000,496102,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-28,50.850000,52.140000,50.260000,51.330000,51.330000,249424,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2018-12-31,51.760000,52.870000,51.410000,52.740000,52.740000,406418,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-02,52.330000,52.610000,51.140000,51.690000,51.690000,439984,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-03,51.730000,51.800000,49.070000,49.450000,49.450000,380304,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-04,50.170000,50.999700,49.710000,50.860000,50.860000,289073,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-07,51.160000,53.740000,50.700000,53.630000,53.630000,629386,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-08,53.890000,55.090000,53.080000,54.830000,54.830000,470473,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-09,54.590000,55.650000,53.880000,54.760000,54.760000,514216,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-10,54.560000,55.420000,53.460000,55.200000,55.200000,298932,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-11,54.810000,55.610000,54.385000,55.100000,55.100000,236920,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-14,54.750000,54.950000,53.850000,54.110000,54.110000,306669,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-15,54.230000,55.670000,54.020000,55.240000,55.240000,184725,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-16,55.670000,55.995000,54.680000,55.600000,55.600000,213084,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-17,55.320000,57.320000,55.250000,56.750000,56.750000,337183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-18,56.910000,58.430000,56.790000,58.330000,58.330000,298721,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-22,57.860000,58.290000,54.505000,55.150000,55.150000,549265,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-23,55.010000,56.260000,53.990000,54.590000,54.590000,274238,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-24,54.630000,56.060000,54.630000,55.810000,55.810000,312582,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-25,55.990000,58.000000,55.545000,57.950000,57.950000,498485,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-28,57.630000,57.962500,54.780000,54.970000,54.970000,337416,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-29,55.020000,55.050000,54.160000,54.620000,54.620000,208873,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-30,55.040000,56.020000,54.620800,55.750000,55.750000,282724,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-01-31,55.750000,57.120000,55.750000,57.010000,57.010000,219186,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-01,57.050000,57.840000,56.695000,57.660000,57.660000,237444,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-04,57.660000,58.460000,57.150000,58.220000,58.220000,184363,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-05,58.420000,59.200000,58.020000,58.150000,58.150000,228783,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-06,58.160000,58.847500,57.726000,57.780000,57.780000,126952,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-07,57.620000,58.410000,56.240000,57.020000,57.020000,254075,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-08,56.750000,57.620000,56.750000,57.500000,57.500000,114556,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-11,57.770000,59.050000,57.300000,59.020000,59.020000,229383,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-12,59.200000,60.250000,58.810000,60.110000,60.110000,349583,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-13,60.320000,60.860000,57.890000,58.460000,58.460000,219934,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-14,58.510000,59.450000,58.160000,58.820000,58.820000,253594,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-15,59.000000,61.100000,58.540000,60.190000,60.190000,428174,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-19,60.190000,60.730000,59.390000,59.510000,59.510000,338210,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-20,59.810000,60.365000,58.310000,59.000000,59.000000,328993,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-21,57.510000,60.130000,55.560100,58.050000,58.050000,513574,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-22,57.860000,59.290000,57.630000,58.880000,58.880000,248186,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-25,59.590000,60.790000,59.110000,60.190000,60.190000,255230,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-26,60.020000,60.780000,59.540000,59.590000,59.590000,291348,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-27,59.760000,60.195000,58.470000,59.710000,59.710000,217823,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-02-28,59.560000,60.080000,58.680000,59.520000,59.520000,210588,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-01,59.930000,62.910000,59.655000,62.800000,62.800000,490907,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-04,62.990000,63.410000,59.020000,59.140000,59.140000,301782,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-05,59.290000,60.005000,57.760000,58.060000,58.060000,248364,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-06,58.130000,58.160000,56.560000,56.640000,56.640000,263648,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-07,56.540000,56.890000,55.615000,56.560000,56.560000,257705,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-08,56.340000,57.540000,56.150000,56.730000,56.730000,205831,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-11,57.230000,58.760000,56.980000,58.660000,58.660000,212379,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-12,58.520000,59.840000,58.060000,59.140000,59.140000,165620,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-13,59.440000,59.900000,58.707500,59.710000,59.710000,215058,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-14,59.560000,59.920000,58.860000,59.170000,59.170000,170102,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-15,59.430000,60.480000,59.400000,60.130000,60.130000,398525,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-18,60.120000,61.060000,58.870000,59.410000,59.410000,218285,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-19,59.500000,59.999900,58.670000,59.370000,59.370000,191962,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-20,59.460000,60.260000,58.915000,59.480000,59.480000,508363,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-21,59.200000,61.880000,59.200000,61.760000,61.760000,563907,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-22,61.120000,61.510000,58.910000,58.910000,58.910000,358663,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-25,59.020000,59.535000,57.865000,59.000000,59.000000,201849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-26,59.430000,60.070000,58.660000,59.210000,59.210000,127408,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-27,59.400000,59.400000,56.490000,57.420000,57.420000,495727,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-28,57.430000,58.800000,57.050000,58.700000,58.700000,223202,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-03-29,59.250000,59.330000,58.460000,59.080000,59.080000,211572,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-01,59.850000,60.075000,58.875000,59.250000,59.250000,170197,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-02,59.360000,59.630000,58.570000,59.320000,59.320000,121025,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-03,59.830000,60.700000,59.120000,59.400000,59.400000,223080,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-04,59.410000,59.460000,56.790000,56.960000,56.960000,301131,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-05,57.140000,57.850000,56.670000,56.900000,56.900000,317494,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-08,56.870000,56.870000,54.820000,56.170000,56.170000,285538,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-09,56.040000,57.880000,55.888400,56.690000,56.690000,226446,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-10,56.550000,58.670000,56.500000,58.240000,58.240000,216928,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-11,58.310000,58.310000,57.020000,57.170000,57.170000,184923,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-12,57.660000,58.150000,55.620000,56.040000,56.040000,186601,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-15,56.100000,56.740000,55.110000,55.590000,55.590000,184827,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-16,55.990000,56.480000,55.110000,55.320000,55.320000,151916,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-17,55.590000,55.590000,53.390000,54.200000,54.200000,287510,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-18,54.140000,54.907500,52.870000,54.760000,54.760000,215626,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-22,54.540000,55.740000,54.540000,54.740000,54.740000,253557,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-23,54.670000,57.910000,54.670000,57.250000,57.250000,218471,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-24,57.390000,57.607000,56.112000,56.190000,56.190000,101043,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-25,56.100000,57.240000,55.440000,57.240000,57.240000,209286,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-26,60.270000,69.340000,58.252500,68.890000,68.890000,1647335,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-29,69.180000,69.780000,67.890000,68.890000,68.890000,647813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-04-30,67.850000,70.920000,66.480000,67.380000,67.380000,599155,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-01,63.050000,66.930000,63.020000,65.820000,65.820000,2856531,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-02,65.550000,67.000000,64.480000,65.750000,65.750000,335658,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-03,66.230000,67.940000,65.350000,67.600000,67.600000,470495,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-06,66.400000,69.230000,65.200000,69.140000,69.140000,380968,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-07,68.650000,69.550000,67.247500,67.690000,67.690000,558756,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-08,67.950000,69.280000,66.750000,67.570000,67.570000,348293,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-09,66.940000,71.070000,66.730000,69.860000,69.860000,695025,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-10,69.850000,71.210000,67.030000,69.280000,69.280000,377153,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-13,67.600000,68.800000,67.110000,67.270000,67.270000,466433,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-14,67.690000,68.230000,66.510000,67.410000,67.410000,404597,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-15,66.610000,68.345000,66.610000,67.710000,67.710000,295484,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-16,67.970000,70.220000,67.947600,69.950000,69.950000,378396,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-17,69.580000,69.890000,66.890000,67.250000,67.250000,623073,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-20,66.610000,68.460000,65.625000,67.260000,67.260000,224865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-21,67.720000,69.430000,67.100000,68.940000,68.940000,334091,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-22,68.610000,69.420000,67.880000,68.520000,68.520000,144970,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-23,68.080000,68.080000,66.210000,67.030000,67.030000,281498,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-24,67.540000,70.420000,67.540000,68.860000,68.860000,462532,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-28,68.810000,70.960000,68.385000,70.260000,70.260000,598356,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-29,68.850000,71.580000,68.450000,71.040000,71.040000,464849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-30,71.540000,72.450000,70.646900,71.780000,71.780000,520375,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-05-31,71.090000,71.630000,69.220000,69.470000,69.470000,491903,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-03,69.450000,70.645000,68.500000,69.490000,69.490000,426064,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-04,70.260000,74.010000,69.350000,73.400000,73.400000,1026706,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-05,74.390000,77.910000,74.229900,75.730000,75.730000,1031428,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-06,75.970000,76.830000,74.520000,74.990000,74.990000,352109,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-07,75.410000,76.310000,74.950000,75.320000,75.320000,306410,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-10,76.630000,76.920000,75.160000,75.890000,75.890000,291550,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-11,76.200000,76.659200,73.680000,74.600000,74.600000,398432,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-12,75.020000,76.290000,74.730000,76.080000,76.080000,343604,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-13,76.450000,77.047100,74.570000,74.980000,74.980000,238211,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-14,75.000000,75.210000,73.570000,74.220000,74.220000,453941,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-17,74.290000,78.200000,74.290000,77.500000,77.500000,706229,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-18,78.210000,79.880000,77.870000,79.050000,79.050000,518146,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-19,79.080000,81.310000,79.050000,81.100000,81.100000,816331,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-20,82.180000,83.630000,80.880000,83.140000,83.140000,793361,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-21,83.280000,83.690000,81.965000,83.040000,83.040000,1002670,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-24,83.120000,83.530000,81.820000,81.910000,81.910000,865044,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-25,83.350000,83.350000,80.180000,80.470000,80.470000,491859,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-26,81.000000,82.150000,80.250000,81.520000,81.520000,474301,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-27,81.880000,83.910000,81.640000,83.820000,83.820000,468360,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-06-28,84.200000,86.160000,83.600000,85.950000,85.950000,1790760,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-01,87.140000,87.420000,85.600000,86.050000,86.050000,445934,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-02,86.160000,86.400000,84.590000,85.630000,85.630000,345587,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-03,86.330000,86.760000,85.650000,86.700000,86.700000,227708,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-05,85.980000,86.220000,83.570000,84.460000,84.460000,327749,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-08,84.220000,85.080000,83.660000,84.740000,84.740000,390019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-09,84.410000,86.510000,84.410000,85.560000,85.560000,315752,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-10,85.860000,86.880000,84.910000,85.560000,85.560000,271403,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-11,85.930000,85.930000,83.815000,85.000000,85.000000,191966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-12,85.180000,86.000000,84.185000,85.000000,85.000000,188264,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-15,85.440000,86.830000,84.500000,85.950000,85.950000,722130,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-16,84.700000,88.940000,83.520000,88.440000,88.440000,794273,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-17,87.640000,89.220000,86.890000,87.200000,87.200000,2081309,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-18,87.000000,88.010000,86.990000,87.790000,87.790000,671440,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-19,87.760000,88.500000,86.770000,86.800000,86.800000,325212,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-22,88.940000,89.710000,87.767000,88.280000,88.280000,592772,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-23,88.590000,88.820000,87.190000,87.880000,87.880000,399149,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-24,87.630000,89.630000,86.410000,89.560000,89.560000,261157,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-25,89.560000,92.730000,88.890000,90.900000,90.900000,1032546,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-26,92.000000,93.350000,91.180000,92.510000,92.510000,898214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-29,93.780000,95.240000,93.000000,94.460000,94.460000,810127,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-30,94.240000,95.090000,93.073500,94.660000,94.660000,675716,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-07-31,94.900000,96.250000,93.110000,94.390000,94.390000,753798,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-01,95.340000,99.250000,94.490000,95.510000,95.510000,1032129,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-02,95.010000,96.010000,89.760000,90.610000,90.610000,1491730,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-05,88.810000,89.970000,85.672900,86.850000,86.850000,947080,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-06,88.210000,92.005000,88.187500,91.360000,91.360000,898378,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-07,90.140000,91.700000,88.845000,89.940000,89.940000,468136,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-08,90.290000,94.000000,90.290000,93.710000,93.710000,439454,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-09,93.310000,93.750000,91.300000,91.840000,91.840000,466958,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-12,91.420000,92.030000,89.710000,90.080000,90.080000,491356,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-13,89.570000,92.210000,88.760000,90.900000,90.900000,365124,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-14,89.270000,90.690000,88.400000,88.810000,88.810000,351178,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-15,89.200000,90.650000,88.040000,88.400000,88.400000,356337,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-16,89.100000,92.900000,89.100000,92.640000,92.640000,1332011,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-19,93.580000,94.327900,92.160000,93.600000,93.600000,389686,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-20,93.480000,93.840000,91.760000,92.150000,92.150000,461709,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-21,93.200000,93.565000,91.940000,93.380000,93.380000,357265,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-22,93.400000,93.600000,90.430000,92.660000,92.660000,468840,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-23,92.860000,94.290000,90.540000,90.860000,90.860000,437193,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-26,91.830000,93.060000,90.500000,92.930000,92.930000,369757,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-27,93.680000,94.110000,91.175000,91.400000,91.400000,447444,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-28,91.330000,93.600000,90.418200,92.290000,92.290000,502193,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-29,93.200000,93.690000,91.680000,93.010000,93.010000,344609,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-08-30,93.370000,94.989000,91.802400,92.810000,92.810000,393223,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-03,92.540000,93.290000,89.710000,90.460000,90.460000,445815,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-04,90.970000,91.680000,90.050000,90.850000,90.850000,489035,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-05,91.910000,94.760000,89.760000,94.230000,94.230000,754383,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-06,94.550000,95.420000,92.835000,93.030000,93.030000,345955,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-09,90.310000,90.360000,80.610000,82.180000,82.180000,1432425,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-10,82.590000,83.080000,77.350000,80.570000,80.570000,1022914,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-11,81.010000,81.670000,78.955400,79.880000,79.880000,1074114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-12,79.990000,81.410000,78.290000,79.010000,79.010000,865015,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-13,79.340000,80.970000,78.010000,79.740000,79.740000,497598,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-16,79.650000,81.420000,78.730000,79.520000,79.520000,864172,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-17,79.500000,82.030000,79.500000,80.990000,80.990000,491791,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-18,81.140000,82.270000,80.410000,82.040000,82.040000,567278,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-19,82.190000,83.860000,81.285000,82.410000,82.410000,563951,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-20,82.320000,83.770000,80.950000,81.790000,81.790000,8648466,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-23,81.800000,82.480000,79.190000,81.090000,81.090000,516404,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-24,81.300000,81.880000,78.660000,79.210000,79.210000,714830,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-25,79.020000,79.590000,77.360000,77.540000,77.540000,673725,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-26,77.320000,78.280000,75.800000,76.690000,76.690000,689729,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-27,77.210000,78.130000,76.360000,76.650000,76.650000,621604,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-09-30,77.090000,79.250000,76.600000,76.690000,76.690000,572646,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-01,76.560000,77.220000,73.740000,73.850000,73.850000,586865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-02,73.230000,74.870000,72.320000,73.840000,73.840000,540984,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-03,73.510000,75.830000,73.270000,75.390000,75.390000,481754,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-04,75.580000,77.000000,75.430000,76.440000,76.440000,354475,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-07,75.960000,78.710000,75.960000,77.390000,77.390000,557295,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-08,76.680000,76.950000,75.130000,75.270000,75.270000,319151,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-09,75.910000,76.700000,75.360000,75.470000,75.470000,345140,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-10,75.450000,76.250000,75.150000,75.900000,75.900000,263257,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-11,77.000000,78.310000,76.540000,77.460000,77.460000,381983,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-14,77.250000,78.980000,77.020000,77.250000,77.250000,218200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-15,78.540000,79.890000,77.760000,79.220000,79.220000,431694,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-16,79.080000,79.270000,76.810000,77.770000,77.770000,257746,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-17,78.200000,79.840000,77.790000,79.260000,79.260000,318019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-18,78.700000,79.740000,77.505000,78.480000,78.480000,329087,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-21,79.210000,79.950000,77.910000,78.460000,78.460000,230412,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-22,78.640000,79.850000,78.640000,79.040000,79.040000,428300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-23,79.120000,80.730000,79.000000,79.730000,79.730000,288109,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-24,80.310000,80.310000,77.580000,78.080000,78.080000,493227,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-25,77.620000,79.870000,76.745000,79.160000,79.160000,254423,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-28,79.240000,81.090000,78.930000,80.220000,80.220000,503303,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-29,80.160000,80.550000,77.760000,78.310000,78.310000,465822,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-30,78.200000,78.640000,76.850000,77.140000,77.140000,481738,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-10-31,77.910000,80.500000,76.870000,79.490000,79.490000,636778,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-01,81.990000,86.080000,81.350000,84.770000,84.770000,789616,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-04,84.610000,85.000000,82.365000,83.560000,83.560000,694624,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-05,83.860000,84.130000,81.314000,81.820000,81.820000,381524,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-06,81.730000,81.960000,80.840000,80.910000,80.910000,343036,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-07,81.460000,81.980000,80.910000,81.690000,81.690000,353473,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-08,81.430000,84.210000,81.242500,84.090000,84.090000,300412,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-11,83.330000,84.120000,82.150000,82.240000,82.240000,230635,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-12,82.250000,83.260000,82.190000,82.720000,82.720000,225813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-13,82.440000,83.840000,82.150000,83.220000,83.220000,243169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-14,82.860000,83.150000,81.640000,81.680000,81.680000,323021,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-15,82.600000,84.740000,82.177600,84.670000,84.670000,319168,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-18,84.560000,86.830000,84.400000,86.430000,86.430000,699487,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-19,86.980000,88.000000,86.075300,86.650000,86.650000,430747,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-20,86.110000,86.870000,84.140000,85.280000,85.280000,421037,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-21,85.370000,85.408800,82.952200,84.290000,84.290000,380558,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-22,84.690000,84.690000,82.770000,83.890000,83.890000,269848,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-25,84.590000,87.750000,84.590000,87.250000,87.250000,635482,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-26,87.100000,88.150000,86.070000,87.700000,87.700000,292494,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-27,87.890000,89.950000,86.540000,89.890000,89.890000,526285,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-11-29,89.520000,89.520000,88.070000,88.750000,88.750000,187960,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-02,88.840000,88.840000,86.328000,88.100000,88.100000,810231,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-03,87.110000,88.000000,85.650100,87.790000,87.790000,430046,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-04,88.100000,89.025000,87.710000,88.610000,88.610000,313828,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-05,89.020000,89.400000,87.445000,88.420000,88.420000,293038,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-06,89.200000,90.580000,88.430000,90.300000,90.300000,389069,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-09,90.120000,91.060000,89.670000,90.270000,90.270000,334745,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-10,90.310000,92.045000,90.270000,91.840000,91.840000,449904,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-11,91.760000,91.800000,90.000000,90.770000,90.770000,341647,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-12,90.790000,91.940000,88.640000,89.130000,89.130000,460443,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-13,89.310000,90.640000,88.210000,88.600000,88.600000,308265,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-16,89.660000,90.785000,88.980300,90.430000,90.430000,401121,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-17,90.640000,90.650000,89.125000,90.390000,90.390000,233559,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-18,90.340000,90.930000,87.820000,89.150000,89.150000,388730,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-19,89.800000,90.740000,89.374900,90.280000,90.280000,457515,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-20,90.960000,93.130000,90.740000,93.080000,93.080000,1953491,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-23,93.280000,93.499600,91.835000,92.720000,92.720000,439383,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-24,93.140000,93.140000,91.680000,92.880000,92.880000,113166,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-26,92.930000,93.170000,91.979600,93.010000,93.010000,270899,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-27,93.490000,93.490000,90.810000,92.230000,92.230000,216428,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-30,91.990000,93.160000,90.450000,91.890000,91.890000,221943,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2019-12-31,91.830000,92.830000,90.833500,92.500000,92.500000,307297,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-02,93.060000,93.790000,91.800000,93.780000,93.780000,315525,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-03,92.370000,94.240000,91.849900,92.740000,92.740000,250379,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-06,91.940000,94.160000,91.100000,93.895000,93.895000,381800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-07,93.790000,95.720000,92.230000,95.000000,95.000000,373168,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-08,95.130000,96.250000,94.950000,95.130000,95.130000,261532,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-09,95.780000,96.840000,94.600000,96.410000,96.410000,341334,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-10,97.090000,98.720000,96.971000,97.880000,97.880000,386100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-13,97.720000,99.490000,97.050000,99.020000,99.020000,377169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-14,98.730000,100.710000,98.070000,99.380000,99.380000,348662,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-15,99.440000,101.000000,99.080000,99.600000,99.600000,417324,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-16,100.190000,100.770000,99.460000,99.900000,99.900000,254974,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-17,100.740000,100.910000,99.660000,100.710000,100.710000,254463,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-21,100.620000,101.360000,99.640000,101.010000,101.010000,340020,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-22,101.470000,102.760000,100.670000,100.850000,100.850000,235107,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-23,100.370000,100.370000,99.250000,99.690000,99.690000,246818,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-24,100.310000,100.500000,98.260000,99.110000,99.110000,255641,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-27,97.420000,100.270000,95.750000,99.620000,99.620000,408282,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-28,100.330000,102.680000,100.330000,101.660000,101.660000,270834,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-29,101.520000,102.640000,101.440000,101.690000,101.690000,221970,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-30,100.830000,101.700000,100.030000,101.640000,101.640000,260724,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-01-31,101.590000,101.590000,99.585000,100.390000,100.390000,412751,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-03,101.720000,102.850000,101.630000,102.430000,102.430000,348723,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-04,103.750000,105.500000,103.265000,104.505000,104.505000,263546,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-05,105.630000,106.300000,100.450000,100.930000,100.930000,410483,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-06,101.340000,101.360000,100.070000,100.620000,100.620000,216796,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-07,100.320000,101.600000,98.905000,101.325000,101.325000,566201,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-10,101.110000,103.980000,100.820000,103.920000,103.920000,325442,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-11,104.500000,105.480000,103.705000,105.170000,105.170000,197085,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-12,105.750000,107.430000,104.390000,106.850000,106.850000,248190,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-13,106.440000,107.200000,105.911700,106.150000,106.150000,243548,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-14,106.090000,106.405000,105.170000,105.970000,105.970000,254177,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-18,105.970000,106.980000,105.500000,106.000000,106.000000,416183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-19,106.820000,109.940000,106.070000,109.140000,109.140000,388866,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-20,102.000000,103.990000,99.020000,101.120000,101.120000,1284714,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-21,101.270000,102.040000,97.010000,98.110000,98.110000,560737,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-24,96.250000,96.250000,91.520000,92.710000,92.710000,561648,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-25,92.640000,92.640000,84.450000,84.960000,84.960000,797983,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-26,85.580000,87.474100,84.660000,85.160000,85.160000,510557,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-27,82.900000,88.370000,81.050000,86.100000,86.100000,866027,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-02-28,82.760000,85.690000,82.010000,85.600000,85.600000,840320,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-02,86.440000,88.600000,83.705000,88.490000,88.490000,558764,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-03,88.500000,90.250000,85.210000,86.650000,86.650000,583825,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-04,88.510000,94.440000,88.490000,94.170000,94.170000,607371,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-05,91.960000,94.595000,91.580000,93.750000,93.750000,809360,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-06,90.580000,95.000000,90.480000,94.470000,94.470000,897357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-09,88.640000,92.840000,87.410100,91.480000,91.480000,743875,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-10,94.030000,95.970000,90.120000,95.860000,95.860000,666530,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-11,93.390000,94.590000,88.570000,91.000000,91.000000,617273,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-12,84.440000,94.240000,84.050000,89.280000,89.280000,947952,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-13,92.920000,98.970000,90.040100,98.710000,98.710000,941247,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-16,91.540000,94.590000,85.540000,87.210000,87.210000,878009,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-17,88.640000,99.470000,88.270000,97.570000,97.570000,1027439,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-18,92.510000,100.990000,91.010000,96.360000,96.360000,823552,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-19,96.090000,96.090000,86.420000,87.090000,87.090000,955655,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-20,86.880000,92.410000,86.880000,88.750000,88.750000,910093,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-23,88.500000,89.500000,78.410000,88.900000,88.900000,870395,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-24,90.300000,99.330000,89.275000,94.680000,94.680000,787389,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-25,93.930000,97.900000,88.660000,89.040000,89.040000,701219,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-26,90.270000,95.170000,88.800000,91.410000,91.410000,625424,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-27,88.290000,94.625000,87.310000,92.550000,92.550000,631726,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-30,94.410000,97.300000,93.555000,95.820000,95.820000,511676,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-03-31,95.220000,97.460000,94.770000,96.540000,96.540000,793453,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-01,94.080000,96.010000,92.000000,94.330000,94.330000,551395,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-02,93.360000,98.840000,92.900000,96.950000,96.950000,360337,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-03,96.660000,100.650000,95.980000,98.210000,98.210000,671264,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-06,100.640000,101.370000,97.910000,100.710000,100.710000,432013,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-07,102.250000,102.666400,96.410000,96.650000,96.650000,442350,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-08,98.140000,98.260000,94.520000,96.500000,96.500000,413870,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-09,97.460000,99.770000,95.505000,98.950000,98.950000,367634,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-13,99.000000,100.260000,95.910000,99.340000,99.340000,269164,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-14,102.880000,105.665000,100.040100,104.910000,104.910000,320684,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-15,104.600000,105.425000,101.070000,102.670000,102.670000,427389,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-16,104.120000,106.750000,103.260000,105.145000,105.145000,380842,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-17,107.600000,107.600000,103.870000,105.610000,105.610000,402833,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-20,104.770000,105.410000,103.500000,104.180000,104.180000,374894,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-21,102.960000,106.190000,102.130000,104.230000,104.230000,376604,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-22,106.100000,113.920000,104.700000,112.510000,112.510000,604349,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-23,110.973500,115.370000,110.777500,113.150000,113.150000,513881,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-24,114.450000,119.230000,113.590000,116.430000,116.430000,494172,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-27,118.170000,123.810000,117.850000,117.980000,117.980000,656292,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-28,119.540000,119.550000,111.010000,111.590000,111.590000,797361,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-29,113.610000,119.800000,109.690000,116.740000,116.740000,653578,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-04-30,116.140000,121.480000,114.250000,116.150000,116.150000,496019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-01,114.530000,115.960000,111.255000,112.910000,112.910000,470218,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-04,113.060000,114.000000,110.440000,113.940000,113.940000,393434,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-05,113.990000,116.190000,112.230000,114.520000,114.520000,342093,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-06,120.790000,127.000000,117.870000,124.710000,124.710000,735309,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-07,127.850000,128.720000,121.210000,122.250000,122.250000,633923,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-08,123.840000,125.310000,122.580000,122.850000,122.850000,332058,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-11,122.430000,129.650000,122.140000,128.130000,128.130000,484832,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-12,128.570000,132.825000,126.110000,128.410000,128.410000,495279,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-13,128.210000,132.480000,125.868600,128.180000,128.180000,416707,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-14,126.170000,133.380000,126.040000,131.970000,131.970000,532105,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-15,133.550000,142.390000,132.300000,140.480000,140.480000,770397,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-18,141.820000,143.930000,134.410000,135.710000,135.710000,575464,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-19,134.300000,136.820000,132.490000,135.620000,135.620000,463314,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-20,137.730000,141.820000,134.940000,139.080000,139.080000,448260,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-21,140.050000,141.680000,138.280000,140.310000,140.310000,495691,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-22,140.500000,140.990000,136.640000,139.510000,139.510000,307924,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-26,143.640000,143.640000,133.060000,133.350000,133.350000,545445,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-27,132.750000,132.750000,123.000000,128.070000,128.070000,830570,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-28,130.000000,132.280000,128.620000,129.210000,129.210000,572845,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-05-29,130.040000,132.660000,127.400000,130.970000,130.970000,810595,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-01,130.490000,132.520000,128.780000,129.955000,129.955000,594057,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-02,129.580000,133.990000,127.330000,133.370000,133.370000,782082,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-03,133.990000,134.447100,126.520000,127.150000,127.150000,585781,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-04,126.500000,128.710000,120.720000,121.820000,121.820000,539684,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-05,120.900000,122.360000,116.230000,120.260000,120.260000,877538,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-08,118.500000,120.240000,116.381000,116.760000,116.760000,660169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-09,117.300000,119.550000,115.540000,115.670000,115.670000,647620,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-10,116.980000,121.030000,115.850000,120.010000,120.010000,490085,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-11,118.910000,120.320000,112.680000,113.780000,113.780000,669975,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-12,116.220000,119.879900,114.360000,116.830000,116.830000,750592,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-15,115.740000,116.860000,112.610000,113.950000,113.950000,527077,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-16,115.650000,117.758600,114.501000,116.740000,116.740000,481144,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-17,117.790000,118.520000,115.550000,117.120000,117.120000,468866,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-18,116.270000,117.185000,113.140000,114.030000,114.030000,512311,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-19,115.020000,116.810000,113.650000,115.590000,115.590000,723980,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-22,115.700000,119.255000,114.500000,118.940000,118.940000,662969,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-23,118.820000,120.666200,117.500000,119.540000,119.540000,756239,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-24,118.780000,119.820000,111.720000,113.140000,113.140000,821075,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-25,113.230000,114.940000,109.380000,114.520000,114.520000,942586,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-26,114.090000,118.620000,113.510000,116.500000,116.500000,6353256,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-29,118.590000,119.220000,113.110000,119.090000,119.090000,773600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-06-30,119.820000,123.980000,119.290000,123.610000,123.610000,1450300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-01,124.410000,126.150000,122.020000,124.190000,124.190000,824300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-02,124.780000,127.640000,124.320000,126.650000,126.650000,460800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-06,128.990000,129.390000,125.410000,126.590000,126.590000,867400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-07,126.320000,128.600000,123.640000,124.140000,124.140000,533400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-08,124.630000,125.810000,123.310000,125.280000,125.280000,397300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-09,125.910000,129.930000,125.570000,128.670000,128.670000,438300,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-10,128.760000,129.070000,125.850000,126.130000,126.130000,242400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-13,126.180000,129.500000,122.430000,122.510000,122.510000,278200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-14,122.890000,124.930000,120.120000,124.840000,124.840000,397800,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-15,125.370000,131.230000,125.250000,130.970000,130.970000,589900,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-16,131.030000,132.900000,129.750000,131.940000,131.940000,442200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-17,132.710000,135.170000,131.950000,134.310000,134.310000,271600,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-20,134.720000,138.390000,134.630000,136.040000,136.040000,337501,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-21,136.620000,136.620000,133.760000,134.990000,134.990000,258253,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-22,135.990000,137.736100,134.150000,135.880000,135.880000,437253,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-23,136.910000,141.120000,135.835000,136.730000,136.730000,495793,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-24,134.530000,135.220000,131.910000,134.360000,134.360000,375695,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-27,135.660000,138.020000,135.230000,137.630000,137.630000,220865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-28,138.170000,139.650000,136.730000,137.070000,137.070000,295841,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-29,137.300000,140.190000,137.150000,138.780000,138.780000,468737,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-30,143.130000,155.270000,142.544200,151.250000,151.250000,853441,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-07-31,152.000000,154.500000,146.800000,150.910000,150.910000,1054320,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-03,152.460000,159.970000,152.460000,158.270000,158.270000,649952,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-04,157.710000,158.130000,154.150000,156.540000,156.540000,513967,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-05,157.000000,158.010000,154.770000,155.880000,155.880000,360265,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-06,156.960000,157.400000,151.155000,154.670000,154.670000,511859,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-07,154.840000,157.010000,152.000000,152.770000,152.770000,462718,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-10,152.560000,153.350000,147.580000,147.810000,147.810000,472550,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-11,147.650000,147.650000,141.001300,142.000000,142.000000,632962,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-12,142.500000,144.750000,141.550000,142.930000,142.930000,442186,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-13,143.870000,147.750000,142.535000,146.260000,146.260000,316721,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-14,146.150000,146.920000,143.410000,143.890000,143.890000,187869,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-17,145.540000,148.710000,144.810000,148.290000,148.290000,349557,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-18,147.920000,147.920000,146.020000,147.260000,147.260000,221951,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-19,147.490000,149.725000,147.280000,147.870000,147.870000,227890,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-20,147.180000,151.540000,146.762000,150.870000,150.870000,417244,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-21,151.560000,153.340000,150.870000,151.640000,151.640000,388067,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-24,153.800000,154.450000,144.820000,145.990000,145.990000,775945,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-25,145.780000,148.650000,145.350000,147.980000,147.980000,248578,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-26,148.870000,149.708900,147.085000,149.440000,149.440000,212405,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-27,148.940000,150.350000,145.100000,149.630000,149.630000,454385,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-28,150.260000,150.800000,147.970000,150.190000,150.190000,250330,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-08-31,150.780000,155.630000,150.270000,154.910000,154.910000,490738,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-01,155.560000,157.455000,153.180000,155.160000,155.160000,421991,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-02,155.890000,156.500000,151.500000,156.060000,156.060000,247580,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-03,153.740000,153.910000,145.750000,147.970000,147.970000,495252,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-04,146.630000,146.967500,138.420000,145.400000,145.400000,485004,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-08,142.900000,147.040000,140.560000,144.320000,144.320000,267666,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-09,146.640000,149.165000,144.330000,147.130000,147.130000,275490,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-10,148.220000,149.716400,145.660000,145.890000,145.890000,322793,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-11,147.490000,148.915000,143.900000,144.660000,144.660000,200987,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-14,145.850000,150.850000,145.540000,149.680000,149.680000,227787,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-15,150.990000,152.770000,149.960000,150.270000,150.270000,301546,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-16,152.000000,152.350000,146.965000,147.150000,147.150000,322839,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-17,145.260000,146.004700,143.020000,145.710000,145.710000,248163,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-18,146.110000,146.700000,142.615000,145.990000,145.990000,682134,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-21,143.920000,144.530000,138.400000,141.850000,141.850000,471725,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-22,141.780000,144.240000,139.740000,143.960000,143.960000,225927,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-23,143.480000,146.005000,142.040000,142.380000,142.380000,222086,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-24,141.010000,141.480000,138.000000,139.940000,139.940000,259466,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-25,139.940000,145.080000,138.630000,144.300000,144.300000,283596,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-28,145.640000,147.545000,144.360000,147.280000,147.280000,215788,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-29,147.940000,152.410000,147.910000,150.590000,150.590000,251964,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-09-30,149.980000,150.500000,145.990000,147.540000,147.540000,610852,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-01,148.000000,150.890000,146.520000,149.630000,149.630000,248082,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-02,147.690000,150.880000,146.970000,148.080000,148.080000,551470,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-05,149.580000,159.980000,149.550000,159.800000,159.800000,853361,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-06,160.720000,165.440000,160.720000,163.720000,163.720000,592365,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-07,166.090000,167.730000,164.720000,165.030000,165.030000,479749,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-08,166.320000,167.640000,161.870000,164.180000,164.180000,409849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-09,165.320000,171.989700,163.767600,170.500000,170.500000,358128,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-12,173.030000,175.450000,170.729100,173.410000,173.410000,372102,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-13,173.340000,174.435000,170.350000,172.160000,172.160000,365005,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-14,173.340000,173.870000,167.520000,169.840000,169.840000,256239,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-15,168.030000,170.760000,166.000000,170.010000,170.010000,330205,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-16,173.970000,173.970000,170.500000,170.770000,170.770000,252972,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-19,171.470000,173.580900,168.280000,168.750000,168.750000,197521,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-20,169.750000,175.240000,168.550000,172.490000,172.490000,317750,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-21,172.530000,175.030000,171.730000,171.760000,171.760000,360901,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-22,171.070000,177.290000,170.940800,176.510000,176.510000,530608,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-23,177.920000,177.920000,173.010000,176.250000,176.250000,231961,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-26,174.950000,179.120000,174.950000,177.540000,177.540000,223732,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-27,178.440000,180.837500,175.230000,175.840000,175.840000,277077,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-28,174.000000,175.635000,169.210000,171.200000,171.200000,285252,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-29,172.210000,173.820000,170.617100,172.220000,172.220000,207704,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-10-30,169.430000,171.340000,163.550000,166.570000,166.570000,431246,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-02,171.360000,173.087200,167.950000,170.140000,170.140000,341096,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-03,171.130000,178.890000,171.130000,178.010000,178.010000,379124,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-04,180.950000,189.670000,180.950000,186.870000,186.870000,597454,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-05,194.450000,203.900000,190.520000,201.860000,201.860000,682365,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-06,200.000000,209.375700,198.910000,201.980000,201.980000,452043,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-09,201.820000,201.820000,188.020000,191.750000,191.750000,513362,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-10,194.070000,197.000000,183.220000,186.900000,186.900000,560253,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-11,188.390000,196.030000,187.240000,194.710000,194.710000,245457,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-12,196.540000,212.550000,196.540000,206.570000,206.570000,1325654,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-13,209.433300,209.433300,203.120000,205.600000,205.600000,502545,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-16,206.090000,206.414500,194.890000,195.370000,195.370000,604246,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-17,195.730000,198.080000,193.220000,193.490000,193.490000,463303,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-18,194.320000,195.035000,183.260000,185.450000,185.450000,754915,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-19,186.130000,189.910000,184.190000,187.290000,187.290000,397160,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-20,188.600000,197.500000,187.610000,193.510000,193.510000,587551,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-23,194.400000,196.420000,184.500000,185.870000,185.870000,423744,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-24,186.000000,187.260000,176.780000,179.150000,179.150000,479563,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-25,180.650000,183.750000,178.540000,181.430000,181.430000,259728,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-27,183.210000,187.130000,182.850000,186.990000,186.990000,218177,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-11-30,189.000000,191.705000,187.340000,189.670000,189.670000,602151,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-01,191.000000,195.919600,189.380000,193.860000,193.860000,438562,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-02,194.030000,194.030000,186.560000,187.000000,187.000000,238998,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-03,187.260000,190.280000,186.122300,187.210000,187.210000,199726,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-04,187.210000,189.389900,186.330000,188.330000,188.330000,191326,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-07,186.460000,188.875000,184.370000,185.910000,185.910000,472183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-08,176.500000,183.760000,176.250000,180.340000,180.340000,1232053,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-09,181.690000,183.440000,178.167500,178.780000,178.780000,561341,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-10,177.880000,182.475000,177.410000,179.530000,179.530000,350233,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-11,180.270000,181.850000,176.571900,180.900000,180.900000,321598,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-14,182.010000,187.450000,181.510000,184.090000,184.090000,367710,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-15,184.690000,186.660000,182.475000,185.610000,185.610000,543281,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-16,186.000000,188.175000,181.050000,182.480000,182.480000,308479,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-17,181.660000,191.300000,181.660000,190.410000,190.410000,468503,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-18,192.630000,194.200000,190.020000,193.900000,193.900000,822979,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-21,191.930000,194.880000,187.000000,193.100000,193.100000,296281,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-22,193.570000,195.480000,191.815000,194.110000,194.110000,270686,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-23,194.000000,199.650000,191.050000,196.920000,196.920000,536700,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-24,198.050000,200.185000,193.510000,195.690000,195.690000,256094,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-28,198.000000,199.250000,185.852800,187.020000,187.020000,316840,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-29,188.670000,191.050000,182.900000,189.020000,189.020000,244719,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-30,189.770000,193.941900,188.690000,189.140000,189.140000,216853,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2020-12-31,190.000000,193.680000,187.420000,191.630000,191.630000,330813,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-04,192.630000,196.000000,187.800000,190.660000,190.660000,248773,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-05,189.640000,195.530000,189.080000,194.670000,194.670000,307599,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-06,195.860000,199.750000,192.234300,197.010000,197.010000,440268,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-07,197.970000,207.130000,197.680000,204.090000,204.090000,416578,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-08,206.500000,209.626000,203.760000,208.360000,208.360000,261334,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-11,209.790000,211.680000,203.705000,205.890000,205.890000,416530,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-12,205.120000,207.260000,201.385000,206.330000,206.330000,429549,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-13,209.990000,210.660000,205.550000,207.970000,207.970000,302781,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-14,208.154700,221.380500,208.154700,212.250000,212.250000,619435,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-15,213.750000,217.778900,212.395000,215.470000,215.470000,417738,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-19,220.560000,226.530000,217.439600,222.190000,222.190000,567516,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-20,223.850000,226.970000,212.513800,216.670000,216.670000,502808,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-21,218.220000,219.450000,213.500000,216.910000,216.910000,331623,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-22,216.540000,219.440000,216.142000,219.320000,219.320000,172749,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-25,220.860000,222.260000,212.570000,215.280000,215.280000,292876,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-26,214.740000,215.205000,200.627900,201.990000,201.990000,679635,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-27,197.090000,197.360000,185.540000,187.330000,187.330000,726581,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-28,187.900000,197.900000,187.360000,195.730000,195.730000,371788,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-01-29,197.520000,201.990000,196.350000,200.000000,200.000000,466981,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-01,201.500000,207.700000,201.370000,206.410000,206.410000,352547,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-02,209.900000,217.410000,209.565000,215.420000,215.420000,391272,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-03,217.510000,218.390000,211.605000,213.970000,213.970000,323733,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-04,214.510000,219.860000,213.000000,217.920000,217.920000,269730,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-05,219.000000,222.199900,217.470000,222.060000,222.060000,235229,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-08,224.900000,225.890000,218.020000,219.140000,219.140000,304476,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-09,219.000000,220.899900,214.100100,216.180000,216.180000,273249,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-10,218.310000,221.540000,213.515000,219.120000,219.120000,393208,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-11,220.660000,224.640000,220.320000,223.390000,223.390000,270551,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-12,222.670000,228.835000,221.165200,226.260000,226.260000,270506,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-16,226.910000,227.750000,220.430000,221.630000,221.630000,236958,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-17,219.580000,220.770000,212.000000,215.030000,215.030000,439529,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-18,214.000000,218.440000,209.000000,215.620000,215.620000,295804,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-19,217.140000,219.570000,213.510000,214.350000,214.350000,341480,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-22,213.830000,214.000000,209.580000,210.770000,210.770000,254001,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-23,204.000000,208.120000,193.010000,206.510000,206.510000,465003,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-24,216.500000,220.870000,210.668500,215.580000,215.580000,602183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-25,219.470000,221.690000,204.870000,207.070000,207.070000,429533,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-02-26,206.513500,214.480000,206.513500,212.390000,212.390000,345618,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-01,216.460000,222.350000,214.010000,221.730000,221.730000,339291,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-02,222.120000,223.165000,212.080000,212.650000,212.650000,296308,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-03,213.330000,213.330000,199.550000,199.870000,199.870000,303189,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-04,196.010000,200.000000,181.300000,183.210000,183.210000,757675,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-05,183.210000,187.655700,173.091300,186.190000,186.190000,572966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-08,185.580000,188.250500,178.670000,181.480000,181.480000,474704,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-09,185.860000,194.345000,185.860000,190.220000,190.220000,358222,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-10,194.090000,194.980000,186.840000,188.490000,188.490000,457031,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-11,191.780000,195.840000,190.822000,194.080000,194.080000,391119,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-12,191.010000,197.120000,189.260000,194.700000,194.700000,344880,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-15,195.790000,204.710000,195.410000,204.010000,204.010000,439825,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-16,205.780000,206.750000,196.155000,197.570000,197.570000,418383,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-17,194.520000,199.000000,192.840000,196.840000,196.840000,427410,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-18,194.680000,203.980000,194.280000,200.010000,200.010000,389879,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-19,202.280000,205.870000,199.440000,203.990000,203.990000,768315,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-22,205.441100,210.990000,203.770000,207.440000,207.440000,377923,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-23,206.510000,208.000000,204.400000,206.580000,206.580000,433503,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-24,206.290000,206.300000,188.130000,189.050000,189.050000,523470,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-25,186.310000,186.310000,178.000000,180.370000,180.370000,635408,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-26,181.010000,184.040000,178.760000,183.510000,183.510000,790086,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-29,182.890000,188.390000,181.535000,184.100000,184.100000,801643,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-30,183.120000,190.100000,182.120800,189.210000,189.210000,416977,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-03-31,189.510000,197.770000,188.000000,194.410000,194.410000,647770,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-01,197.390000,198.750000,193.097200,195.440000,195.440000,401154,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-05,197.330000,200.580000,195.568500,200.420000,200.420000,291157,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-06,200.920000,206.190000,199.035000,204.970000,204.970000,340983,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-07,205.790000,205.790000,200.410000,201.310000,201.310000,208807,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-08,204.180000,207.365000,202.905000,204.160000,204.160000,284230,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-09,202.010000,206.780000,201.380000,206.100000,206.100000,216513,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-12,205.350000,207.540000,202.750000,207.020000,207.020000,229357,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-13,208.620000,212.970000,208.260000,212.860000,212.860000,279491,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-14,212.830000,213.400000,205.170000,205.290000,205.290000,250561,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-15,209.130000,215.000000,207.730000,213.570000,213.570000,209164,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-16,214.180000,214.455000,211.950000,213.300000,213.300000,140884,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-19,212.010000,213.580000,208.061900,212.040000,212.040000,232547,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-20,211.030000,214.460000,208.170000,211.990000,211.990000,182664,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-21,211.070000,217.860000,210.220000,217.590000,217.590000,313065,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-22,218.040000,221.257000,214.880000,216.320000,216.320000,303921,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-23,217.660000,220.825000,214.510000,218.320000,218.320000,302529,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-26,218.420000,223.030000,218.000000,220.040000,220.040000,316807,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-27,218.950000,222.240000,218.210000,220.950000,220.950000,224256,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-28,220.620000,221.970000,217.360000,219.740000,219.740000,257500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-29,219.440000,219.810000,212.520000,213.140000,213.140000,217191,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-04-30,211.870000,216.760000,210.550000,211.710000,211.710000,303580,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-03,211.770000,212.680000,206.860000,208.110000,208.110000,274906,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-04,215.100000,215.100000,194.040000,194.670000,194.670000,572619,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-05,197.450000,199.489900,193.665000,194.810000,194.810000,414178,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-06,191.940000,191.940000,181.550000,185.220000,185.220000,554723,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-07,186.460000,193.349900,186.080000,187.800000,187.800000,435202,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-10,185.000000,186.000000,171.050000,175.130000,175.130000,533437,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-11,169.460000,178.370000,167.090000,175.460000,175.460000,716326,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-12,173.350000,177.000000,171.035000,171.600000,171.600000,347129,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-13,172.140000,173.540000,164.290000,169.650000,169.650000,550887,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-14,168.980000,174.780000,168.470000,171.960000,171.960000,377775,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-17,170.940000,171.900000,162.290000,165.870000,165.870000,783880,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-18,164.920000,172.840000,164.900000,171.990000,171.990000,650846,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-19,168.410000,177.130000,167.000000,176.280000,176.280000,884292,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-20,177.480000,182.240000,177.010000,181.410000,181.410000,603969,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-21,182.100000,183.249900,178.420000,180.000000,180.000000,413596,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-24,181.560000,183.020000,176.130000,176.690000,176.690000,483213,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-25,177.230000,180.720000,176.080000,179.470000,179.470000,372242,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-26,179.930000,181.000000,176.775000,178.910000,178.910000,311019,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-27,178.440000,183.965000,177.990000,181.450000,181.450000,363945,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-05-28,183.480000,187.200000,182.295000,182.610000,182.610000,301551,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-01,182.610000,182.610000,172.405000,172.750000,172.750000,656180,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-02,173.250000,179.840000,172.590000,178.440000,178.440000,434955,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-03,176.070000,177.960000,172.915000,175.600000,175.600000,345078,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-04,176.600000,180.962700,176.600000,177.790000,177.790000,303939,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-07,176.900000,184.350000,175.340000,183.850000,183.850000,605605,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-08,186.490000,187.300000,179.500000,182.490000,182.490000,392166,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-09,184.980000,187.785000,183.430000,186.230000,186.230000,324958,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-10,186.190000,190.990000,185.240000,190.000000,190.000000,332827,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-11,191.370000,192.970000,189.600000,191.520000,191.520000,248623,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-14,191.950000,196.240000,191.950000,195.140000,195.140000,288312,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-15,193.910000,196.300000,188.710000,189.640000,189.640000,258084,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-16,190.130000,193.700000,187.520000,190.140000,190.140000,228957,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-17,188.750000,201.430000,188.750000,199.640000,199.640000,509040,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-18,199.060000,203.310000,194.900000,197.340000,197.340000,1123875,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-21,197.800000,200.150000,192.370000,196.140000,196.140000,282604,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-22,197.040000,198.180000,195.140000,197.150000,197.150000,431676,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-23,196.780000,197.970000,191.860000,192.920000,192.920000,530403,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-24,194.980000,195.821400,192.240000,192.870000,192.870000,242969,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-25,192.690000,193.650000,189.190000,191.620000,191.620000,618719,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-28,193.390000,201.320000,193.390000,201.180000,201.180000,312713,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-29,201.000000,204.750000,198.890000,204.030000,204.030000,318537,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-06-30,203.850000,203.850000,197.730000,199.620000,199.620000,192990,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-01,199.300000,200.635000,197.220000,199.710000,199.710000,269054,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-02,200.950000,201.990000,198.120000,201.900000,201.900000,200877,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-06,201.950000,206.350000,201.950000,204.070000,204.070000,383404,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-07,205.940000,207.950000,204.000000,206.450000,206.450000,331998,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-08,202.000000,207.640000,200.760000,206.360000,206.360000,268898,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-09,206.230000,207.040000,203.716900,205.780000,205.780000,214681,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-12,206.590000,207.890000,201.810100,204.310000,204.310000,265200,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-13,204.010000,205.500000,200.360000,200.850000,200.850000,135647,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-14,201.250000,202.800000,193.740000,194.770000,194.770000,324452,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-15,194.140000,198.060000,193.030000,197.110000,197.110000,200838,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-16,197.750000,202.750000,196.810000,200.140000,200.140000,578006,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-19,197.860000,202.560000,195.850000,199.380000,199.380000,302193,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-20,201.200000,203.600000,198.270000,202.970000,202.970000,437057,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-21,202.440000,203.885000,197.480000,203.600000,203.600000,374783,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-22,204.860000,207.590000,203.005200,206.010000,206.010000,161176,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-23,206.400000,210.610000,203.740000,209.920000,209.920000,531576,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-26,209.220000,209.770000,204.990000,206.010000,206.010000,310935,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-27,212.500000,226.480000,210.440000,226.380000,226.380000,1134134,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-28,226.260000,240.490000,224.560000,235.280000,235.280000,834262,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-29,232.410000,243.720000,231.010000,241.000000,241.000000,474111,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-07-30,241.360000,248.250000,239.040000,245.700000,245.700000,459991,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-02,246.620000,248.560000,239.620000,247.870000,247.870000,313858,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-03,247.870000,251.250000,245.500000,249.070000,249.070000,238161,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-04,248.740000,253.720500,248.250000,252.590000,252.590000,268831,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-05,253.000000,255.340000,249.780000,254.670000,254.670000,281644,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-06,251.900000,252.250000,248.269500,250.650000,250.650000,202473,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-09,252.670000,255.430000,250.133300,255.430000,255.430000,164383,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-10,255.840000,256.510000,248.960000,250.130000,250.130000,232823,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-11,251.210000,252.010000,246.563800,249.640000,249.640000,210757,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-12,249.100000,255.500000,248.630000,255.250000,255.250000,245536,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-13,255.190000,258.240000,252.430000,257.960000,257.960000,234977,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-16,257.690000,257.690000,251.580000,255.990000,255.990000,157710,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-17,254.820000,257.655000,250.220000,256.990000,256.990000,230819,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-18,260.000000,262.310000,254.650000,254.670000,254.670000,209567,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-19,252.100000,261.685000,251.110000,259.560000,259.560000,233473,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-20,260.920000,267.590000,260.700000,262.690000,262.690000,302776,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-23,262.630000,268.110000,262.630000,266.080000,266.080000,429986,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-24,266.540000,271.204500,265.000000,270.350000,270.350000,166310,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-25,270.190000,274.665000,269.505000,274.010000,274.010000,172160,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-26,274.450000,275.640000,269.239200,272.690000,272.690000,346756,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-27,274.010000,276.520000,271.500000,275.830000,275.830000,284714,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-30,276.240000,284.410000,276.240000,282.840000,282.840000,254814,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-08-31,284.330000,285.160000,277.590000,282.980000,282.980000,240535,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-01,281.080000,286.747500,278.630000,285.870000,285.870000,346613,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-02,288.030000,290.800000,284.730000,288.540000,288.540000,222079,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-03,287.650000,293.900000,286.525200,292.420000,292.420000,132114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-07,291.100000,297.580000,290.265000,296.100000,296.100000,340509,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-08,294.230000,296.999900,292.568900,294.400000,294.400000,197196,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-09,296.210000,296.725000,293.310000,294.670000,294.670000,328438,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-10,295.220000,296.495000,292.060000,295.030000,295.030000,258169,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-13,295.900000,295.900000,287.555000,289.570000,289.570000,477460,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-14,290.160000,296.630000,290.160000,294.500000,294.500000,332397,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-15,295.010000,299.741700,294.290000,296.400000,296.400000,374985,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-16,296.570000,300.090000,293.730000,299.880000,299.880000,482112,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-17,304.830000,310.685000,301.525000,306.900000,306.900000,1174147,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-20,301.330000,311.290000,297.690000,306.050000,306.050000,545555,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-21,308.100000,316.470000,306.920000,314.180000,314.180000,344781,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-22,314.000000,318.025000,309.330000,313.100000,313.100000,525162,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-23,315.060000,327.320000,313.735000,324.210000,324.210000,498776,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-24,323.480000,325.860000,315.532900,323.260000,323.260000,341141,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-27,322.270000,322.270000,301.020000,307.370000,307.370000,689132,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-28,299.550000,300.886000,284.460000,285.570000,285.570000,758183,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-29,288.110000,296.559100,284.400000,286.190000,286.190000,460237,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-09-30,287.300000,293.880000,287.300000,288.990000,288.990000,428292,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-01,288.490000,288.490000,268.380000,281.600000,281.600000,628468,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-04,283.240000,283.240000,270.825000,272.900000,272.900000,384292,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-05,273.330000,277.380000,269.840000,270.390000,270.390000,364058,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-06,268.660000,274.130000,263.570000,267.940000,267.940000,505463,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-07,267.750000,275.600000,267.670000,272.170000,272.170000,249860,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-08,273.070000,273.760000,257.970000,258.780000,258.780000,405057,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-11,257.060000,257.520000,253.290000,253.700000,253.700000,259913,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-12,254.870000,254.870000,248.550000,251.030000,251.030000,375073,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-13,253.220000,254.395000,249.664700,253.010000,253.010000,226211,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-14,258.160000,269.130000,257.920000,268.570000,268.570000,620501,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-15,274.781000,276.304100,266.350000,266.920000,266.920000,430440,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-18,266.780000,267.940000,261.900000,263.780000,263.780000,390608,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-19,265.160000,269.990000,262.370000,262.650000,262.650000,293910,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-20,264.300000,270.690000,264.300000,268.250000,268.250000,346106,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-21,269.850000,271.159900,263.015000,270.760000,270.760000,251844,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-22,271.870000,275.430000,267.600000,274.950000,274.950000,210472,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-25,275.400000,279.490000,271.009100,274.670000,274.670000,270843,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-26,275.940000,276.835000,267.100000,273.830000,273.830000,280210,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-27,272.130000,278.630000,269.820000,271.040000,271.040000,349081,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-28,269.250000,291.000000,268.000000,290.020000,290.020000,551682,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-10-29,289.720000,291.440000,277.705000,290.500000,290.500000,564128,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-01,290.580000,305.670000,290.580000,304.470000,304.470000,410590,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-02,305.240000,306.980000,296.780000,302.730000,302.730000,281148,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-03,303.190000,304.000000,290.710000,292.340000,292.340000,490943,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-04,291.260000,291.260000,276.250000,277.030000,277.030000,469048,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-05,266.000000,269.180000,251.250000,266.820000,266.820000,808925,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-08,267.420000,273.630000,263.800000,273.310000,273.310000,308197,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-09,274.620000,274.620000,268.285000,273.210000,273.210000,283676,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-10,271.280000,271.280000,258.960000,263.700000,263.700000,318392,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-11,267.540000,268.410000,264.405000,267.020000,267.020000,213854,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-12,268.000000,268.000000,257.410000,258.500000,258.500000,272724,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-15,259.950000,264.769900,258.010000,261.450000,261.450000,218249,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-16,260.540000,270.490000,258.300000,268.980000,268.980000,472104,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-17,270.880000,277.780000,267.525000,277.480000,277.480000,571225,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-18,277.300000,282.005000,273.150000,280.000000,280.000000,421660,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-19,281.990000,286.460000,281.360000,284.890000,284.890000,325400,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-22,284.370000,284.755000,271.630000,274.100000,274.100000,324141,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-23,270.460000,276.120000,260.410000,269.830000,269.830000,408527,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-24,269.010000,272.210000,263.510000,271.840000,271.840000,232659,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-26,280.910000,300.230000,273.110000,286.010000,286.010000,438364,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-29,286.350000,295.290000,281.605000,291.180000,291.180000,485865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-11-30,292.300000,299.490000,285.520000,286.500000,286.500000,739518,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-01,286.600000,292.000000,273.790000,276.840000,276.840000,592110,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-02,271.410000,277.340000,264.700000,268.820000,268.820000,324649,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-03,271.510000,271.510000,251.690000,262.880000,262.880000,299307,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-06,259.390000,259.945000,243.290000,247.590000,247.590000,383338,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-07,253.950000,263.050000,253.075000,258.670000,258.670000,296668,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-08,260.720000,267.660000,255.430000,266.030000,266.030000,304251,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-09,266.200000,269.090000,251.940000,252.320000,252.320000,305448,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-10,250.490000,259.630000,246.270000,247.640000,247.640000,346335,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-13,247.700000,260.760000,245.150000,258.710000,258.710000,372114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-14,253.340000,259.005000,247.470000,252.530000,252.530000,376898,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-15,252.910000,262.160000,248.080000,261.830000,261.830000,305624,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-16,265.986200,265.986200,252.630000,256.860000,256.860000,279887,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-17,256.130000,269.195000,252.960000,265.420000,265.420000,510919,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-20,265.860000,271.599900,263.500000,269.700000,269.700000,275842,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-21,269.290000,273.035000,261.800000,267.590000,267.590000,302477,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-22,267.620000,271.240000,263.210000,269.670000,269.670000,198362,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-23,274.086700,274.086700,263.560400,264.650000,264.650000,316840,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-27,263.220000,268.371700,261.820000,267.860000,267.860000,322436,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-28,269.830000,270.000000,250.175000,253.770000,253.770000,352352,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-29,255.160000,261.715000,251.250000,257.900000,257.900000,418053,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-30,257.700000,265.488000,257.660000,260.980000,260.980000,436549,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2021-12-31,259.830000,268.100000,259.830000,264.840000,264.840000,376165,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-03,265.780000,265.780000,251.040000,257.960000,257.960000,536127,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-04,254.540000,254.870000,225.000000,229.330000,229.330000,708287,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-05,227.730000,230.000000,214.520000,216.030000,216.030000,619701,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-06,210.000000,223.000000,208.430000,216.800000,216.800000,663446,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-07,214.890000,217.980000,204.100000,206.790000,206.790000,600207,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-10,203.230000,211.060000,199.590000,210.530000,210.530000,680061,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-11,213.880000,215.000000,205.740000,210.590000,210.590000,671950,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-12,212.170000,215.020000,209.805900,210.950000,210.950000,639485,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-13,211.790000,211.790000,190.110000,191.560000,191.560000,873412,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-14,190.350000,194.580000,183.850000,193.260000,193.260000,837889,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-18,188.980000,193.240000,183.410000,186.610000,186.610000,495373,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-19,189.540000,193.820000,187.952800,189.580000,189.580000,634836,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-20,191.370000,196.010000,188.310000,188.460000,188.460000,441620,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-21,187.650000,190.000000,183.180000,183.810000,183.810000,293930,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-24,179.980000,190.390000,172.180000,189.790000,189.790000,690422,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-25,185.680000,189.040000,180.350000,185.400000,185.400000,526436,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-26,188.000000,190.450300,180.505000,181.560000,181.560000,377500,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-27,185.060000,187.430000,176.700000,177.070000,177.070000,328656,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-28,178.360000,190.000000,176.850000,189.990000,189.990000,355256,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-01-31,191.790000,198.590000,189.200000,198.340000,198.340000,394063,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-01,200.550000,203.390000,197.010000,202.890000,202.890000,343845,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-02,204.320000,206.050000,201.275000,204.130000,204.130000,213121,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-03,198.190000,202.249400,194.590100,198.360000,198.360000,252954,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-04,198.000000,203.890000,196.860000,200.950000,200.950000,180548,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-07,200.430000,208.200000,198.330000,201.390000,201.390000,277218,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-08,198.010000,199.340000,188.440000,191.830000,191.830000,549348,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-09,196.220000,200.140000,195.730000,197.160000,197.160000,474806,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-10,189.280000,199.610000,189.280000,193.790000,193.790000,282682,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-11,193.520000,197.080000,186.660000,188.970000,188.970000,334204,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-14,187.880000,191.480000,184.005000,185.500000,185.500000,460114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-15,191.340000,193.600000,184.705000,187.050000,187.050000,359963,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-16,184.150000,184.750000,179.110000,184.030000,184.030000,788456,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-17,189.620000,189.620000,173.390000,182.420000,182.420000,742458,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-18,183.000000,184.480000,176.170000,180.680000,180.680000,428220,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-22,178.460000,183.130000,177.170000,181.460000,181.460000,568195,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-23,183.980000,186.530000,174.640000,174.810000,174.810000,380753,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-24,169.390000,189.555000,169.390000,189.210000,189.210000,501135,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-25,189.730000,192.600000,185.140000,192.100000,192.100000,331250,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-02-28,190.930000,198.750000,188.080000,196.700000,196.700000,538648,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-01,197.030000,203.730000,192.010000,194.060000,194.060000,477349,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-02,194.060000,196.990000,190.730000,195.010000,195.010000,246940,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-03,195.800000,195.800000,186.180000,188.810000,188.810000,378128,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-04,188.810000,188.810000,177.295000,178.800000,178.800000,349544,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-07,179.250000,179.680000,163.230000,163.660000,163.660000,559298,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-08,161.660000,165.700000,156.275000,161.190000,161.190000,618770,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-09,165.250000,174.980000,164.900000,173.690000,173.690000,346849,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-10,169.220000,172.700000,167.600000,172.000000,172.000000,309822,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-11,175.260000,175.260000,166.420000,167.020000,167.020000,271274,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-14,167.810000,173.040000,163.010000,165.300000,165.300000,348039,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-15,167.490000,170.525000,163.140000,169.820000,169.820000,300319,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-16,173.560000,180.205000,172.640000,178.650000,178.650000,270280,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-17,177.970000,182.535000,176.770000,180.890000,180.890000,286710,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-18,178.660000,193.000000,178.660000,191.430000,191.430000,593544,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-21,189.250000,192.745000,186.001800,188.070000,188.070000,263594,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-22,187.140000,190.060000,183.140000,183.890000,183.890000,583540,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-23,183.020000,183.020000,175.115000,176.790000,176.790000,399057,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-24,176.530000,179.830000,171.945800,179.660000,179.660000,223205,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-25,181.080000,182.210000,173.010000,180.550000,180.550000,337786,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-28,181.130000,183.970000,174.190000,179.570000,179.570000,408299,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-29,183.350000,187.040000,180.910000,184.320000,184.320000,631384,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-30,183.130000,189.030000,181.740000,188.560000,188.560000,358430,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-03-31,188.840000,192.550000,185.040000,188.090000,188.090000,456882,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-01,186.680000,190.590000,182.030000,188.020000,188.020000,288399,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-04,188.800000,190.170000,184.030000,186.910000,186.910000,392987,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-05,186.280000,187.470000,178.375000,182.060000,182.060000,531579,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-06,179.680000,179.860000,174.060000,177.960000,177.960000,378846,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-07,177.180000,183.945000,177.110000,180.860000,180.860000,834759,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-08,178.610000,178.950000,169.630000,169.980000,169.980000,402981,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-11,167.190000,167.490000,162.640000,163.150000,163.150000,606342,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-12,166.120000,166.760000,155.520000,156.790000,156.790000,693663,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-13,157.180000,161.390000,157.180000,160.160000,160.160000,383225,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-14,160.960000,160.960000,154.730000,157.670000,157.670000,462518,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-18,157.920000,158.930000,149.720000,152.450000,152.450000,437507,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-19,152.320000,156.020000,149.070000,154.080000,154.080000,695017,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-20,155.070000,159.000000,150.130000,156.190000,156.190000,716121,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-21,159.020000,161.420000,152.985000,153.470000,153.470000,626632,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-22,151.710000,153.050000,145.450000,145.600000,145.600000,788104,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-25,144.060000,149.000000,142.460000,148.640000,148.640000,601116,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-26,146.920000,147.720000,138.405000,142.560000,142.560000,900568,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-27,147.360000,171.980000,145.560000,157.510000,157.510000,2034032,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-28,157.070000,159.250000,148.325000,153.640000,153.640000,932256,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-04-29,154.150000,161.384000,154.040000,157.240000,157.240000,974147,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-02,154.120000,161.080000,152.010000,158.820000,158.820000,558699,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-03,159.050000,164.185000,158.960000,161.490000,161.490000,778937,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-04,161.720000,168.060000,157.150000,167.740000,167.740000,584235,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-05,164.690000,165.252900,155.010000,158.510000,158.510000,611266,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-06,155.420000,157.940000,149.830000,156.970000,156.970000,665053,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-09,153.050000,153.050000,142.935000,145.500000,145.500000,633420,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-10,149.400000,151.600000,142.515000,147.690000,147.690000,616309,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-11,145.740000,150.320000,141.610000,141.930000,141.930000,387907,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-12,139.890000,146.450000,137.210000,144.070000,144.070000,456279,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-13,146.330000,152.005000,146.320000,150.400000,150.400000,423920,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-16,148.990000,153.360000,147.216700,149.960000,149.960000,331559,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-17,153.480000,155.140000,151.430000,154.680000,154.680000,282511,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-18,151.660000,155.480000,149.765000,150.550000,150.550000,297774,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-19,149.450000,156.485000,148.960000,154.630000,154.630000,346279,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-20,157.250000,158.000000,150.090000,154.530000,154.530000,247865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-23,155.510000,155.510000,150.190000,153.390000,153.390000,231099,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-24,151.870000,152.034900,148.530000,151.430000,151.430000,255167,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-25,151.190000,154.370000,148.610000,154.180000,154.180000,491966,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-26,155.360000,160.000000,154.000000,159.170000,159.170000,428145,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-27,159.470000,170.791700,159.430000,170.040000,170.040000,518100,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-05-31,168.580000,168.835000,162.750000,164.470000,164.470000,520727,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-01,165.220000,167.590000,161.360000,166.700000,166.700000,593936,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-02,166.230000,174.690000,164.485000,172.360000,172.360000,465989,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-03,169.330000,170.290000,164.550000,165.190000,165.190000,366872,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-06,167.330000,168.710000,164.010000,165.400000,165.400000,224089,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-07,163.330000,169.820000,163.260000,169.500000,169.500000,265412,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-08,168.750000,170.760000,166.660000,167.090000,167.090000,190284,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-09,164.810000,164.810000,158.750000,159.350000,159.350000,589775,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-10,156.430000,156.670000,146.270000,149.160000,149.160000,570419,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-13,143.140000,145.000000,138.930000,140.680000,140.680000,468154,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-14,140.440000,144.360000,137.645000,144.130000,144.130000,1341406,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-15,145.790000,150.000000,145.000000,148.010000,148.010000,540401,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-16,142.240000,143.620000,139.649200,141.020000,141.020000,446460,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-17,142.480000,145.550000,140.960000,142.750000,142.750000,698052,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-21,144.770000,147.940000,144.240000,145.850000,145.850000,435613,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-22,143.230000,149.480000,143.230000,148.710000,148.710000,422545,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-23,149.710000,162.090000,149.310000,160.330000,160.330000,437628,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-24,162.520000,166.410000,160.710000,165.880000,165.880000,776999,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-27,166.340000,168.275000,163.220000,164.870000,164.870000,415837,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-28,164.570000,166.240000,163.440000,165.430000,165.430000,454252,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-29,164.380000,167.490000,161.480000,165.850000,165.850000,335791,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-06-30,162.920000,163.990000,157.700000,162.400000,162.400000,364455,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-01,162.190000,166.810000,161.920000,166.520000,166.520000,181586,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-05,164.970000,167.810000,163.295000,167.680000,167.680000,338293,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-06,169.030000,170.860000,168.070000,168.450000,168.450000,307405,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-07,167.420000,176.000000,167.420000,175.800000,175.800000,479327,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-08,173.710000,177.700000,172.320000,175.500000,175.500000,243670,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-11,174.760000,174.760000,170.500000,172.620000,172.620000,188590,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-12,171.690000,173.060000,160.690000,161.940000,161.940000,311330,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-13,157.900000,166.580000,157.330000,165.670000,165.670000,970936,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-14,164.410000,164.410000,159.750000,162.750000,162.750000,444250,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-15,165.030000,167.970000,161.330000,166.780000,166.780000,241338,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-18,168.120000,168.160000,159.960000,160.420000,160.420000,388677,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-19,163.480000,168.185000,160.640000,168.070000,168.070000,259971,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-20,172.610000,177.029000,169.740000,176.700000,176.700000,532458,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-21,184.000000,205.310000,184.000000,203.640000,203.640000,1890945,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-22,204.220000,205.225000,199.060000,201.740000,201.740000,675909,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-25,199.850000,204.400000,194.380000,197.070000,197.070000,547824,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-26,196.370000,203.250000,196.110000,202.000000,202.000000,541715,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-27,202.180000,207.870000,201.890000,205.710000,205.710000,445003,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-28,208.030000,214.040000,205.280000,213.100000,213.100000,602601,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-07-29,212.810000,215.380000,211.920000,213.360000,213.360000,387862,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-01,212.990000,220.250000,211.320000,212.560000,212.560000,802328,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-02,212.660000,244.490000,212.370000,237.380000,237.380000,1850869,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-03,242.000000,244.229900,237.290000,240.400000,240.400000,1130387,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-04,240.630000,246.440000,239.590000,243.300000,243.300000,540467,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-05,238.280000,248.390000,236.275000,246.270000,246.270000,968273,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-08,246.410000,255.850000,245.900000,250.460000,250.460000,650180,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-09,246.870000,254.600000,243.630000,244.850000,244.850000,623935,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-10,249.900000,256.400000,248.280000,256.210000,256.210000,444265,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-11,257.550000,262.260000,244.400000,246.490000,246.490000,1489918,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-12,248.000000,251.640000,243.080000,251.350000,251.350000,457154,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-15,251.000000,258.220000,250.260000,255.730000,255.730000,454530,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-16,254.800000,254.800000,248.160000,252.390000,252.390000,413654,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-17,248.810000,251.830000,244.035000,248.500000,248.500000,393818,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-18,248.960000,249.740000,240.610000,241.210000,241.210000,331421,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-19,239.220000,241.820000,235.820000,237.750000,237.750000,290511,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-22,232.950000,236.050000,225.520000,225.730000,225.730000,493960,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-23,224.160000,225.000000,220.470000,224.010000,224.010000,398461,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-24,225.050000,230.535000,224.645000,229.860000,229.860000,370493,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-25,231.460000,238.185000,228.620000,237.650000,237.650000,392646,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-26,235.750000,237.025000,226.090000,227.150000,227.150000,249213,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-29,223.230000,226.170000,220.420000,220.940000,220.940000,305949,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-30,223.470000,223.470000,216.880000,219.710000,219.710000,276759,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-08-31,222.720000,223.410000,214.200000,219.370000,219.370000,283975,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-01,216.770000,226.720000,211.925000,213.780000,213.780000,555646,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-02,216.210000,216.210000,208.010000,210.340000,210.340000,333363,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-06,210.110000,214.300000,208.170000,212.770000,212.770000,240796,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-07,212.790000,224.040000,212.530000,222.370000,222.370000,451109,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-08,219.420000,227.240000,219.420000,227.180000,227.180000,295832,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-09,226.800000,234.300000,225.312500,233.570000,233.570000,305392,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-12,231.900000,233.490000,229.980000,232.460000,232.460000,315442,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-13,224.230000,225.010000,221.340000,222.780000,222.780000,267296,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-14,223.970000,231.340000,222.790000,227.030000,227.030000,422831,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-15,224.700000,235.060000,224.700000,232.220000,232.220000,419875,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-16,229.800000,229.950000,216.175000,221.320000,221.320000,690279,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-19,218.390000,226.250000,216.325000,225.200000,225.200000,531810,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-20,221.850000,224.010000,210.000000,214.870000,214.870000,515986,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-21,215.540000,218.440000,206.270000,206.490000,206.490000,436302,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-22,204.120000,204.120000,184.870000,189.940000,189.940000,861403,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-23,189.650000,189.920000,177.630000,181.240000,181.240000,796909,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-26,180.990000,183.380000,177.030000,179.330000,179.330000,441114,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-27,181.860000,182.320000,176.920000,180.960000,180.960000,507796,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-28,184.520000,190.195000,180.980000,188.770000,188.770000,469145,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-29,187.500000,191.310000,186.300000,191.060000,191.060000,469459,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-09-30,191.150000,193.905000,186.600000,187.110000,187.110000,447519,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-03,188.090000,199.160000,187.265000,197.870000,197.870000,389541,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-04,203.330000,213.830000,202.795000,213.550000,213.550000,753046,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-05,211.240000,221.950000,210.730000,220.560000,220.560000,621125,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-06,220.830000,225.620000,217.191400,218.400000,218.400000,446075,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-07,214.520000,214.520000,208.670000,209.890000,209.890000,384835,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-10,211.320000,213.450000,203.935000,207.900000,207.900000,394930,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-11,202.680000,206.730000,194.445000,199.130000,199.130000,648529,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-12,200.640000,202.460000,196.880000,199.620000,199.620000,506654,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-13,192.130000,200.470000,186.440000,198.460000,198.460000,733865,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-14,202.460000,202.735000,192.770000,193.540000,193.540000,568011,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-17,198.140000,208.250000,198.000000,204.650000,204.650000,486840,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-18,210.320000,212.370000,201.670000,206.840000,206.840000,784687,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-19,195.000000,197.240000,175.265000,179.500000,179.500000,1953994,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-20,177.730000,179.790000,165.220000,170.950000,170.950000,1417720,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-21,170.870000,172.000000,165.232500,167.030000,167.030000,771886,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-24,167.500000,169.090000,160.670000,167.940000,167.940000,558758,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-25,169.990000,178.500000,169.215000,177.120000,177.120000,505644,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-26,176.350000,188.415000,176.290000,182.200000,182.200000,537076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-27,182.060000,184.370000,174.065000,180.710000,180.710000,611663,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-28,180.710000,184.522500,178.340000,181.990000,181.990000,540214,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-10-31,178.980000,183.650000,174.300000,182.490000,182.490000,691023,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-01,168.000000,188.580000,166.810000,185.550000,185.550000,1446946,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-02,183.190000,183.880000,171.050000,171.520000,171.520000,977230,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-03,168.830000,175.320000,166.010000,173.460000,173.460000,489903,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-04,176.450000,178.720000,172.220000,174.360000,174.360000,453844,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-07,176.490000,176.490000,170.660000,172.050000,172.050000,316552,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-08,173.610000,179.960000,170.310000,174.750000,174.750000,423575,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-09,174.100000,178.640000,174.100000,174.710000,174.710000,359097,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-10,185.470000,190.160000,183.870000,189.160000,189.160000,649751,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-11,192.870000,207.730000,189.200000,199.290000,199.290000,1038703,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-14,197.940000,203.530000,196.055000,200.720000,200.720000,428084,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-15,206.120000,212.170000,205.545000,210.840000,210.840000,499163,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-16,210.210000,210.210000,187.345000,190.970000,190.970000,646970,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-17,187.000000,187.000000,172.410000,174.690000,174.690000,835961,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-18,175.170000,176.330000,169.177200,175.930000,175.930000,591315,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-21,175.300000,177.510000,172.000000,174.010000,174.010000,425634,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-22,172.570000,173.445000,169.100000,171.920000,171.920000,678750,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-23,172.100000,173.880000,169.520000,172.580000,172.580000,631215,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-25,170.240000,173.830000,168.810000,171.580000,171.580000,262027,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-28,169.670000,173.310000,169.405000,171.640000,171.640000,806581,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-29,171.750000,173.770000,167.000000,167.490000,167.490000,676259,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-11-30,168.260000,181.570000,167.800000,178.840000,178.840000,3135908,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-01,179.580000,189.745000,178.520000,188.170000,188.170000,712890,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-02,184.170000,189.580000,180.110000,186.050000,186.050000,389505,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-05,183.710000,186.690000,176.400000,178.610000,178.610000,646176,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-06,177.710000,178.400000,165.810000,169.130000,169.130000,588785,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-07,165.230000,174.060000,165.230000,170.330000,170.330000,444325,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-08,169.790000,175.905000,167.810000,173.870000,173.870000,348630,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-09,173.150000,173.420000,162.970000,163.320000,163.320000,495891,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-12,163.410000,170.150000,163.410000,166.880000,166.880000,629082,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-13,175.920000,179.900000,173.260000,177.990000,177.990000,539136,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-14,173.250000,180.220000,171.320000,177.420000,177.420000,417426,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-15,174.800000,174.850000,164.540000,168.250000,168.250000,433231,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-16,165.870000,166.720000,160.900000,164.840000,164.840000,562836,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-19,164.500000,164.650000,158.600000,162.420000,162.420000,320076,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-20,160.210000,164.255000,158.580000,163.980000,163.980000,361616,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-21,165.950000,171.500000,164.380000,169.250000,169.250000,447057,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-22,167.700000,172.820000,167.580000,172.260000,172.260000,493017,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-23,171.690000,172.100000,165.780000,167.540000,167.540000,259886,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-27,165.640000,167.590000,162.010000,166.560000,166.560000,254616,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-28,165.920000,169.640000,162.330000,163.820000,163.820000,390278,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-29,166.430000,173.042000,164.370000,170.900000,170.900000,304765,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
2022-12-30,167.920000,170.100000,165.721100,169.310000,169.310000,269174,0.000000,1.000000,RGEN,Common Stock,Repligen Corporation,"Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.",730272,NASDAQ,USD,USA,LIFE SCIENCES,"BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)","41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES",https://www.repligen.com,December,2025-03-31,7161660000,113392000,None,2.59,35.34,None,None,-0.42,11.61,-0.0353,0.0559,0.0092,-0.0116,650429000,332694000,-0.42,0.693,0.104,181.41,4,10,5,0,0,-,76.92,11.01,3.607,10.99,82.53,1.112,182.52,102.97,128.08,141.28,56183000,52572000,6.406,105.183,None,None
